SCM12 Final Program - National Kidney Foundation

SCM12
NATIONAL KIDNEY FOUNDATION
2012 Spring Clinical Meetings
Gaylord National • Washington, D.C. • May 9–13, 2012
PROGRAM

In the TARGET study, initiating Sensipar® at iPTH > 300 pg/mL and Ca ≥ 8.4 mg/dL and reducing
vitamin D to 2 µg † two weeks later improved achievement of PTH, calcium, and phosphorus goals. 1‡
† 2.0 μg paricalcitol or their equivalents. Paricalcitol equivalents defi ned as paricalcitol 2.0 μg = doxercalciferol 1.0 μg = calcitriol 0.5 μg. 1
‡ Goal results based on the TARGET study. 1
Sensipar® simultaneously lowers2 TARGET results from a multicenter, single-arm, open-label study in patients on dialysis with moderate to severe secondary HPT (N = 444). 1
TARGET = Treatment strategies to Achieve Recommended KDOQI Goals in ESRD patients on cinacalceT.
Indication
Sensipar® is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis.
Sensipar® can be used alone or in combination with vitamin D sterols and/or phosphate binders.
Important Safety Information
• Sensipar® treatment should not be initiated if serum calcium is less than the lower limit of the normal range (8.4 mg/dL).
• Sensipar® lowers serum calcium; therefore, it is important that patients are carefully monitored for the occurrence of hypocalcemia.
• Signifi cant reductions in calcium may lower the threshold for seizures. Secondary hyperparathyroidism (HPT) patients, particularly those
with a history of seizure disorder, should be carefully monitored for the occurrence of low serum calcium or symptoms of hypocalcemia.
• In Sensipar® postmarketing use, isolated, idiosyncratic cases of hypotension, worsening heart failure, and/or arrhythmia were reported in
patients with impaired cardiac function. The causal relationship to Sensipar® therapy could not be completely excluded and may be
mediated by reductions in serum calcium levels.
• Adynamic bone disease may develop if intact parathyroid hormone (iPTH) levels are suppressed below 100 pg/mL.
• Patients with moderate to severe hepatic impairment should be monitored throughout treatment with Sensipar®, as cinacalcet exposure
assessed by area under the curve (AUC) was higher than in patients with normal hepatic function.
• Serum calcium and serum phosphorus should be measured within 1 week and PTH should be measured 1 to 4
weeks after initiation or dose adjustment of Sensipar®. Once the maintenance dose has been established, serum
calcium and serum phosphorus should be measured approximately monthly, and PTH every 1 to 3 months.
• The most commonly reported side eff ects were nausea, vomiting, and diarrhea.
Please see brief summary of prescribing information on next page.
KDOQI is a trademark of the National Kidney Foundation, Inc.
References: 1. Block GA, Zeig S, Sugihara J, et al; for the TARGET Investigators. Combined therapy with cinacalcet and
low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial
Transplant. 2008;23:2311-2318. 2. Sensipar® (cinacalcet) prescribing information, Amgen.
For patients with secondary HPT on dialysis,
GET YOUR
REGIMEN
IN GEAR
*Sensipar® plus low-dose vitamin D and
phosphate binders, if prescribed.
*

Brief Summary
See package insert for full prescribing information
SENSIPAR ® (cinacalcet) Tablets
INDICATIONS AND USAGE
Sensipar ® is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with
chronic kidney disease (CKD) on dialysis.
CONTRAINDICATIONS
Hypocalcemia: Sensipar ® treatment should not be initiated if serum calcium is less than the lower
limit of the normal range.
WARNINGS AND PRECAUTIONS
Hypocalcemia
Sensipar ® lowers serum calcium and, therefore, patients should be carefully monitored for the
occurrence of hypocalcemia. Potential manifestations of hypocalcemia include paresthesias,
myalgias, muscle cramping, tetany, and convulsions.
Serum calcium should be measured within 1 week after initiation or dose adjustment of
Sensipar ® . Once the maintenance dose has been established, serum calcium should be measured
approximately monthly [see Dosage and Administration].
If serum calcium falls below 8.4 mg/dL but remains above 7.5 mg/dL, or if symptoms of
hypocalcemia occur, calcium-containing phosphate binders and/or vitamin D sterols can be used
to raise serum calcium. If serum calcium falls below 7.5 mg/dL, or if symptoms of hypocalcemia
persist and the dose of vitamin D cannot be increased, withhold administration of Sensipar ® until
serum calcium levels reach 8.0 mg/dL and/or symptoms of hypocalcemia have resolved. Treatment
should be reinitiated using the next lowest dose of Sensipar ® [see Dosage and Administration].
In 26-week studies of patients with CKD on dialysis, 66% of patients receiving Sensipar ® compared
with 25% of patients receiving placebo developed at least one serum calcium value < 8.4 mg/dL.
Less than 1% of patients in each group permanently discontinued study drug due to hypocalcemia.
Sensipar ® is not indicated for patients with CKD not on dialysis. In patients with secondary
HPT and CKD not on dialysis, the long-term safety and efficacy of Sensipar ® have not been
established. Clinical studies indicate that Sensipar ® -treated patients with CKD not on dialysis have
an increased risk for hypocalcemia compared with Sensipar ® -treated patients with CKD on dialysis,
which may be due to lower baseline calcium levels. In a phase 3 study of 32 weeks duration and
including 404 patients with CKD not on dialysis (302 cinacalcet, 102 placebo), in which the median
dose for cinacalcet was 60 mg per day at the completion of the study, 80% of Sensipar ® treated
patients experienced at least one serum calcium value < 8.4 mg/dL compared with 5% of patients
receiving placebo.
Seizures
In clinical studies, seizures (primarily generalized or tonic-clonic) were observed in 1.4% (43/3049)
of Sensipar ® -treated patients and 0.7% (5/687) of placebo-treated patients. While the basis for the
reported difference in seizure rate is not clear, the threshold for seizures is lowered by significant
reductions in serum calcium levels. Therefore, serum calcium levels should be closely monitored in
patients receiving Sensipar ® , particularly in patients with a history of a seizure disorder.
Hypotension and/or Worsening Heart Failure
In postmarketing safety surveillance, isolated, idiosyncratic cases of hypotension, worsening heart
failure, and/or arrhythmia have been reported in patients with impaired cardiac function, in which a
causal relationship to Sensipar ® could not be completely excluded and which may be mediated by
reductions in serum calcium levels [see Adverse Reactions].
Adynamic Bone Disease
Adynamic bone disease may develop if iPTH levels are suppressed below 100 pg/mL. One clinical
study evaluated bone histomorphometry in patients treated with Sensipar ® for 1 year. Three patients
with mild hyperparathyroid bone disease at the beginning of the study developed adynamic bone
disease during treatment with Sensipar ® . Two of these patients had iPTH levels below 100 pg/mL at
multiple time points during the study. In three 6-month, phase 3 studies conducted in patients with CKD
on dialysis, 11% of patients treated with Sensipar ® had mean iPTH values below 100 pg/mL during
the efficacy-assessment phase. If iPTH levels decrease below 150 pg/mL in patients treated with
Sensipar ® , the dose of Sensipar ® and/or vitamin D sterols should be reduced or therapy discontinued.
Hepatic Impairment
Cinacalcet exposure, as defined by the Area Under the Curve (AUC 0-inf), is increased by 2.4 and
4.2 fold in patients with moderate and severe hepatic impairment, respectively. These patients
should be monitored throughout treatment with Sensipar ® [see Use in Specific Populations
and Clinical Pharmacology].
Laboratory Tests: Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
on Dialysis
Serum calcium and serum phosphorus should be measured within 1 week and iPTH should be
measured 1 to 4 weeks after initiation or dose adjustment of Sensipar ® . Once the maintenance dose
has been established, serum calcium and serum phosphorus should be measured approximately
monthly, and iPTH every 1 to 3 months [see Dosage and Administration]. Measurements of PTH
during the Sensipar ® studies were obtained using the Nichols iPTH immunoradiometric assay (IRMA).
In patients with end-stage renal disease, testosterone levels are often below the normal range.
In a placebo-controlled study in patients with CKD on dialysis, there were reductions in total and
free testosterone in male patients following 6 months of treatment with Sensipar ® . Levels of total
testosterone decreased by a median of 15.8% in the Sensipar ® -treated patients and by 0.6% in
the placebo-treated patients. Levels of free testosterone decreased by a median of 31.3% in the
Sensipar ® -treated patients and by 16.3% in the placebo-treated patients. The clinical significance
of these reductions in serum testosterone is unknown.
ADVERSE REACTIONS
Because clinical trials are conducted under widely varying conditions, adverse reaction rates
observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of
another drug and may not reflect the rates observed in clinical practice.
Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease on Dialysis
In three double-blind placebo-controlled clinical trials, 1126 CKD patients on dialysis received study
drug (656 Sensipar ® , 470 placebo) for up to 6 months. The most frequently reported adverse events
(incidence of at least 5% in the Sensipar ® group and greater than placebo) are provided in Table 1.
The most frequently reported events in the Sensipar ® group were nausea, vomiting, and diarrhea.
Seizures were observed in 1.4% (13/910) of cinacalcet-treated patients and 0.7% (5/641) of
placebo-treated patients across all completed placebo controlled trials.
Table 1. Adverse Event Incidence (≥ 5%) in Patients On Dialysis
Placebo Sensipar ®
n=470 n=656
Event*: (%) (%)
Nausea 19 31
Vomiting 15 27
Diarrhea 20 21
Myalgia 14 15
Dizziness 8 10
Placebo Sensipar ®
n=470 n=656
Event*: (%) (%)
Hypertension 5 7
Asthenia 4 7
Anorexia 4 6
Pain Chest, Non-Cardiac 4 6
Access Infection 4 5
* Included are events that were reported at a greater incidence in the Sensipar ® group than in the
placebo group.
The incidence of serious adverse reactions was similar in the Sensipar ® and placebo groups
(29% vs. 31%, respectively).
12-Month Experience with Sensipar ® : Two hundred and sixty-six patients from two of the phase
3 studies continued to receive Sensipar ® or placebo treatment in a 6-month double-blind extension
study (12-month total treatment duration). The incidence and nature of adverse reactions in this
long-term extension study were comparable to those observed in the original phase 3 studies.
Postmarketing Experience with Sensipar ® : The following adverse reactions have been identified
during postapproval use of Sensipar ® . Because these reactions are reported voluntarily from a
population of uncertain size, it is not always possible to reliably estimate their frequency or establish
a causal relationship to drug exposure. Rash, hypersensitivity reactions (including angioedema and
urticaria), diarrhea and myalgia have been identified as adverse reactions during post-approval
use of Sensipar ® . Isolated, idiosyncratic cases of hypotension, worsening heart failure, and/or
arrhythmia have been reported in Sensipar ® -treated patients with impaired cardiac function in
postmarketing safety surveillance.
DRUG INTERACTIONS
Strong CYP3A4 Inhibitors: Cinacalcet is partially metabolized by CYP3A4. Dose adjustment of
Sensipar ® may be required if a patient initiates or discontinues therapy with a strong CYP3A4
inhibitor (e.g., ketoconazole, itraconazole). The iPTH and serum calcium concentrations should be
closely monitored in these patients [see Clinical Pharmacology].
CYP2D6 Substrates: Cinacalcet is a strong inhibitor of CYP2D6. Dose adjustments may
be required for concomitant medications that are predominantly metabolized by CYP2D6
(e.g., desipramine, metoprolol, and carvedilol) and particularly those with a narrow therapeutic index
(e.g., flecainide and most tricyclic antidepressants) [see Clinical Pharmacology].
USE IN SPECIFIC POPULATIONS
Pregnancy: Category C: In pregnant female rats given oral gavage doses of 2, 25, 50 mg/kg/day
cinacalcet during gestation, no teratogenicity was observed at doses up to 50 mg/kg/day (exposure
4 times those resulting with a human oral dose of 180 mg/day based on area under the curve
[AUC] comparison). Decreased fetal body weights were observed at all doses (less than 1 to 4
times a human oral dose of 180 mg/day based on AUC comparison) in conjunction with maternal
toxicity (decreased food consumption and body weight gain). In pregnant female rabbits given oral
gavage doses of 2, 12, 25 mg/kg/day cinacalcet during gestation, no adverse fetal effects were
observed (exposures less than with a human oral dose of 180 mg/day based on AUC comparisons).
Reductions in maternal food consumption and body weight gain were seen at doses of 12 and
25 mg/kg/day. Sensipar ® has been shown to cross the placental barrier in rabbits. In pregnant rats
given oral gavage doses of 5, 15, 25 mg/kg/day cinacalcet during gestation through lactation, no
adverse fetal or pup (post-weaning) effects were observed at 5 mg/kg/day (exposures less than with
a human therapeutic dose of 180 mg/day based on AUC comparisons). Higher doses of 15 and
25 mg/kg/day cinacalcet (exposures 2 to 3 times a human oral dose of 180 mg/day based on AUC
comparisons) were accompanied by maternal signs of hypocalcemia (periparturient mortality and
early postnatal pup loss), and reductions in postnatal maternal and pup body-weight gain. There
are no adequate and well-controlled studies of Sensipar ® in pregnant women. Sensipar ® should be
used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Women who become pregnant during Sensipar ® treatment are encouraged to enroll in Amgen’s
Pregnancy Surveillance Program. Patients or their physicians should call 1-800-772-6436 (1-800-
77-AMGEN) to enroll.
Nursing Mothers: Studies in rats have shown that Sensipar ® is excreted in the milk with a high
milk-to-plasma ratio. It is not known whether this drug is excreted in human milk. Considering
these data in rats, and because many drugs are excreted in human milk and there is a potential for
clinically significant adverse reactions in infants who ingest Sensipar ® , a decision should be made
whether to discontinue nursing or to discontinue the drug, taking into account the importance of
the drug to the lactating woman.
Pediatric Use: The safety and efficacy of Sensipar ® in pediatric patients have not been established.
Geriatric Use: Of the 1136 patients enrolled in the Sensipar ® phase 3 clinical program in patients
with CKD on dialysis, 26% were ≥65 years old, and 9% were ≥75 years old. No differences in the
safety and efficacy of Sensipar ® were observed in patients greater or less than 65 years of age. No
dosage adjustment is required for geriatric patients [see Clinical Pharmacology].
Renal Impairment: No dosage adjustment is necessary for renal impairment [see Clinical
Pharmacology].
Hepatic Impairment: Patients with moderate and severe hepatic impairment should have serum
calcium, serum phosphorus, and iPTH levels monitored closely throughout treatment with Sensipar ®
because cinacalcet exposure (AUC 0-inf) is increased by 2.4 and 4.2 fold, respectively, in these
patients [see Warnings and Precautions and Clinical Pharmacology].
OVERDOSAGE
Doses titrated up to 300 mg once daily have been safely administered to patients on dialysis.
Overdosage of Sensipar ® may lead to hypocalcemia. In the event of overdosage, patients should
be monitored for signs and symptoms of hypocalcemia and appropriate measures taken to correct
serum calcium levels [see Warnings and Precautions]. Since Sensipar ® is highly protein bound,
hemodialysis is not an effective treatment for overdosage of Sensipar ® .
Storage: Store at 25ºC (77ºF); excursions permitted to 15-30ºC (59-86ºF). [See USP controlled
room temperature]. Rx Only: This product, or its use, may be covered by one or more US Patents
including US Patent Nos. 6,313,146; 6,211,244; 6,031,003; 6,011,068, and 7,829,595, in addition to
others, including patents pending.
DOSAGE AND ADMINISTRATION
Sensipar ® tablets should be taken whole and should not be divided. Sensipar ® should be taken with
food or shortly after a meal. Dosage must be individualized.
Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease on Dialysis
The recommended starting oral dose of Sensipar ® is 30 mg once daily. Serum calcium and serum
phosphorus should be measured within 1 week and intact parathyroid hormone (iPTH) should be
measured 1 to 4 weeks after initiation or dose adjustment of Sensipar ® . Sensipar ® should be titrated
no more frequently than every 2 to 4 weeks through sequential doses of 30, 60, 90, 120, and 180 mg
once daily to target iPTH levels of 150 to 300 pg/mL. Serum iPTH levels should be assessed no
earlier than 12 hours after dosing with Sensipar ® .
Sensipar ® can be used alone or in combination with vitamin D sterols and/or phosphate binders.
During dose titration, serum calcium levels should be monitored frequently and if levels decrease
below the normal range, appropriate steps should be taken to increase serum calcium levels, such
as by providing supplemental calcium, initiating or increasing the dose of calcium-based phosphate
binder, initiating or increasing the dose of vitamin D sterols, or temporarily withholding treatment
with Sensipar ® [see Warnings and Precautions].
Manufactured for: Amgen
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
©2004-2011 Amgen Inc. All rights reserved.
v9-Issue Date 08/2011
Amgen
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
©2011 Amgen Inc. All rights reserved.
61559-R1-V1
SENP1X0612_B_MBS_V9.r6.indd 1 9/6/11 6:30 PM

Comprehensive Management of Mineral and Bone
Disorders in Advanced Chronic Kidney Disease
A breakfast symposium during the National Kidney Foundation 2012 Spring Clinical Meetings
Thursday, May 10, 2012 | 6:00 A.M. - 7:45 A.M. | Gaylord National | Woodrow Wilson Ballroom | Washington DC
Program Purpose
Chronic kidney disease mineral bone disorder (CKD-MBD) can be manifested in one or more ways including
abnormalities of calcium, phosphorus, parathyroid hormone, vitamin D metabolism, abnormalities in bone turnover and
mineralization, and vascular and/or soft tissue calcification. Although clinical guidelines exist for optimal levels of
serum markers related to CKD-MBD, target parameters are not achieved in many hemodialysis patients. The process of
treating CKD-MBD requires a multifaceted approach to treat laboratory abnormalities, bone changes and calcifications
while avoiding adverse effects of therapy. Maintaining balance in serum calcium, phosphorus and PTH while treating
CKD-MBD requires frequent monitoring, patient education and a multidisciplinary renal health team. Members of the
renal health team, including nephrologists, nurses, dietitians, pharmacists, social workers, occupational therapists and
physiotherapists can work together in order to provide patients with the education and comprehensive team-based care
required to manage CKD-MBD. This symposium will provide members of this team with the latest advancements in
comprehensive management of CKD-MBD. The proposed educational program will provide 1) a presentation of what we
know, what we surmise, and what we do not know related to CKD-MBD and racial differences in prevalence and types
of this disease, 2) strategies for integrating the therapeutic options of phosphate binders, vitamin D, and cinacalcet, and
3) recommendations for a comprehensive treatment approach.
Program Objectives
At the completion of this activity, participants will be able to:
• Summarize important considerations in the strategy for
addressing phosphorous retention
• Understand the clinical application of cinacalcet alone and as
part of comprehensive management of CKD-MBD
• Evaluate the role of the various vitamin D therapies for
managing patients with CKD
• Refresh knowledge of KDOQI and KDIGO guidelines for mineral
and bone disease
• Understand the racial differences in the prevalence and types
of CKD-MBD
Target Audience: Nephrology professionals
How you will learn: This CME/CE activity will
be a live symposium consisting of lectures with
panel discussion and audience participation.
Accreditation: The National Kidney Foundation
is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
The National Kidney Foundation designates this live
activity for a maximum of 1.5 AMA PRA Category
1 Credit TM receive 1.5 continuing professional education units
(CPEUs) for completion of this program/material.
Declaration of Disclosure: It is the policy
of the National Kidney Foundation (NKF) to ensure
balance, independence, objectivity, and scientific
rigor in all CME/CE activities. Any individual who
has control over CME content is required to disclose
to to learners learners prior prior to to the the activity activity any any relevant relevant financial financial
relationship(s) they may have with commercial
interests interests supporting this this activity or or whose products products
or devices are discussed in this activity. If, on the
. Physicians should claim only the credit basis of information disclosed, a perceived conflict
commensurate with the extent of their participation exists, resolution will be achieved based on NKF’s
in the activity.
Disclosure and Conflict of Interest policy.
The National Kidney Foundation
Unlabeled/Investigational Use
(OH-337, 12/12/2012) is an approved provider of Declaration: During their their presentations, faculty
continuing nursing education by the Ohio Nurses may discuss an unlabeled use or an investigational
Association (OBN-001-91), an accredited approver use not approved for a commercial product.
by the American Nurses Credentialing Commission Each faculty member is required to disclose this
on Accreditation.
information to the audience when referring to an
This activity will provide 1.5 contact hours.
unlabeled or investigational use.
This program is pending approval with the American Disclaimer: The faculty, National Kidney
Academy of Nurse Practitioners.
Foundation, Amgen and The Med Ed Group, Inc.
The National Kidney Foundation is a Continuing
Professional Education (CPE) Accredited
Provider with the Commission
on Dietetic Registration (CDR).
Registered dietitians (RDs) and dietetic
technicians, registered (DTRs) will
do not recommend the use of any pharmaceutical,
diagnostic test, or device outside of the labeled
indications as approved by by the FDA. Please refer to
the official prescribing prescribing information for each product
for approved indications, contraindications, and
warnings.
Accredited by the National Kidney Foundation Supported by an educational donation from Amgen
Faculty and Agenda
6:00 A.M. Breakfast
6:30 A.M. Introduction
Hartmut H. Malluche, MD, FACP
Robert G. “Robin” Luke Chair in Nephrology
Professor and Chief
Division of Nephrology, Bone & Mineral Metabolism
Department of Medicine
University of Kentucky Chandler Medical Center
Lexington, KY
6:35 A.M. When, Why and How to Address Phosphate
Retention in Patients with CKD
Ravi Thadhani, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Boston, MA
6:55 A.M. When to Consider Cinacalcet in Patients with CKD
Csaba P. Kovesdy, MD, FASN
Chief of Nephrology
Salem VA Medical Center
Salem, VA
Clinical Associate Professor of Medicine
University of Virginia
Charlottesville, VA
7:15 A.M. Initiation and Limits of Vitamin D
in Patients with CKD
Kevin J. Martin, MB, BCh, FACP
Professor of Internal Medicine
Director, Division of Nephrology
Saint Louis University
St. Louis, MO
7:35 A.M. Question and Answer /Panel Session
7:45 A.M. Closing Remarks
Hartmut H. Malluche, MD, FACP
• Pre-registration for this symposium is not required. Seating is
limited and will be available on a first come, first serve basis.
• You must be registered for the NKF 2012 Spring Clinical
Meetings to attend this symposium and receive CME/CE credit

N K F 2 0 1 2 S P R I N G C L I N I C A L M E E T I N G S
BONE-INTESTINAL-VASCULAR-RENAL AXIS:
Modeling and Managing Calcium & Phosphorus Disturbances in Chronic Kidney Disease
THURSDAY, MAY 10, 2012
FACULTY
Sophie Jamal, MD, FRCPC
Associate Professor of Medicine
University of Toronto
Director of Research
Osteoporosis Program at Women’s College Hospital
Toronto, Ontario, Canada
12:00 pm – 2:00 pm
Room: Woodrow Wilson Ballroom
Gaylord National
National Harbor, MD
David M. Spiegel, MD, FACP
Professor of Medicine
University of Colorado Denver
Denver, Colorado
CME INFORMATION
How You Will Learn
This symposium is held in a panel discussion format, incorporating case-based presentations,
didactic lectures, and audience participation using the audience response system (ARS).
Activity Purpose
The purpose of this symposium is to educate nephrologists, advanced practitioners,
pharmacists, nurses, and dietitians about how to manage mineral and bone disturbances
(MBD) in chronic kidney disease (CKD).
Educational Objectives
• Describe the pathophysiology and calcium homeostasis of CKD-MBD compared with the
general population, and its relationship to vascular and soft-tissue calcification
• Apply calcium modeling to clinical situations to understand the emerging science of calcium
balance and to analyze current mineral management options in patients with CKD
• Discuss the use of available mineral approaches in the early management of patients with
CKD to establish a rational approach to calcium use in this population
Target Audience
This program is intended for nephrologists and other health care professionals who treat and
manage patients with CKD.
Accreditation Statement
Physicians • The National Kidney Foundation is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
Designation Statements
Physicians • The National Kidney Foundation designates this live activity for a
maximum of 1.5 AMA PRA Category 1 Credits TM . Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Nurses • The National Kidney Foundation (OH-337, 12/12/2012) is an approved provider of
continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited
approver by the American Nurses Credentialing Commission on Accreditation.
This activity will provide 1.5 contact hours.
Nurse Practitioners • This program is pending approval with the American Academy
of Nurse Practitioners.
Dietitians • The National Kidney Foundation is a Continuing Professional
Education (CPE) Accredited Provider with the Commission on Dietetic Registration
(CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will
receive 1.5 continuing professional education units (CPEUs) for completion of this
program/material.
PROGRAM AGENDA
12:00 pm – 12:20 pm Registration and Lunch
12:20 pm – 12:30 pm Welcome and Introduction
12:30 pm – 1:05 pm Calcium Use in the
Non-Nephrology Setting
1:05 pm – 1:40 pm A Reappraisal of Calcium Balance
in Chronic Kidney Disease
1:40 pm Questions and Answers
2:00 pm Adjourn
You must be registered for the NKF 2012 Spring Clinical Meetings
to attend this symposium and receive CME/CE credit.
Declaration of Disclosure
It is the policy of the National Kidney Foundation (NKF) to
ensure balance, independence, objectivity, and scientific rigor
in all CME/CE activities. Any individual who has control over
CME/CE content is required to disclose to learners prior to
the activity any relevant financial relationship(s) they may have
with commercial supporters of this activity or whose products
or devices are discussed in this activity. If, on the basis of
information disclosed, a perceived conflict exists, resolution
will be achieved based on NKF’s Disclosure and Conflict of
Interest policy.
Unlabeled/Investigational Use Declaration
During their presentations, faculty may discuss an unlabeled
use or an investigational use not approved for a commercial
product. Each faculty member is required to disclose this
information to the audience when referring to an unlabeled or
investigational use.
Disclaimer
The faculty, National Kidney Foundation, and Sanofi Renal do not
recommend the use of any pharmaceutical, diagnostic test, or device
outside of the labeled indications as approved by the FDA. Please refer
to the official prescribing information for each product for approved
indications, contraindications, and warnings. Information contained in
this National Kidney Foundation (NKF) educational resource is based
upon current data available at the time of presentation. Information
is intended to help clinicians become aware of new scientific findings
and developments. This NKF educational resource is not intended to
set out a preferred standard of care and should not be construed as
one. Neither should the information be interpreted as prescribing an
exclusive course of management.
Variations in practice will inevitably and appropriately occur when
clinicians take into account the needs of individual patients, available
resources, and limitations unique to an institution or type of practice.
Every health care professional making use of information in this NKF
educational resource is responsible for interpreting the data as it
pertains to clinical decision making in each individual patient.
Accredited by the National Kidney Foundation. Supported by an educational grant from Sanofi Renal.

Nobody likes
REJECTION!
Practical Guidance on Immunosuppression for 2012
Presented at the National Kidney Foundation 2012 Spring Clinical Meetings
Thursday, May 10 th • Dinner 7:30 p.m. • Symposium 8:00 p.m. – 9:30 p.m.
Gaylord National Hotel and Conference Center • Woodrow Wilson Ballroom
Faculty and Agenda:
From Clinical Practice to Clinical Guidelines: The Evolution in
Recommendations in Immunosuppressant Therapies
Ali J. Olyaei, PharmD
Professor of Medicine and Pharmacotherapy
Oregon State University/Oregon Health & Sciences
University
Portland, OR
Outcomes in Immunosuppression Therapies: A Case Study Model
Erika Meredith, PharmD
Clinical Specialist, Kidney Transplant
Emory University Hospital
Atlanta, GA
Team Approach to Managing Immunosuppression: The Central Role
of the Empowered Patient
Rebecca Hays, MSW, APSW
Living Donor Social Worker
University of Wisconsin Hospital and Clinics
Madison, WI
Target Audiences:
Nephrologists, nurse practitioners, nurses, pharmacists, social
workers
Accreditation and Designation Statements: The National Kidney
Foundation is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for
physicians.
The National Kidney Foundation designates this educational activity for
a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should
only claim credit commensurate with the extent of their participation in
the activity.
The National Kidney Foundation (OH-337, 12/12/2012) is an
approved provider of continuing nursing education by the Ohio Nurses
Association (OBN-001-91), an accredited approver by the American
Nurses Credentialing Commission on Accreditation.
This activity will provide 1.5 contact hours.
This program is pending approval with the American Academy of
Nurse Practitioners.
Accredited by the National Kidney Foundation
The National Kidney Foundation is a
Continuing Professional Education (CPE)
Accredited Provider with the Commission
on Dietetic Registration (CDR). Registered
dietitians (RDs) and dietetic technicians,
registered (DTRs) will receive 1.5 continuing
professional education units (CPEUs) for
completion of this program/material.
You must be registered for the NKF 2012 Spring Clinical Meetings to
attend this symposium and receive CME/CE credits.
Declaration of Disclosure: It is the policy of the National Kidney
Foundation (NKF) to ensure balance, independence, objectivity, and
scientific rigor in all CME/CE activities. Any individual who has control
over CME content is required to disclose to learners prior to the activity
any relevant financial relationship(s) they may have with commercial
interests supporting this activity or whose products or devices are
discussed in this activity. If, on the basis of information disclosed, a
perceived conflict exists, resolution will be achieved based on NKF’s
Disclosure and Conflict of Interest policy.
Purpose:
To provide nephrology team members with an overview of
immunosuppressant therapy, including current guidelines,
individualized patient outcomes, team coordination of care, and
patient adherence.
Educational Objectives:
1) Describe current KDIGO and NICE immunosuppressive
guidelines and how these guidelines can be incorporated into
clinical practice.
2) Explain the potential risks and benefits associated with
immunosuppressive regimens and apply this knowledge, illustrating
how therapies can be used in concert to maximize outcomes
3) Discuss how the landscape of immunosuppressive therapies has
changed, and how the evolution in therapeutic approaches is leading
to improved options and outcomes.
4) Describe team roles in managing immunosuppressive adherence,
including the central role of the patient as an empowered team
member.
How You Will Learn:
This CME/CE activity will be a live symposium consisting of lectures,
interactive audience response, and faculty debate.
Unlabeled/Investigational Use Declaration: During their
presentations, faculty may discuss an unlabeled use or an
investigational use not approved for a commercial product. Each
faculty member is required to disclose this information to the audience
when referring to an unlabeled or investigational use.
Disclaimer: The faculty, National Kidney Foundation, and
Bristol-Myers Squibb do not recommend the use of any
pharmaceutical, diagnostic test, or device outside of the labeled
indications as approved by the FDA. Please refer to the official
prescribing information for each product for approved indications,
contraindications, and warnings.
Information contained in this National Kidney Foundation (NKF)
educational resource is based upon current data available at the time
of presentation.
Supported by a medical education grant from
Bristol-Myers Squibb

Anemia in CKD Stage 5: Balancing Morbidity, Mortality, and Quality of Life
BONE-INTESTINAL-VASCULAR-RENAL N K F 2 0 1 2 S P R I N G C L IAXIS: N I C A L M E E T I N G S
Modeling and Managing Calcium & Phosphorus Disturbances in Chronic Kidney Disease
FRIDAY, MAY 11, 2012 Room: Woodrow Wilson Ballroom 12:00 pm – 2:00 pm
6:00 am – 7:45 am
Gaylord National
Gaylord National • National Harbor, National MD Harbor, MD
FACULTY
Anil K. Agarwal, MD, FACP, FASN, FNKF
Professor of Internal Medicine
Director, Interventional Nephrology
The Ohio State University
Columbus, Ohio
Jay B. Wish, MD
Professor of Medicine
Case Western Reserve University
Medical Director, Dialysis Program
University Hospitals
Case Medical Center
Cleveland, Ohio
Csaba P. Kovesdy, MD, FASN
Chief of Nephrology
Salem VA Medical Center
Associate Professor
University of Virginia
Charlottesville, Virginia
CME INFORMATION
How You Will Learn
This symposium is held in a panel discussion format, incorporating case-based
presentations, didactic lectures, and audience participation using the audience response
system (ARS).
Activity Purpose
The purpose of this symposium is to educate nephrologists, primary care physicians,
hospitalists, nurse practitioners, nurses, and other health care practitioners who are
involved in the treatment of patients with anemia of chronic kidney disease.
Educational Objectives
• Review hemoglobin variability and management approaches to minimize excursions
• Identify therapeutic interventions to optimize quality of life while minimizing
cardiovascular risk in patients with ESRD
• Describe emerging treatments for dialysis-associated anemia in patients with ESRD
Target Audience
This program is intended for nephrologists, primary care physicians, hospitalists, nurse
practitioners, nurses, and other health care practitioners who are involved in the treatment
of patients with anemia of chronic kidney disease.
Accreditation Statement
Physicians • The National Kidney Foundation is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
Physicians • The National Kidney Foundation designates this live activity for a maximum
of 1.5 AMA PRA Category 1 Credits TM . Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
Nurses • The National Kidney Foundation (OH-337, 12/12/2012) is an approved provider of
continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited
approver by the American Nurses Credentialing Commission on Accreditation.
This activity will provide 1.5 contact hours.
Nurse Practitioners • This program is pending approval with the American Academy of
Nurse Practitioners.
Dietitians • The National Kidney Foundation is a Continuing Professional
Education (CPE) Accredited Provider with the Commission on Dietetic
Registration (CDR). Registered dietitians (RDs) and dietetic technicians,
registered (DTRs) will receive 1.5 continuing professional education units
(CPEUs) for completion of this program/material.
N K F 2 0 1 2 S P R I N G C L I N I C A L M E E T I N G S
PROGRAM AGENDA
6:00 am – 6:10 am Registration and Breakfast
6:10 am – 6:15 am Welcome and Introduction
6:15 am – 6:40 am Evaluation and Management
of Hemoglobin Variability
6:40 am – 7:05 am Individualization of Therapy
for Anemia
7:05 am – 7:30 am Analyzing Emerging Treatment
Data for Patients with Anemia
of ESRD
7:30 am Questions and Answers
7:45 am Adjourn
You must be registered for the NKF 2012 Spring Clinical Meetings
to attend this symposium and receive CME/CE credit.
DISCLOSURE INFORMATION
Declaration of Disclosure
It is the policy of the National Kidney Foundation (NKF) to
ensure balance, independence, objectivity, and scientific rigor
in all CME/CE activities. Any individual who has control over
CME/CE content is required to disclose to learners prior to
the activity any relevant financial relationship(s) they may
have with commercial supporters of this activity or whose
products or devices are discussed in this activity. If, on the
basis of information disclosed, a perceived conflict exists,
resolution will be achieved based on NKF’s Disclosure and
Conflict of Interest policy.
Unlabeled/Investigational Use Declaration
During their presentations, faculty may discuss an unlabeled
use or an investigational use not approved for a commercial
product. Each faculty member is required to disclose this
information to the audience when referring to an unlabeled or
investigational use.
Disclaimer
The faculty, National Kidney Foundation, Affymax, Inc.
and Takeda Pharmaceuticals North America, Inc.do not
recommend the use of any pharmaceutical, diagnostic test,
or device outside of the labeled indications as approved by
the FDA. Please refer to the official prescribing information
for each product for approved indications, contraindications,
and warnings. Information contained in this National Kidney
Foundation (NKF) educational resource is based upon current
data available at the time of presentation. Information is
intended to help clinicians become aware of new scientific
findings and developments. This NKF educational resource
is not intended to set out a preferred standard of care and
should not be construed as one. Neither should the
information be interpreted as prescribing an exclusive
course of management.
Variations in practice will inevitably and appropriately occur
when clinicians take into account the needs of individual
patients, available resources, and limitations unique to an
institution or type of practice. Every health care professional
making use of information in this NKF educational resource is
responsible for interpreting the data as it pertains to clinical
decision making in each individual patient.
Accredited by the National Kidney Foundation. Supported by an educational grant from Affymax, Inc. and Takeda Pharmaceuticals North America, Inc.

Saturday, May
12 th
6:00 AM – 7:45 AM
Buffet Breakfast
Woodrow Wilson Ballroom
Gaylord National | Washington, DC
ACTIVITY PURPOSE
Despite increased knowledge on
hyponatremia in recent years, this
electrolyte disorder largely remains
underdiagnosed and is often poorly
managed. Studies show that mild
hyponatremia is associated with
serious health risks, including e� ects
on bone mass, subtle CNS impairment,
increased risk for falls and fractures,
and death.
Clinicians are challenged with
diagnosis of chronic mild
hyponatremia as it often does
not manifest with overt clinical
symptoms and, due to the
complexity of its etiology, requires a
di� erential diagnosis. Conventional
treatment strategies for chronic mild
hyponatremia are suboptimal;
however, vasopressin receptor
blockade o� ers an e� ective and
tolerable treatment option and
enhances the likelihood that chronic
mild hyponatremia will be correctable
in the near future.
This CME/CE activity will bridge
clinical practice gaps by increasing
recognition of the risks associated with
chronic mild hyponatremia, addressing
diagnostic challenges, and providing
evidence-based treatment options
for the management of mild to
moderate hyponatremia.
TARGET AUDIENCE
This activity is designed to meet the
educational needs of physicians,
fellows and residents, pharmacists,
physician assistants, nurse practitioners,
nephrology nurses and technicians,
nephrology social workers, and renal
and clinical dietitians.
REGISTRATION
You must be registered for the NKF 2012
Spring Clinical Meetings to attend this
symposium and receive CME/CE credit.
Pre-registration for this symposium is
not required; attendance will be based
on a � rst-come, � rst-served basis.
National Kidney Foundation 2012 Spring Clinical Meetings
Chronic Mild
hyponatremia
Is Not Benign:
IMPLICATIONS FOR CLINICAL PRACTICE
agenda
6:15 AM Opening Remarks
Audience Response System (ARS)
Pre-Questions
6:25 AM Adverse E� ects of Chronic Mild Hyponatremia
6:45 AM Q & A / ARS Post-Questions
6:55 AM Applicability of Vasopressin Antagonists in
Management of Chronic Mild Hyponatremia
7:15 AM Q & A / ARS Post-Questions
7:25 AM Case Studies: Diagnosis and E� ective
Management of Chronic Mild Hyponatremia
7:45 AM Closing Remarks
LEARNING DESIGN
This CME/CE activity is a live interactive symposium using an audience
response system; it includes lectures and case studies supported by slide
presentations and course handouts, and opportunity for questions from
participants.
Accreditation Statement
The National Kidney Foundation (NKF) is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
Designation Statement
The NKF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits TM . Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
The National Kidney Foundation (OH-337, 12/12/2012) is an approved provider of continuing nursing education by the Ohio Nurses
Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Commission on Accreditation.
This activity will provide 1.5 contact hours.
This program is pending approval with the American Academy of Nurse Practitioners.
The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the
Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and Dietetic Technicians, Registered (DTRs) will
receive 1.5 continuing professional education units (CPEUs) for completion of this program/material.
Declaration of Disclosure
It is the policy of the NKF to ensure balance, independence, objectivity, and scienti� c rigor in all CME/CE activities.
Any individual who has control over CME content is required to disclose to learners prior to the activity any relevant
� nancial relationship(s) they may have with commercial interests supporting this activity or whose products or devices
are discussed in this activity. If, on the basis of information disclosed, a perceived con� ict exists, resolution will be
achieved based on NKF’s Disclosure and Con� ict of Interest policy.
Unlabeled/Investigational Use Declaration
During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product.
Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.
Disclaimer
The faculty, National Kidney Foundation, and Otsuka America Pharmaceutical, Inc. do not recommend the use of any pharmaceutical,
diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the o� cial prescribing information
for each product for approved indications, contraindications, and warnings.
Information contained in this National Kidney Foundation (NKF) educational resource is based upon current data available at the
time of presentation. Information is intended to help clinicians become aware of new scienti� c � ndings and developments. This NKF
educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the
information be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available
resources, and limitations unique to an institution or type of practice. Every health care professional making use of information in this
NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.
Accredited by the National
Kidney Foundation
faculty
Joseph G. Verbalis, MD
Professor of Medicine and
Physiology
Chief, Division of Endocrinology
and Metabolism
Co-Director, Georgetown-
Howard Universities Center for
Clinical and Translational Science
Georgetown University
Medical Center
Washington, DC
Mitchell H. Rosner, MD, FACP
Associate Professor of Medicine
Chairman, Department of Medicine
University of Virginia
Health System
Charlottesville, Virginia
PROGRAM OBJECTIVES
Upon successful completion of this
activity, participants will be able to:
1. List the common causes of chronic
mild hyponatremia
2. Identify mechanisms by which
chronically low sodium levels
increase fracture risk and reduce
bone mass
3. Cite current research on the
association of chronic mild
hyponatremia with
fracture risk and bone loss
4. Di� erentiate between the
available vasopressin receptor
antagonists and their clinical
applications in the management
of patients with chronic
mild hyponatremia
5. Diagnose and e� ectively manage
chronic mild hyponatremia
Supported by an unrestricted medical educational
grant from Otsuka America Pharmaceutical, Inc.

What is critical to you?
www.covidien.com
COVIDIEN, COVIDIEN with logo and Covidien logo are U.S. and internationally registered trademarks of Covidien AG.
©2012 Covidien. 12MAN0017 04/12
Dialysis is Critical
Confi dence
is Essential
Speak with your Covidien Sales Representative at Booth 817.

Questcor
Proud sponsor of the
National Kidney Foundation
2012 Spring Clinical Meeting
Visit us at Booth 801
www.acthar.com
H.P. Acthar ® Gel and Questcor ® are registered trademarks of Questcor Pharmaceuticals, Inc.
©2012 Questcor Pharmaceuticals, Inc. PM-484-03 04/12 Printed in USA.

Available Spring 2012. Preproduction model shown. Actual production model may vary.
©2012 General Motors. All rights reserved. Cadillac ® XTS ®
THE ALL-NEW CADILLAC XTS
IS COMING, AND IT’S BRINGING THE
FUTURE FORWARD.
THE ALL-NEW CADILLAC XTS. From its highly intuitive CUE driver
interface—which leaps two generations ahead—to its exhilarating driving
experience, the stunningly modern yet meticulously crafted XTS is a
brilliant example of what the future will hold. Learn more at cadillac.com/xts

the more we can
do about ESRD.
The more we
think about it
talk about it
and feel
about it
02-12-00019-A.; DSG-00088. ©2012 Affymax, Inc. and Takeda Pharmaceutical Company Limited. All rights reserved. The Affymax mark
and Affymax design mark are trademarks of Affymax Inc. registered with the U.S. Patent and Trademark Offi ce. The Takeda mark and Takeda
design mark are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Offi ce.
COMMUNI•K — making
connections that matter
Affymax and Takeda are teaming up with the
renal community to target the relevant issues
in patient care for end-stage renal disease
(ESRD). We want to listen to you, learn about
your challenges, and leverage your wisdom
to work toward developing smart solutions.

American Journal
of Kidney Diseases
www.ajkd.org
Andrew S. Levey, MD, Editor-in-Chief
• The leader in clinical nephrology content,
publishing the latest findings in kidney
disease, hypertension, dialysis therapies,
and kidney transplantation, as well as
educational and special features such as
editorials, reviews, and teaching cases!
• Online at www.ajkd.org for the latest issue,
articles in press, online-only case reports and
supplements, full text archives of past issues,
and more!
• 2010 Impact Factor 5.242, 5th of 69
journals in the Urology Nephrology category
Official journal of the
AJKD
AMERICAN JOURNAL OF KIDNEY DISEASES
www.ajkd.org
eAJKD
the official AJKD blog!
www.eajkd.org
• Learn more about the research
and other behind-the-article
stories via author interviews
• Check out the latest
commentaries to stay up to date
on the buzz
• Test your knowledge with quizzes and puzzles
• Listen to author Q&As online or grab a podcast for the road
• Share your perspective and see what your colleagues are saying
Scan the code with your smart
phone to visit the Blog
Need a code reader for you phone?
www.getneoreader.com
AJKD on Facebook
www.facebook.com/ajkdonline
• Follow AJKD on
Facebook!
• Access freely available
AJKD articles
• Receive summaries of
highlighted journal
content

In conjunction with the National Kidney Foundation 2012 Spring Clinical Meetings
Understanding and Managing
Hyponatremia: A Specifi c
Approach to Treatment
Faculty Presenter
Jeff Giullian, MD
Nephrology, Transplant and Hypertension
South Denver Nephrology Associates
Denver, Colorado
Lunch will be provided. Seating is limited!
This promotional program is sponsored by:
Friday, May 11, 2012
12:15 – 12:50 PM
Gaylord National Hotel & Convention Center
Prince George’s Exhibition Hall
Washington, DC
Program Overview:
Join your colleagues at this program to discuss the diagnostic considerations and management
of hyponatremia, a common electrolyte disorder in the hospital setting. 1
1. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337:169-172.
© 2012 Otsuka America Pharmaceutical, Inc. March 2012 0712M-4160B

You already know
about the value of
certified PAs
in nephrology...
Over 90% of nephrologists say
working with certified PAs allows
them more time for critical
cases and improves work
flow throughout the day.
Certified Physician Assistants
in Nephrology
going beyond general certification
www.nccpa.net
...but do you know
about the Certificate of
Added Qualifications
(CAQ) they can earn
in nephrology?
“Preparing for and earning the
Nephrology CAQ was a great way
to make sure my knowledge is
current and affirmed that I can
fulfill other roles in the specialty
if needed.” – Donna Anderson, PA-C
See our poster in the exhibit hall:
Profile and Impact of Physician Assistants in Nephrology
Then contact us at SpecialtyCAQ@nccpa.net for your copy
and more information about the Nephrology CAQ.

Download the SCM12 App Today!
Mobile App available for iphone,
ipad, android, & blackberry
NKF 2012

WHAT’S INSIDE…
Welcome to SCM12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20
SCM12 Program Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
NKF Leadership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
NKF Distinguished Lecture and Award Recipients . . . . . . . . . . . . . . . . . 23
NKF Professional Council Awards . . . . . . . . . . . . . . . . . . . . . . . . . . 30
SCM12 Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Meeting Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Poster Presentation Information . . . . . . . . . . . . . . . . . . . . . . . . . . .37
Exhibit Hall Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Corporate Supporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39
Corporate Supported Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Disclosure Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
NKF CME Mission Statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46
Program Tracks
Physician and Pharmacist . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
Advanced Practitioner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Nephrology Nurse and Technician . . . . . . . . . . . . . . . . . . . . . . . .77
Renal and Clinical Dietitian . . . . . . . . . . . . . . . . . . . . . . . . . . . .86
Nephrology Social Worker . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
FNKF Inductees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Exhibit Hall Map and Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
SCM12 Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Exhibitor Showcase Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
Gaylord National Hotel Maps . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
VISIT OUR
Exhibitor Showcase
BOOTH #1135
NKF SCM12
19 19

20
DEAR COLLEAGUE
LINDA FRIED, MD,
MPH, FNKF
Program Co-Chair
CHARMAINE E. LOK,
MD, MSc, FNKF
Program Co-Chair
LYNDA A. SZCZECH,
MD, MSCE, FNKF
NKF President
On behalf of the National Kidney Foundation (NKF) and the 2012 Program
Committee, welcome to Washington, DC! SCM12 offers you a carefully designed
combination of pre-conference courses, workshops, debates, and a series of
thought-provoking symposia. The rich mix of educational experiences includes
discussions of contemporary dialysis care with emphasis on the effects of the
bundle and home dialysis therapies, clinical challenges and controversies in
transplantation, and multidisciplinary sessions in chronic kidney disease care.
Be sure to join us on Thursday afternoon for the NKF Presidential Address
followed by the Shaul G. Massry Distinguished Lecture, delivered this year by Ravi
Thadhani, MD. Other program highlights include a new pre-conference course
on renal pathology, and workshops and symposia on what’s new with KEEP ® and
KDOQI ® . There will be important updates for hypertension, diabetes, electrolyte
disorders, glomerular disease, acute kidney injury, anemia, bone-mineral
disorders, vascular access, peritoneal dialysis, and hemodialysis. In addition, we
have an outstanding set of corporate-supported breakfast, lunch, and dinner
symposia this year.
Plan to join us at the Opening Ceremonies and Faculty Reception on Thursday
evening, May 10th at 6:00pm for the official opening of the Exhibit Hall where
you will have an opportunity to network with colleagues, view the selection of
outstanding poster presentations, and learn about the newest products and
services in kidney care.
Before leaving on Sunday, please take a few moments to complete your Program
Evaluation. Your comments and suggestions are important to us and provide
a critical component of planning for upcoming NKF Spring Clinical Meetings.
Also, it’s not too early to mark your calendars for the NKF 2013 Spring Clinical
Meetings, April 2 – 6 at the Walt Disney World Swan and Dolphin, Orlando, FL.
We hope you find the next few days filled with activities that meet our objective
of translating science into practice. Have a great meeting!
Sincerely,
Linda Fried,
MD, MPH, FNKF
SCM12 Program Chair
Charmaine E. Lok,
MD, MSc, FNKF
SCM12 Program Co-Chair
NKF SCM12
Lynda A. Szczech,
MD, MSCE, FNKF
NKF President

SCM12 PROGRAM COMMITTEE
Linda Fried, MD, MPH, FNKF
Program Chair
VA Pittsburgh
Healthcare System
Pittsburgh, PA
Charmaine E. Lok, MD, MSc, FNKF
Program Co-Chair
Toronto General Hospital
University of Toronto
Toronto, ON, Canada
Marie Becker, MS, RD, LDN
Renal and Clinical Dietitian
Program Co-Chair
DaVita Central Orlando Dialysis
Orlando, FL
Laurie E. Benton, PhD, MPAS, BS,
PA-C, RN
Advanced Practitioner Program
Co-Chair
Scott & White Hospital
Temple, TX
Kerri Cavanaugh, MD, MHS, FNKF
Vanderbilt University Medical Center
Nashville, TN
Micah R. Chan, MD, MPH, FNKF
University of Wisconsin
School of Medicine and Public Health
Madison, WI
Fernando C. Fervenza, MD, MPH,
PhD, FNKF
Mayo Clinic
Rochester, MN
Bina George-Figueroa, MS, CCMEP
Director of Continuing Medical
Education
National Kidney Foundation
New York, NY
Debra Gromo, RN, CNN
Nephrology Nurse and Technician
Program Chair
Fresenius Medical Care –
North America
Santa Rosa, CA
Rebecca Hays, MSW, APSW, NSW-C
Nephrology Social Worker
Program Chair
University of Wisconsin
Hospital and Clinics
Madison, WI
Joachim Ix, MD
UC San Diego
VA San Diego Healthcare System
San Diego, CA
Aimee Jaremowicz, RD, LDN
Renal and Clinical Dietitian
Program Chair
Pentec Health, Inc.
Chicago Ridge, IL
Jessica Joseph, MBA
Director of Professional
Membership Programs
National Kidney Foundation
New York, NY
Holly Kramer, MD, MPH
Loyola University
Medical Center
Maywood, IL
Rajnish Mehrotra, MBBS, MD, FNKF
Harbor – UCLA Medical Center
Torrance, CA
Ann O’Hare, MD
University of Washington
Seattle, WA
Paul Palevsky, MD, FNKF
VA Pittsburgh Healthcare System
Pittsburgh, PA
Heidi M. Schaefer, MD, FNKF
Vanderbilt University Medical Center
Nashville, TN
Laura Schmidt, RN, BSN, CNN, MHR
Nephrology Nurse and Technician
Program Co-Chair
Renal Venture
Los Lunas, NM
Amma Sewaah-Bonsu, MSN, DNP, NP-C
Advanced Practitioner
Program Chair
Nephrology Associates of
Central Florida
Orlando, FL
John Sperati, MD, MHS, FNKF
Johns Hopkins University
School of Medicine
Baltimore, MD
NKF SCM12
Wendy St. Peter, PharmD, FCCP, FASN,
FNKF, BCPS
University of Minnesota
United States Renal Data System
Minneapolis, MN
Kristin Stockard, MSW, LICSW, NSW-C
Nephrology Social Worker
Program Co-Chair
Seattle’s Children’s Hospital and
Regional Medical Center
Seattle, WA
Marilyn D. Swartz, RN, MSN
Director of KLS Curriculum
National Kidney Foundation
New York, NY
Harold Szerlip, MD, FACP, FCCP, FASN,
FNKF
The University of Arizona
Tucson, AZ
Charuhas V. Thakar, MD, FASN, FNKF
Cincinnati VA Medical Center
University of Cincinnati
Cincinnati, OH
Bradley A. Warady, MD, FNKF
Children’s Mercy Hospital
Kansas City, MO
Adam Whaley-Connell, DO, MSPH,
FAHA, FNKF
University of Missouri –
Columbia School of Medicine
Columbia, MO
EX OFFICIO
Lynda A. Szczech, MD, MSCE, FNKF
NKF President
Duke University Medical Center
Durham, NC
Joseph Vassalotti, MD, FASN
Chief Medical Officer
National Kidney Foundation
New York, NY
21 21

22
THE LEADERSHIP of the NATIONAL KIDNEY FOUNDATION
Over its 60-year history, the NKF has grown to become the
preeminent voluntary healthcare organization dedicated to
improving outcomes for people on dialysis and those with
chronic kidney and urologic diseases.
The Foundation has made tremendous advances in its
mission through the visionary leadership of the National
Presidents and Chairmen.
The mission of the National Kidney Foundation is to prevent
kidney and urinary tract diseases, improve the health and
well-being of individuals and families affected by these
diseases and increase the availability of all organs for
transplantation.
PRESIDENT
Lynda A. Szczech, MD, MSCE, FASN, FNKF . . 2010–2012
PAST PRESIDENTS
Bryan Becker, MD . . . . . . . . . . . . . . .2008–2010
Allan J. Collins, MD, FACP . . . . . . . . . . 2006–2008
David Warnock, MD . . . . . . . . . . . . . 2004–2006
Brian J.G. Pereira, MD . . . . . . . . . . . . 2002–2004
William F. Keane, MD . . . . . . . . . . . . .2000–2002
Joel D. Kopple, MD . . . . . . . . . . . . . . 1998–2000
Garabed Eknoyan, MD . . . . . . . . . . . . 1996–1998
Alan R. Hull, MD . . . . . . . . . . . . . . . 1994–1996
Neil A. Kurtzman, MD . . . . . . . . . . . . 1992–1994
Shaul G. Massry, MD . . . . . . . . . . . . . 1990–1992
Saulo Klahr, MD . . . . . . . . . . . . . . . .1988–1990
Richard J. Glassock, MD . . . . . . . . . . . 1986–1988
Robert W. Schrier, MD . . . . . . . . . . . . 1984–1986
David A. Ogden, MD . . . . . . . . . . . . . 1982–1984
Richard M. Freeman, MD . . . . . . . . . . 1980–1982
Stuart A. Kleit, MD . . . . . . . . . . . . . . 1978–1980
Arvin Weinstein, MD . . . . . . . . . . . . . 1976–1978
James C. Hunt, MD . . . . . . . . . . . . . . 1973–1976
E. Lovell Becker, MD . . . . . . . . . . . . . 1970–1973
George E. Schreiner, MD . . . . . . . . . . . 1968–1970
George Lingua . . . . . . . . . . . . . . . . .1967–1968
William J. Jones, MD . . . . . . . . . . . . . 1966–1967
NKF SCM12
Wallace W. McCrory, MD . . . . . . . . . . .1964–1966
Daniel P. Richman, MD . . . . . . . . . . . . 1960–1964
William A . Wargo . . . . . . . . . . . . . . . 1959–1960
Henry Kessler, MD . . . . . . . . . . . . . . 1954–1959
Mrs. John E. Tedford . . . . . . . . . . . . . 1952–1954
Mrs. Ada U. DeBold (Founder) . . . . . . . .1950–1952
CHAIRMAN
Ed Walter . . . . . . . . . . . . . . . . . 2011–Present
PAST CHAIRMEN
William Cella . . . . . . . . . . . . . . . . . 2009–2011
Tom McDonough . . . . . . . . . . . . . . . 2007–2009
Charles B. Fruit . . . . . . . . . . . . . . . . 2005–2007
Fred L. Brown, MBA, FACHE . . . . . . . . . 2003–2005
Andrew Baur . . . . . . . . . . . . . . . . . 2001–2003
Frederick A. Herbert . . . . . . . . . . . . . 1999–2001
Joseph L. Brand . . . . . . . . . . . . . . . . 1997–1999
Wendy Brown, MD . . . . . . . . . . . . . . 1995–1997
A. Bruce Bowden . . . . . . . . . . . . . . . 1993–1995
Donald R. Wilson . . . . . . . . . . . . . . . 1991–1993
Charles E. Westcott . . . . . . . . . . . . . .1989–1991
William P. Hunter, Jr. . . . . . . . . . . . . . 1987–1989
The Honorable John N. Kirkendall . . . . . .1985–1987
John Hoag . . . . . . . . . . . . . . . . . . . 1983–1985
E. Burns McLindon . . . . . . . . . . . . . . 1981–1983
Oliver W. Porter . . . . . . . . . . . . . . . .1979–1981
Harold D. Schwartz . . . . . . . . . . . . . . 1977–1979
Jack C. Kent . . . . . . . . . . . . . . . . . . 1975–1977
Jordan E. Ringel . . . . . . . . . . . . . . . .1973–1975
The office of Chairman was created in 1973.

NKF DISTINGUISHED LECTURE and AWARD RECIPIENTS
THE SHAUL G. MASSRY DISTINGUISHED LECTURE
This lectureship was established to honor Dr. Shaul G.
Massry for his scientific achievements and his contributions
to the kidney healthcare community and the National Kidney
Foundation. The 2012 honored lecturer is Ravi Thadhani,
MD, MPH. Dr. Thadhani will be presenting “Translating
Biology and Observations into Human Trials: The New Era of
CKD-MBD” on Thursday, May 10.
Ravi Thadhani, MD, MPH, is an
Associate Professor of Medicine at
Harvard Medical School. He has two
major areas of interest: preeclampsia
and dialysis mortality. His focus is to
bring novel therapies and diagnostics
to patients with renal failure in hopes to improve outcomes.
He is currently working on therapeutic strategies to alleviate
the symptoms of preeclampsia and prolonged pregnancy,
and interventions including vitamin D and related analogs to
prevent cardiovascular disease and infection in patients
with chronic renal failure. Dr. Thadhani has served as a
reviewer for and has published in several journals including
the New England Journal of Medicine, the Lancet, Journal of
the American Society of Nephrology, and Kidney
International. He has published over 130 manuscripts. He
also reviews grants for several organizations such as the
National Institutes of Health. Dr. Thadhani was inducted into
the American Society of Clinical Investigators and the
American Epidemiology Society in 2008.
Past Shaul G. Massry Distinguished Lecture Recipients
2011 Glenn M. Chertow, MD, MPH
2010 Allan J. Collins, MD, FACP
2009 Mohamed Sayegh, MD
2008 Tom Greene, PhD
2007 Eberhard Ritz, MD
2006 Giuseppe Remuzzi, MD, FRCP
2005 Edmund J. Lewis, MD
2004 Hans-Henrik Parving, MD, DMSc
2003 Robert Alpern, MD
2002 Joseph V. Bonventre, MD, PhD
2001 Andrzej S. Krolewski, MD, PhD
2000 Richard J. Glassock, MD
1999 Giuseppe Bianchi, MD
1998 Josephine Briggs, MD
1997 Gary E. Striker, MD
1996 Alfred Michael, MD
NKF SCM12
THE DONALD W. SELDIN AWARD
The Donald W. Seldin Award was established to recognize
excellence in clinical nephrology in the tradition of one of the
foremost teachers and researchers in the field, Dr. Donald
W. Seldin. The 2012 award recipient is Gerald B. Appel, MD.
Gerald B. Appel, MD, is Director of
Clinical Nephrology at Columbia
University Medical Center at The New
York-Presbyterian Hospital, and is a
tenured Professor of Clinical Medicine
at Columbia University College of
Physicians and Surgeons. He is Chief of the Glomerular
Kidney Disease Center at Columbia U. He received his BA
from Cornell University in three years with distinction in all
subjects and as a member of Phi Beta Kappa. He received
his medical degree from Albert Einstein College of Medicine
in 1972, where he was elected to the medical honor society
Alpha Omega Alpha. He completed his internship and
residency in Internal Medicine at Columbia Presbyterian
Medical Center. He then completed fellowships in
Nephrology at both Columbia-Presbyterian (1975 – 1976)
and at Yale-New Haven Medical Center (1976 – 1978).
Dr. Appel has been listed in New York magazine as one of
the “Best Doctors in New York” annually between 1992 and
2011, is listed in “Best Doctors in America,” and in “How to
Find the Best Doctors in the NY Metro Area.” He has been
an Associate Editor of CJASN and is currently on the editorial
board of Up-To-Date. Dr. Appel is a member of numerous
societies and has served on the Medical Advisory Board
and as the Chairman of the Research Committee of the
National Kidney Foundation Serving Greater New York and
The Kidney and Urology Foundation of America, as a Past
President of the New York Society of Nephrology, and as
Chair of the Council of Glomerulonephritis of the National
Kidney Foundation. He has been the director of a number
of courses, including The Columbia University Internal
Medicine Course in NYC , Renal Biopsy in Medical Diseases
of the Kidney in NYC, and for many years (1998 – 2010)
directed the annual course in The Treatment of Glomerular
Diseases at the American Society of Nephrology meetings.
Dr. Appel has authored and co-authored almost 300
peer-reviewed articles and book chapters. His career has
been devoted to the care and welfare of patients with
glomerular disease.
23 23

24
AWARD RECIPIENTS continued
Past Donald W. Seldin Award Recipients
2011 Sharon G. Adler, MD, FASN
2010 Fredric L. Coe, MD, FACP, FASN
2009 William F. Keane, MD
2008 Thomas DuBose, Jr., MD
2007 L. Lee Hamm, MD, FACP
2006 Heine Murer, MD, and Bernard Rossier, MD
2005 Roland C. Blantz, MD
2004 Gerhard H. Giebisch, MD
2003 William M. Bennett, MD
2002 Professor Carl Erik Mogensen
2001 Friedrich K. Port, MD, MS, FACP
2000 Tilman B. Drüeke, MD
1999 Shaul G. Massry, MD
1998 Alan R. Hull, MD
1997 Thomas F. Parker, III, MD
1996 Floyd C. Rector, MD
1995 Barry M. Brenner, MD
1994 Manuel Martinez-Maldonado, MD
DAVID M. HUME MEMORIAL AWARD
The David M. Hume Award was created in memory of one
of the National Kidney Foundation’s most distinguished
members. The Hume Award is the highest honor given
to a distinguished scientist-clinician in the field of kidney
and urologic diseases. It is bestowed upon an individual
who exemplifies the high ideals of scholarship and
humanitarianism in an outstanding manner. The 2012
award recipient is Andrew S. Levey, MD, FNKF.
Dr. Levey is the Dr. Gerald J. and
Dorothy R. Friedman Professor of
Medicine at Tufts University School
of Medicine, Chief of the William B.
Schwartz, MD Division of Nephrology
at Tufts Medical Center, Senior
Scientist at the U.S. Department of Agriculture Human
Nutrition Research Center on Aging at Tufts University,
and Professor of Clinical Research at the Sackler School of
Graduate Biomedical Sciences at Tufts University.
His research is mainly in the areas of epidemiology
of chronic kidney disease and cardiovascular disease
in chronic kidney disease, controlled trials to slow the
progression of chronic kidney disease, clinical assessment of
kidney function, assessment and improvement of outcomes
in dialysis and transplantation, and clinical practice
NKF SCM12
guideline development and implementation. Dr. Levey is
currently Program Director for a NIDDK-funded clinical
research training program, “Clinical Trials, Epidemiology
and Outcomes Research in Nephrology.” He is the Director
of the National Kidney Foundation Center for Clinical
Practice Guideline Development and Implementation
at Tufts Medical Center. He is Past Chair of the National
Kidney Foundation’s Task Force on Cardiovascular Disease
in Chronic Renal Disease. He was a member of the KDOQI ®
Work Group on Chronic Kidney Disease: Evaluation,
Classification and Stratification, and the KDOQI Work Group
on Hypertension and Antihypertensive Agents in Chronic
Kidney Disease. Dr. Levey received the National Kidney
Foundation’s President Award in 1998 and the Garabed
Eknoyan Award in 2002, and the Tufts University School of
Medicine Distinguished Faculty Award in 2004.
Past David M. Hume Memorial Award Recipients
2011 Jeremy R. Chapman, MD
2010 John Sedor, MD
2009 Brian J.G. Pereira, MD, MBA
2008 Lawrence Hunsicker, MD
2007 William G. Couser, MD
2006 Frank Delmonico, MD
2005 Roland C. Blantz, MD
2004 John Stewart Cameron, MD
2003 Franklin H. Epstein, MD
2002 Barry M. Brenner, MD
2001 William E. Mitch, MD
2000 [No Award]
1999 Neil A. Kurtzman, MD
1998 Jared J. Grantham, MD
1997 Thomas E. Andreoli, MD
1996 Edmund G. Lowrie, MD
1995 Joseph W. Eschbach, MD
1994 Wadi N. Suki, MD
1993 Joel D. Kopple, MD
1992 Saulo Klahr, MD
1991 Professor August Heidland
1990 Richard J. Glassock, MD
1989 Professor Priscilla Kincaid-Smith
1988 Shaul G. Massry, MD
1987 Robert W. Schrier, MD
1986 Robert Heptinstall, MD
1985 Willem J. Jolff, MD
1984 Charles R. Kleeman, MD
1983 Robert W. Berliner, MD
1982 Professor Hugh E. de Wardener
1981 Donald W. Seldin, MD
1980 George E. Schreiner, MD

Past David M. Hume Memorial Award Recipients (Continued)
1979 John P. Merrill, MD
1978 Thomas E. Starzl, MD
1977 Henry L. Barnett, MD
1976 Carl W. Gottschalk, MD
1975 Belding Scribner, MD
1974 Robert M. Kark, MD
1973 Jean Hamburger, MD
THE GARABED EKNOYAN AWARD
The Garabed Eknoyan Award was created to recognize an
individual who has promoted the mission of the National
Kidney Foundation in making lives better for people with
kidney disease through exceptional contributions to key
initiatives of NKF such as the Kidney Disease Outcomes
Quality Initiative (KDOQI ® ) or clinical research in the field of
kidney disease. The 2012 award recipient is Bryan N. Becker,
MD, MMM, FNKF.
Dr. Becker moved into the role of
Assistant VP for Health Affairs at the
University of Illinois after the
restructuring at the University of
Illinois Hospital and Health Sciences
System. He recently served as Senior
Associate Dean for Clinical Affairs at the UIC College of
Medicine and executive director of its practice plan.
Dr. Becker remains a clinician, caring for individuals with
chronic kidney disease and kidney transplant recipients
and used that experience during his time as President of
the National Kidney Foundation and Chair of its Scientific
Advisory Board. He has been engaged in local, regional, and
national committees, ranging from NIH review panels to
measurement development for the Wisconsin Collaborative
for Healthcare Quality. His constant focus has been how
to work with others to combine policy and care innovation
to deliver better patient outcomes. Dr. Becker has also
served as a member of and advisor to the board of several
companies, academic groups, and community organizations.
Dr. Becker received his BA in English from Dartmouth
College, his MD from the University of Kansas School of
Medicine, and followed that training in internal medicine
and nephrology at Duke and Vanderbilt Universities,
respectively. He received his master’s degree in Medical
Management from Tulane University in 2009.
Past Garabed Eknoyan Award Recipients
2011 Kai-Uwe Eckardt, MD
2010 Josef Coresh, MD
2009 Sharon M. Moe, MD
NKF SCM12
Past Garabed Eknoyan Award Recipients (Continued)
2008 Adeera Levin, MD, FRCP(C)
2007 Norbert H. Lameire, MD
2006 Francesco Locatelli, MD
2005 Nathan W. Levin, MD, FACP
2004 Neil R. Powe, MD, MPH, MBA
2003 Bertram L. Kasiske, MD
2002 Andrew S. Levey, MD
JOEL D. KOPPLE AWARD
The Joel D. Kopple Award is an annual award honoring an
individual who has made significant contributions to the
field of renal nutrition. Accepting his year’s Joel D. Kopple
Award on behalf of recipient Nathan W. Levin, MD, FACP,
are Jerrilynn Burrowes, PhD, RD, CDN, and George Kaysen,
MD, PhD, who will be who will be giving a presentation
on “Interaction of Lipids and Inflammation in Health and
Chronic Kidney Disease” on Thursday May 10.
Dr. Nathan W. Levin is one of the most
renowned and accomplished figures in
both clinical nephrology and
nephrology research. He has authored
multiple book chapters and over 350
peer-reviewed publications, including
articles in leading journals such as Nature, The New England
Journal of Medicine, and The Lancet. He is a founder of the
Renal Research Institute, LLC, an organization dedicated to
improving the outcomes of patients with kidney disease,
particularly those requiring dialysis. Dr. Levin received his
medical degree from the University of the Witwatersrand in
Johannesburg, South Africa. Later, he became a diplomat of
the American Board of Internal Medicine and a fellow of the
American College of Physicians.
Dr. Levin has held prominent positions in many professional
societies, including President of the Michigan End-Stage
Renal Disease (ESRD) Network, President of the Renal
Physicians Association (RPA), and President of the RPA
Research and Education Foundation. He was Co-Chairman
of the AAMI Hemodialysis Reuse Committee and the
National Kidney Foundation Kidney Disease Outcomes
Quality Initiative (NKF–KDOQI). He was a member of the
Clinical Practice Committee of the American Society of
Nephrology (ASN), the International Society of Nephrology’s
Membership Committee, the International Society of Renal
Nutrition and Metabolism (ISRNM), and the American
Diabetes Association.
Dr. Levin has been recognized with several distinguished
awards, including the Belding Scribner Trailblazer Award,
the Distinguished Nephrology Service Award of the RPA,
25 25

26
AWARD RECIPIENTS continued
the AAKP Medal of Excellence, the Fresenius Lifetime
Achievement Award, the AAMI Recognition Award, the
Garabed Eknoyan Award of the National Kidney Foundation,
and the Recognition Award for his role as Co-Chairman of
the DOQI Advisory Council.
Dr. Levin’s most prominent scientific achievements include
his roles as a Principal Investigator of the HEMO study,
CHOICE Study, and the Frequent Hemodialysis Network
(FHN) Study. The NKF Council on Renal Nutrition (NKF-CRN)
is honored to present the most prestigious award in renal
nutrition to Dr. Nathan W. Levin.
Past Joel D. Kopple Award Recipients
2011 T. Alp Ikizler, MD
2010 Laura Byham-Gray, PhD, RD
2009 Raymond Hakim, MD
2008 Alison Steiber, PhD, RD, LD
2007 Kamyar Kalantar-Zadeh, MD, PhD, MPH
2006 Mary Pat Kelly, MS, RD, GNP
2005 Jerrilynn D. Burrowes, PhD, RD
2004 Judith Beto, PhD, RD, FADA
2003 Linda M. McCann, RD, LD, CSR
2002 Linda Moore, RD, LDN
NKF SCM12
THE J. MICHAEL LAZARUS LECTURE
This lectureship was established to honor Dr. J. Michael
Lazarus for his major contributions to the clinical science
and care of dialysis patients, and to recognize individuals
whose research has yielded novel insights related to renal
replacement therapy. The 2012 award recipient is Jonathan
Himmelfarb, MD.
Dr. Himmelfarb is Director of the
Kidney Research Institute, a Professor
of Medicine, and holds the Joseph
W. Eschbach, MD, Endowed Chair in
Kidney Research at the University of
Washington. He has served on
numerous study sections, grant review committees, and
scientific advisory boards, and has held leadership positions
in many national and international nephrology societies.
He has been a member of the American Board of Internal
Medicine Subspecialty Board on Nephrology, and is
currently a Councilor of the American Society of
Nephrology. Dr. Himmelfarb has served on numerous
editorial boards, including the Journal of the American
Society of Nephrology (JASN), Clinical Journal of the
American Society of Nephrology (CJASN), Kidney
International, BMC Medicine, and on the Faculty of 1000
in Medicine.
His current research interests include: development and
evaluation of risk biomarkers in acute and chronic kidney
disease; studies of oxidative stress, inflammation and insulin
resistance in kidney disease; performance of numerous
investigator-initiated clinical trials and cohort studies, as
well as multicenter collaborative studies. Dr. Himmelfarb is
the author of more than 160 peer-reviewed publications,
including original research, reviews, and editorials. He
currently holds eight research grants from the National
Institutes for Health (NIH).
Past J. Michael Lazarus Award Recipients
2011 John T. Dauguirdas, MD

SCM12 INTERNATIONAL DISTINGUISHED MEDAL RECIPIENTS
The International Distinguished Medal was established in 1990 to honor the achievements of individuals who have made
significant contributions to the field of kidney disease and extended the goals of the National Kidney Foundation. The Foundation
President presents medals each year to recognize the accomplishments of individuals through their clinical work,
roles in academia, scientific discoveries or volunteer work in organizations similar to the Foundation.
Jianghua Chen, MD
Professor Jianghua Chen is now the
Chief of the Kidney Disease Center,
1st Affiliated Hospital, College of
Medicine, Zhejiang University. He is
the Associate Director of the Chinese
Hemodialysis Association of the CMA (Chinese Medical
Association), Associate Director and General Secretary of
the Chinese Scientific Registry of Kidney Transplantation,
Associate Director of the Key Laboratory of Multiple Organ
Transplantation, Ministry of Health, Chief Director of
Zhejiang Province branch of CMA, Chief Director of Zhejiang
Province branch of Chinese Nephrology Association of CMA.
Dr. Chen is specializing in the prevention and treatment of
chronic kidney disease, blood purification therapy, and renal
transplantation. He is leading 15 ongoing scientific projects,
and has received 8 awards for his projects. 57 SCI papers
have been published by the research group directed by
Professor Chen.
Raymond Krediet, MD, PhD
Raymond (Ray) Krediet graduated
in 1973 from the University of
Amsterdam. In 1978, he completed his
training as an internist-nephrologist.
He became Head of Nephrology at the
Binnengasthuis in 1979, where he introduced treatment
with continuous ambulatory dialysis (CAPD). In 1986,
he became a PhD; his thesis was entitled “Peritoneal
Permeability in Continuous Ambulatory Peritoneal Dialysis
Patients.” In 1999, he became Professor and Head of the
Department of Nephrology at the Academic Medical Centre,
University of Amsterdam.
Professor Krediet supervised the research of 26 PhD
students, and is the author of 470 publications in scientific
journals. His h-index is 51.
He is former chairman of the Dialysis Group Netherlands,
the International Society for Peritoneal Dialysis, and the
Nephrology Section of the European Union for Medical
Specialists. He retired October 2010, but is still involved
in research and a number of academic and organizational
activities.
NKF SCM12
Philip K.T. Li, MD, FRCP, FACP, FNKF
Professor Philip Kam-Tao Li is the Chief
of Nephrology and Consultant
Physician of the Department of
Medicine and Therapeutics at the
Prince of Wales Hospital (PWH), Hong
Kong. He is also the Honorary Professor of Medicine at the
Chinese University of Hong Kong.
Professor Li is dedicating his efforts to promoting
nephrology both locally and internationally. He serves
on the Council of the International Society for Peritoneal
Dialysis, and the Executive Council of the Asian Pacific
Society of Nephrology. He is on the Board of Directors for
Kidney Disease: Improving Global Outcomes (KDIGO ® ) and is
a Steering Committee Member for World Kidney Day, as well
as an Executive Committee Member of the Asian Forum for
CKD Initiatives. He is the Past Chairman of the Hong Kong
Society of Nephrology and Past President of the Hong Kong
Transplantation Society, and has served on the Executive
Committee of the International Society of Nephrology (ISN).
Professor Li has been President of both of the Organizing
Committees for the ISN 2004 Conference on Prevention of
Progression of Kidney Diseases, and the 11th International
Congress of the International Society for Peritoneal Dialysis
in 2006, respectively. He was the Scientific Vice President
and Program Chair for the 2nd Congress of International
Society for Hemodialysis in 2009. He is the Chairman of
the Local Organizing Committee and Scientific Co-Chair for
the World Congress of Nephrology 2013 to be held in Hong
Kong. He serves as the Honorary Secretary for the Hong
Kong College of Physicians.
Professor Li is the founding Editor-in-Chief of the Hong Kong
Journal of Nephrology, Deputy Editor of Nephrology, and
Editor of the Nephrology Dialysis & Transplantation and
the International Journal of Artificial Organs . He is on the
editorial boards of Clinical Nephrology, Peritoneal Dialysis
International, Chinese Journal of Nephrology, Dialysis &
Transplantation, Medical Progress, and the Indian Journal of
Peritoneal Dialysis. He is a regular reviewer for all the major
nephrology journals. He has published over 400 original
27 27

28
MEDAL RECIPIENTS continued
and review articles in peer-reviewed journals, two books
and 17 book chapters. He has given lectures to over 100
international congresses and meetings.
His research interests include peritoneal dialysis (residual
renal function, cardiovascular disease, connectology,
peritonitis, biocompatible solutions adequacy),
cardiovascular mortality in dialysis patients, IgA
nephropathy, prevention of progression of chronic kidney
disease, diabetes in renal failure and immunogenetics of
nephropathies, drug pharmacokinetics and complications
after transplantation.
Peter Stenvinkel, MD, PhD
Peter Stenvinkel, MD, PhD, serves as a
professor and senior lecturer at the
Department of Renal Medicine,
Huddinge University Hospital,
Karolinska Institutet, in Stockholm. He
has published more than 325 original publications and
reviews, and 25 book chapters on various aspects of
inflammation, wasting and metabolism in chronic kidney
disease patients. His Hirsch index is 49. He has given more
than 230 invited lectures at various international meetings
and congresses in about 30 different countries. He received
the prize for the best Swedish thesis in diabetology 1994,
and was a Baxter Extramural Grant awardee in 1996. He was
a Karolina Price awardee in 2005, and a Vizenca Prize
awardee in 2009. He received the Addis Gold Medal by the
ISRNM for nutritional research in 2010. He is a member of
the councils of the International Society of Nephrology and
ERA-EDTA. He is an Associate Editor of NDT and Editor-in-
Chief of NDT-E. He received an honorary membership in the
Australian and New Zealand Society of Nephrology in 2010
and in the Polish Society of Nephrology in 2012.
Past International Distinguished Medal Recipients
2011
Nan Chen, MD, China
Angela, D’Angelo, MD, Italy
Ron T. Gansevoort, MD, PhD, The Netherlands
David C. Wheeler, MD, FRCP, United Kingdom
2010
Jonathan Craig, MD, Westmead, Australia
Paul E. de Jong, MD, Groningen, The Netherlands
Alison MacLeod, MD, Aberdeen, United Kingdom
Dimitrios Oreopoulos, MD, Toronto, ON, Canada
NKF SCM12
2009
Guillermo Garcia Garcia, MD, Guadalarjara, Mexico
Donal O’Donoghue, MD, Salford, England
Gregorio Obrador, MD, Mexico City, Mexico
Kim Solez, MD, Edmonton, AB, Canada
2008
Bernard Charra, MD, Tassin, France
Wendy Hoy, MD, Queensland, Australia
Michel Jadoul, MD, Bruxelles, Belgium
Yves Vanrenterghem, MD, PhD, Leuven, Belgium
2007
Mona Al-Rukhaimi, MD, Dubai, United Arab Emirates
Dick de Zeeuw, MD, PhD, Groningen, The Netherlands
Sayyid Ali Jaffer Naqvi, MD, Karachi, Pakistan
Susumu Takahashi, MD, PhD, Tokyo, Japan
Christoph Wanner, MD, Wurzburg, Germany
2006
Jorge Cannata-Andia, MD, Oviedo, Spain
Prakesh Keshaviah, MD, Dehradun, Uttaranchal, India
Gabriel Mircescu, MD, Bucharest, Romania
Yusuke Tsukamoto, MD, Tokyo, Japan
Haiyan Wang, MD, Beijing, China
2005
John Dirks, MD, Toronto, Ontario, Canada
Saraladevi Naicker, MD, Johannesburg, South Africa
Luis Revert, MD, Barcelona, Spain
Wu Chang Yang, MD, Taiwan, China
2004
Peter G. Blake, MB, FRCP, Toronto, ON, Canada
Kai-Uwe Eckardt, MD, Erlangen, Germany
S. Adibul Hasan Rizvi, MBBS, FRCS, FRCSE, FCPS, FRCP,
Karachi, Pakistan
Bernardo Rodriguez-Iturbe, MD, Maracaibo, Venezuela
Claudio Ronco, MD, Vicenza, Italy
2003
Georgi Abraham, MD, Chennai, India
Shanyan Lin, MD, Shanghai, China
Nester Schor, MD, PhD, Sao Paolo, Brazil
Carmine Zoccali, MD, Reggio, Italy
2002
Gavin Becker, MD, Victoria, Australia
Francesco Locatelli, MD, Lecco, Italy
Sergio Mezzano, MD, Valdivia, Chile
Giuseppe Piccoli, MD, Torino, Italy
Wladyslaw Sulowica, MD, PhD, Kracow, Poland

2001
Elvira Emilia Arrizurieta, MD, Buenos Aires, Argentina
Hans-Henrick Parving, MD, DMSC,
Copenhagen, Denmark
Yahya Sagliker, MD, Adana, Turkey
Fernando Valderrababo, MD, PhD, Madrid, Spain
2000
Vittorio Andreucci, MD, PhD, Naples, Italy
Norbert Lameire, MD, PhD, Gent, Belgium
Florian Lang, MD, PhD, Tubingen, Germany
1999
Jonas Bergstrom, MD, PhD, Huddinge, Sweden
Walter H. Hörl, MD, PhD, Vienna, Austria
Vincenzo Savica, MD, Messina, Italy
Gianfranco Guarnieri, MD, Trieste, Italy
1998
Professor Rosario Maiorca, Brescia, Italy
John Walls, MD, Leicester, England
Shaul M. Shasha, MD, Nahariya, Israel
Professor Jean-Pierre Grunfeld, Paris, France
1997
Professor Guido Bellinghieri, Sicily, Italy
Professor Hirotoshi Morii, Osaka, Japan
Professor Momir H. Polenakovic, Skopje, Macedonia
Professor Boleslaw Rutkowski, Gdansk, Poland
1996
Professor Judit Nagy, Pecs, Hungry
Professor Karel Opatrny, Plzen, Czech Republic
Miguel C. Riella, MD, Curitba, Brazil
1995
Maurice Slapak, MD, Hampshire, England
Guy Laurent, MD, Tassin, France
David N. Kerr, MD, London, England
Alexander P. Disney, MD, Adelaide, South Australia
Andrzej Ksiazek, MD, Lublin, Poland
1994
Stefan Angielsi, MD, Gdansk, Poland
Natale G. De Santo, MD, Naples, Italy
Professor Miroslaw Mydilk, Kosice, Slovac Republic
1993
Jamie Herrera-Acosta, MD, Mexico City, Mexico
Jose L. Rodicio, MD, Madrid, Spain
Professor Sandor, Sonkodi, Hungary
Visith Sitprija, MD, Bangkok, Thailand
NKF SCM12
1992
Professor Albert Valek, Czechoslovakia
Professor Mary G. McGeown, Ireland
Professor Ori Better, Haifa, Israel
Professor Rashad Barsoum, Cairo, Egypt
Professor Karl M. Koch, Hannover, Germany
M. Derome Tremblay, France
1991
Professor Nobuhiro Sugino, Tokyo, Japan
Professor K.S. Chugh, Mumbai, India
Professor Renee Habib, Paris, France
Professor Franciszek Kokot, Poland
Professor Sevrin Ringoir, Ghent, Belgium
1990
Professor Kazimierz Baczyk, Poznan, Poland
Professor Vittorio Bonomini, Bologna, Italy
Professor J. Stewart Cameron, London, England
T.T. Durai, MD, Singapore
Professor Henri Jahn, Strasbourgh-Cedex, France
Professor Eberhard Ritz, Heidelberg, Germany
29 29

30
SCM12 NKF PROFESSIONAL COUNCIL AWARDS
COUNCIL OF ADVANCED PRACTITIONERS
AWARD RECIPIENTS
NOSTRADAMUS AWARD
A 16th century seer, Nostradamus has long been portrayed
as someone who could see into the future. This award will
be given annually to an individual or organization that,
through forethought and vision, recognizes and promotes
the contributions of advanced practitioners in nephrology.
Dolph Chianchiano, JD, MPRA
Dolph Chianchiano, recently retired
from his position as National Kidney
Foundation Senior Vice President of
Health Policy and Research, embodies
the attributes and characteristics of
advocacy and leadership. For more than 30 years he has
served the kidney community with his vision, wisdom,
insight and action. His education includes an undergraduate
degree in foreign service and a graduate degree in law. His
intention was to practice international law, but there were
other things in store for him. The American Heart
Association (AHA) offered him a research and policy position
and, after serving in that position for several years (while
earning his master’s degree in public administration), he left
the AHA and joined the NKF.
Throughout his tenure at the NKF, he has developed and
shaped the NKF’s public policy and advocacy agendas.
When asked by his colleagues what he is most proud of
during his years of service at the NKF, he cites creating
and influencing legislation to extend Medicare coverage of
immunosuppressant drugs to kidney transplant recipients,
launching the American Journal of Kidney Diseases (one
of the premier journals for nephrology professionals), and
establishing the NKF Spring Clinical Meetings.
In 2008, the Medicare Improvements for Patients and
Providers Act (MIPPA), providing an educational benefit
for individuals with stage 4 chronic kidney disease (CKD),
was recommended and supported by the NKF. Through
his advocacy and education of members of Congress
and the renal community, he and his colleague, Troy
Zimmerman, helped to shepherd its passage and eventual
implementation. Regularly, he solicits input from advanced
practitioners (APs) regarding public policy and laws that
impact the lives of those with CKD/ESRD. He has been and
is there to support the work of advanced practitioners who
provide care to this vulnerable population.
Even though he announced his retirement in 2011, he
has continued to serve the NKF as a consultant and the
NKF SCM12
kidney community as a whole, through membership in the
Kidney Care Partners Coalition. He remains a passionate
ally and an advocate for changes that positively impact the
quality of life of individuals with chronic kidney disease and
the professionals who serve them. There is no one more
deserving of this award than Dolph Chianchiano.
TIM POOLE MEMORIAL AWARD
This award was established in honor of Tim Poole, PAC, who
passed away in 2008. Tim was an exceptional clinician and
incredible human being who dedicated his life to the care
and well-being of CKD patients and their families. The Tim
Poole Memorial Award will be given to a CAP member who
follows in Tim’s footsteps and demonstrates the qualities
that made him so outstanding.
Marty Bergman, MS, RD, PA-C
There are advanced practitioners who
work behind the scenes and never try
to call attention to themselves. Yet,
without them, no work would be done
and no plans would be carried out.
Without these APs, the job of the CAP Executive Committee
would also be impossible. The Tim Poole Memorial Award is
given to the CAP member who demonstrates the qualities
that made Tim so outstanding in his work and life:
dedication to community service, education of patients and
practitioners, leadership in nephrology and commitment of
time and energy to an organization for the betterment of
kidney patients. Marty Bergman, MS, RD, PA-C, embodies all
of the above in her work.
Ms. Bergman was the Member-At-Large for the CAP
Executive Committee, a catch-all position which takes on
special projects that the Committee delegates. She was
instrumental in developing and writing the first NKF-CAP
Salary and Benefits Survey in 2010; the 2012 survey is,
again, mostly of her design. She developed and exhibited
the poster of the 2010 Salary and Benefits Survey and
presented it at the NKF and ASN meetings to show what
APs can do. Without outreach to the physicians and practice
managers, APs would be unable to do all the wonderful
and necessary work of which we are capable. Ms. Bergman
made sure that the outreach was professional, fact-based,
and showed APs in the best possible light. She coordinated
and assisted in the development and writing of “Dialysis
Essentials,” an online training program offered by CAP,
intended to mentor new APs in dialysis units. When Sydney
(the CAP educational traveling kidney mascot) went missing,
she arranged to have a new Sydney made...more durably,
but just as cute as the original. Whenever there was a job

that needed to be done or a project that required a leader,
she was always there. However, she never took credit and
always stayed behind the scenes.
Ms. Bergman also works behind the scenes for her group
in North Carolina. She has scheduled and coordinated all
the APs in her practice between hospitals, dialysis units
and office coverage for the last eight years. She sits on the
Hospital Allied Health Peer Committee as its Chair and has
done so for six years, representing APs and looking out
for their interests. She is responsible for the physician and
AP quarterly meetings within her group. She developed
Nephrology Notes, an orientation brochure to train internal
medicine and family practice residents at Moses Cone
Hospital in nephrology. She trains new APs at Wake Forest
University and has mentored all the new APs who have
joined her group in the last 10 years. Prior to PA school, she
worked as a registered dietitian. She has a special love of
teaching her nephrology patients the importance of diet
and exercise in both combating the progression of CKD and
staving off the ravages of kidney failure.
Ms. Bergman makes time for her family even while being
the glue behind the CAP Executive Board and Carolina
Kidney Associates. CAP could not have accomplished nearly
as much as they did in the last three years without her, and
she is thanked for her dedication and work prior to her 2011
retirement from the Committee.
COUNCIL OF NEPHROLOGY NURSES AND
TECHNICIANS AWARD RECIPIENTS
LEADERSHIP AWARD
Patricia Vaughan, BSN, RN, CNN
Patricia Vaughan has been
professionally committed to the
nephrology community for more than
19 years. She has served as a manager,
leader, and mentor for many
nephrology nurses and technicians, and is currently
employed as an Acute Hemodialysis Nurse Manager for
Little Company of Mary Hospital in Evergreen Park, IL. She
has been an advocate for professionals in nephrology by
promoting continuing education and certification. She
served two consecutive terms as Region III Vice Chair on the
CNNT Executive Committee and will continue on as Chair-
Elect in 2012, promoting greater involvement across the
membership. She has also served as Chair of the Illinois
CNNT Chapter (ICNNT), which has approximately 200
members and provides two educational meetings annually.
In her leadership role for ICNNT, Ms. Vaughan recruited 150
attendees to the educational meetings, 70 to 80 of whom
NKF SCM12
were technicians. When national certification became a
requirement for dialysis technicians, the ICNNT addressed
their continuing education needs by including technicians to
a greater extent in the planning process for programs for
their peers. Ms. Vaughan has been instrumental in
advocating for both kidney patients and nephrology
professionals. She has found that nurses and technicians
have similar educational needs, and has focused on practical
solutions for everyday problems. She has earned respect
both locally and nationally for her collaborative approach to
best practices.
DISTINGUISHED SERVICE AWARD
Becky DeLaCruz, RN, CHN, CNN
In her 38 years of experience as a
registered nurse and more than 32
years working with kidney patients,
Becky DeLaCruz has worked in all
aspects of nephrology, both in the U.S.
and beyond its borders. Her role as Global HD Marketing
Manager for Baxter Healthcare has taken her to sites in such
countries as Ireland and China. During her last 18 years with
Baxter, she has worked in clinical education and software
training for both PD and HD. Her commitment to the
National Kidney Foundation has been extensive, and
includes work on the CNNT Executive Committee in multiple
roles. She served as NKF Spring Clinical Meetings CNNT
Program Chair and Co-Chair over a span of five years,
promoting high-level educational programs for nurses and
technicians. She has held the offices of CNNT Chair and
Region III Vice-Chair, and is currently Cybernephrology Chair.
Ms. DeLaCruz also served as President-Elect and
Chairperson of the Spring Workshop Planning Committee
for the Iowa CNNT Chapter. Whether she is networking with
local professionals or international leaders, Ms. DeLaCruz
promotes the mission of the National Kidney Foundation.
She encourages others to get involved, and supports the
achievements of fellow colleagues. She has been a mentor
to many leaders within the CNNT and continues to recruit
new members.
31 31

32
PROFESSIONAL COUNCIL AWARDS continued
COUNCIL OF NEPHROLOGY SOCIAL WORKERS
AWARD RECIPIENTS
ROBERT W. WHITLOCK LIFETIME ACHIEVEMENT AWARD
The CNSW Lifetime Achievement Award is named in honor
of Robert W. Whitlock, MSSW, MHA, LCSW, Director of the
Missouri Kidney Program (MoKP), a leader in the kidney
community who passed away in 2008. Bob was a dedicated
nephrology social worker and an outstanding contributor
to research, teaching, and clinical practice in nephrology
social work.
Sandra Coorough, ACSW, LCSW, NSW-C
Ms. Coorough is a Pediatric Renal and
Kidney Transplant Social Worker at
Phoenix Children’s Hospital in Arizona.
She has focused on the “kid” in kidney
work with her pediatric patients. She
has been actively involved in program development,
targeted therapies, advocacy, education, and support to
help families improve their quality of life. She never forgets
that her patients are kids first. She has been highly involved
with CNSW locally and nationally for years, serving as
Education Chair on the Executive Committee, and working
with the NKF Spring Clinical Meetings Program Committee.
Ms. Coorough was instrumental in the development of the
Nephrology Social Work Certification (NSW-C) program.
Along with the Robert W. Whitlock Lifetime Achievement
Award, Ms. Coorough will also be presented with the Social
Worker in a Pediatric Setting Award .
MERIT AWARD
This year, CNSW will present the Merit Award to two
recipients, Jennifer Miller, LICSW, NSW-C, and Renata Sledge,
MSW, LCSW.
Jennifer Miller, LICSW, NSW-C
Ms. Miller is a nephrology social
worker with DaVita in New Hope, MN.
She served as the sole social worker
with the DaVita Bridge of Life Medical
Missions team to assist with opening
two dialysis units in India, and raised extensive funds prior
to the mission trip. At home, she has actively assisted
chronic kidney disease patients all over Minnesota, serving
rural, urban, and suburban units. She has been an active
participant in her local CNSW Chapter, and in the NKF Spring
Clinical Meetings. She has worked hard to promote and
support professional roles and responsibilities through CNSW,
including volunteer work on the CNSW Certification Board.
NKF SCM12
Renata Sledge, MSW, LCSW
Ms . Sledge is the lead social
worker with Renal Advantage in
Fairview Heights, IL. She was the
Coordinator for the STI (Symptom
Targeted Interventions) Pilot Practice
Outcome Evaluation project in 2011. Along with her fellow
investigators, she has published extensively on STI, as well
as such subjects as KDQOL, the Centers for Medicare &
Medicaid Conditions for Coverage, and the use of music
therapy. She has been actively involved with her local
CNSW Chapter, as well as the NKF of Illinois Medical
Advisory Board and Board of Directors. She has also worked
extensively for her employer to develop corporate policy,
and create and implement patient education and staff
training.
NEW WORKER AWARD
Amy Elaine Stoll, MSW, CISW
Ms. Stoll works as a clinical transplant
social worker at the University of
Wisconsin Hospital and Clinics.
Although she is relatively new to the
nephrology social work field, she has
been actively involved in her local CNSW Chapter, and helps
the Chapter obtain CEUs for their meetings. She created a
social work manual for her fellow colleagues at the hospital.
She is currently working with Transplant Wisconsin, Inc. to
develop a renal transplant camp for children in Wisconsin.
REGIONAL SOCIAL WORKER AWARD – REGION V
Gloria Lozano Ramos, MSW, MPA
Ms. Ramos is a nephrology social
worker with Fresenius Medical Care in
East Los Angeles. As a bilingual and
bicultural social worker, she created a
Cultural Awareness Toolkit that she
will present at the NKF 2012 Spring Clinical Meetings. She is
also an adjunct instructor at East Los Angeles Community
College and Pasadena City College. She was recognized by
her CNSW Chapter colleagues in 2009 as Social Worker of
the Year, receiving the Outstanding Achievement Award for
her leadership and contributions.

COUNCIL ON RENAL NUTRITION
AWARD RECIPIENTS
RECOGNIZED RENAL DIETITIAN AWARD
Chhaya Patel, MA, RD, CSR
Ms. Patel has been a renal dietitian since
1978 and has experience with
hemodialysis, home hemodialysis and
peritoneal dialysis therapies. Her
expertise is in cultural foods, and she
published Cultural Foods and Renal Diets for Clinical Dietitians
in 1997. Her recent article on diabetic diet for Asian Indians
was published by the American Association of Physicians of
Indian Origin. She has received many awards, including the
CRN Leadership Award, the Service Excellence Award for
DaVita Dietitians, and the DaVita Shining Star Award.
Her work with the NKF and CRN is extensive, and she has
experience on committees both at the local and national
levels. Locally, she was Chairperson of the Northern California/
Northern Nevada CRN, and served on the Board of Directors
and the Medical Advisory Board for the NKF of Northern
California, earning an NKF Merit Award and an Outstanding
Achievement Award for her volunteer work.
On the CRN Executive Committee, Ms. Patel’s roles included
Region V Representative, Chair of the Patient Education
Committee, Associate Chair, Legislative/Communications
Chair, Nominating Committee Chair, and Research Grant
Chair. She has been involved with the NKF Spring Clinical
Meetings as part of the CRN Program Committee and by
performing abstract reviews. She works with NKF nationally
on the Advances in Chronic Kidney Disease Editorial Board
and the KLS Editorial Board. In addition, she serves on the
Patient Education Committee for the American Kidney Fund
(AKF) and as Coordinator for Area 1 and CQI/Outcome Chair
for the Renal Practice Group of the Academy of Nutrition and
Dietetics.
SUSAN B. KNAPP EXCELLENCE IN EDUCATION AWARD
Sara Colman-Carlson, RD, CDE
Ms. Colman-Carlson has worked in the
field of renal nutrition since 1991. She is
currently employed as the DaVita.com
Nutrition Specialist, is a Partner at
Culinary Kidney Cooks in Huntington
Beach, CA, and also instructs at Long Beach City College.
Ms. Colman-Carlson sees her calling in life to provide
resources to kidney patients, and has lived up to it in a big
way. She developed and tested renal-friendly recipes and
has created meal planning tools for kidney patients. She
NKF SCM12
translated the renal diet into practical tools for patients by
co-writing Cooking for David: A Culinary Dialysis Cookbook, a
contribution that has helped thousands of kidney patients and
their families. From this cookbook came the “Food Pyramid
for the Kidney Diet,” which she created in Spanish and English
to help simplify the complicated renal diet. She has supported
dramatic improvements in patient adherence with her creative
educational tools.
She holds community activities for patients, including speaking
engagements, cooking classes, cooking demonstrations, and
shopping tours. She has personally driven patients to meetings
and participated in a 240-mile biking event to raise funds
for patients. Ms. Carlson shares the spirit of Susan Knapp by
never passing up an opportunity to share her knowledge of
renal nutrition with patients and colleagues. She has equipped
and launched many renal dietitians and mentored dietetic
interns in the field of kidney disease. Dietitians know her as a
person who is always ready to help, and who puts passion and
enthusiasm into all that she does.
RECOGNIZED RENAL DIETITIAN – REGION I
Micki (Mary) Misiaszek, RD, LDN
Ms. Misiaszek has worked extensively in
the field of renal nutrition. She has been
involved with the Maryland CRN
Chapter since 1991, and has served in
many leadership capacities, including
Co-Chair and Renal Nutrition Symposium Coordinator. She
currently serves as Treasurer. She was the developer and
coordinator of the Kidney Disease Nutrition Supplement
Program for Maryland patients. She served as an instructor for
the “People Like us Live” program in her area. She is an
excellent role model and mentor for renal dietitians through
her work developing patient education materials, coordinating
CQI projects in the field of renal nutrition, and supervising
dietetic interns.
33 33

34
PROFESSIONAL COUNCIL AWARDS continued
RECOGNIZED RENAL DIETITIAN – REGION II
Deborah J. Burt, RD, CSR
Ms. Burt has been an active member of
the Virginia Council on Renal Nutrition
since 2001, serving twice as Chapter
Chair. During her tenure, she assisted in
the creation of a website for the
Chapter, organized continuing education meetings, and
volunteered to promote kidney disease awareness and
prevention within the group. She was a participant in the Tour
DaVita Challenge to promote kidney disease awareness and
prevention. She is a proven leader both within her
organization and the nephrology field as a whole, and has
received many awards, including Virginia’s Kidney Professional
of the Year. She also works to educate dietetic interns, fosters
growth and leadership across the profession of renal nutrition,
and still finds time to provide private counseling for patients
with CKD stages 3-4.
RECOGNIZED RENAL DIETITIAN – REGION III
Jennifer M. Kernc, RD, CSR, LD
Ms. Kernc has been involved in
leadership at both the local and national
level. She served as Secretary for three
terms with the Northeast Ohio CRN
Chapter, and for two terms as CRN
Executive Committee Region III Alternate Representative. She
has contributed to the field of renal education as an Adjunct
Instructor for Case Western Reserve University dietetic interns,
Subject Reviewer for the CSR exam, Contributing Editor of the
Journal of Renal Nutrition Product Updates, and editor of two
chapters of A Clinical Guide to Nutrition Care in Kidney
Disease. She has presented many lectures on bone and
mineral management in CKD, and participated in the
Strategies I Dietitian Program for SCM11. She continues to
promote leadership skills and enthusiasm in the field of
renal nutrition.
NKF SCM12
RECOGNIZED RENAL DIETITIAN – REGION IV
Mary Rockwell, RD, CSR, LD
Ms. Rockwell has extensive experience
in the field of renal nutrition. She has
been actively involved in the South
Plains CRN Chapter and served as its
Chair. She previously served on the NKF
of West Texas Board of Directors and as a committee member.
She has assisted with NKF publications as a Journal of Renal
Nutrition manuscript reviewer, and as a secondary reviewer
for the Pocket Guide to Nutrition Assessment of the Patient
with CKD, 4th Edition. She has worked nationally with NKF on
the CRN Executive Committee, serving as Region IV Alternate
Representative, Region IV Representative, Membership Chair,
Secretary and member of the Nominations Committee. In
addition to developing nutrition education materials, creating
renal presentations, and facilitating leadership and guidance
for renal dietitians, she has also been a preceptor for interns.
RECOGNIZED RENAL DIETITIAN – REGION V
Madelyn Koontz, RD, LD
Ms. Koontz has been an active member
of the Oregon CRN Chapter, having
previously served as Chair and Treasurer.
She currently works to serve the
nutritional needs of dialysis patients in a
low socioeconomic status area, where her expertise and
kindness have assisted in providing patients with selfmotivation
and knowledge. She assists with the supervision of
dietetic interns in her facility, and has been recognized for her
multifaceted use of educational materials to reach her patients.
She is Past Chair for the Licensure Board, and continues to
support legislative activities that promote dietitians in her state.

CONTRIBUTORS
The National Kidney Foundation gratefully acknowledges the support of the following
organizations that helped make the NKF 2012 Spring Clinical Meetings possible:
PRIMARY CONTRIBUTORS
Corporate Supported Symposia
Affymax, Inc. and Takeda Pharmaceuticals North America, Inc.
Amgen
Bristol-Myers Squibb
Otsuka America Pharmaceutical, Inc.
Sanofi
GENERAL CONTRIBUTORS
Conference Materials, Sessions, Events, General and In-Kind Support
Affymax, Inc. and Takeda Pharmaceuticals North America, Inc.
Amgen
Covidien
Bard
Baxter Healthcare Corporation
GE Healthcare, Inc.
Keryx Biopharmaceuticals, Inc.
Mitsubishi Tanabe Pharma
NxStage Medical, Inc.
Otsuka America Pharmaceutical, Inc.
Pentec Health
Pfizer
Questcor Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.
Sanofi
NKF SCM12
35 35

36
GENERAL INFORMATION
MEETING OBJECTIVES
At the conclusion of this activity, participants will be able to:
z Identify important changes in healthcare policy and
advances in clinical and translational research, and
consider how their application may impact the care of
patients with kidney disease
z Utilize knowledge of new discoveries in the continuum
of chronic kidney disease, dialysis, transplantation,
hypertension, and general nephrology to improve
clinical practice
z Enhance skills and optimize coordination of the
interdisciplinary team to improve care of patients with
kidney disease.
NKF’S EXPECTATION OF PRESENTERS
Through the National Kidney Foundation Spring Clinical
Meetings and continuing education programs, NKF
promotes excellence in kidney healthcare education. NKF
expects that all presenters affiliated with the NKF 2012
Spring Clinical Meetings will provide informative and fully
accurate content that reflects the highest level of scientific
rigor and integrity.
TARGET AUDIENCE
• Physicians
• Pharmacists
• Fellows and Residents
• Physician Assistants
• Nurse Practitioners
• Nurses and Technicians
• Dietitians
• Social Workers
ADA COMPLIANCE
NKF makes every effort to comply with the Americans
with Disabilities Act. For assistance, please contact us at
clinicalmeetings@kidney.org.
NKF SCM12
HOW TO OBTAIN CME/CE CREDIT
NKF has established an online system for tracking your
CME/CEs. With an easy scan of a badge, attendance at
sessions will automatically be recorded. CME and CE credit
information will be uploaded to a website for easy viewing
after the conference. You are able to print a certificate
of attendance at your own convenience and without any
hassle! Access this system conveniently by visiting
www.expobadge.com/certification/nkf2012
The online service is available through August 30, 2012.
NKF REGISTRATION, TICKET SALES
AND INFORMATION
Location: Level 2, Gaylord National Convention Center
Registration Hours are:
Tuesday 3:00pm – 8:00pm
Wednesday 6:30am – 6:00pm
Thursday 5:30am – 6:00pm
Friday 7:00am – 5:00pm
Saturday 7:00am – 5:00pm
Sunday 7:00am – 1:00pm (information only)
Tickets for programs requiring separate registration and/
or a separate fee are available at the Ticket Sales Booth in
the Registration Area. Staff are available at the Meeting
Information Booth to answer any questions that you may
have.
BADGES
Please wear your registration badge for admission to all
meetings and activities. There is a $10.00 replacement fee
for lost badges.
POSTER PRESENTATIONS
Over 360 abstracts will be presented as poster
presentations. Take advantage of this outstanding
opportunity to share in the authors’ research experience
and discuss significant areas of development in the everevolving
field of kidney disease. The 2012 posters are
available for viewing in the Exhibit Hall beginning on
Thursday, May 10, at 6:00pm through Saturday, May 12,
until 11:30am .

2012 POSTER PRESENTATION & EXHIBIT HALL ACTIVITIES
Thursday, May 10 6:00pm – 7:30pm Opening Ceremonies and Faculty Reception –
Poster Authors Available for Q&A
Friday, May 11 7:00am – 8:00am Continental Breakfast – Visit Posters/Exhibits
EXHIBIT HALL INFORMATION
Exhibits and posters are located in the Prince George’s
Exhibition Hall on Level 1 of the Gaylord National
Convention Center. Exhibitors are a vital part of the NKF
Spring Clinical Meetings. The NKF thanks our exhibitors for
their continued support of our educational programs, and
cordially invites attendees to the following receptions:
z Thursday, May 10, for the Exhibit Hall Opening
Reception which will be held at 6:00pm in the Exhibit
Hall. Posters will also be on display with authors
present. Top poster presenters announced!
z Friday, May 11, for a Networking Reception held in the
Exhibit Hall from 6:00pm – 7:30pm. Meet colleagues for
cocktails and hors d’oeuvres in a relaxed atmosphere
before you attend one of the dinner symposia.
SCM12 EVALUATIONS
Your feedback really matters!
Evaluations will be distributed at the beginning of each
session and collected at the end. There will be evaluation
drop-off boxes located around the meeting area or you can
drop off your evaluations at the Meeting Information Booth.
Evaluations are very important. The planning and execution
of useful and sound continuing education programs are
largely guided by input provided by program participants—
such as yourself. Your responses will help ensure that future
programs are informative and meet your educational needs.
Please take a few minutes to let us know what you think.
NATIONAL YOUNG INVESTIGATOR’S FORUM
Wednesday, May 9
12:00pm – 2:00pm Lunch 12:15pm – 1:15pm – Visit Posters/Exhibits
6:00pm – 7:30pm Networking Reception – Visit Posters/Exhibits
Saturday, May 12 8:00am – 11:30am Continental Breakfast 8:00am – 9:00am – Visit Posters/Exhibits
11:30am Exhibit Hall Closes
The National Kidney Foundation is pleased to host the
Seventh National Young Investigators Forum chaired by
Rob Star, MD, and Jonathan Himmelfarb, MD. Participants
include the winners of the four regional Young Investigators
Forums held in the first quarter of 2012 as well as those
NKF SCM12
from the 2011 Forums. Presenters will compete in the
Clinical Research or Basic Science categories. A panel of
faculty judges will select the award winners in each category.
Participation by invitation only.
NKF gratefully acknowledges the support of Amgen who has
made this program possible.
DAILY CLINICALS
Look for the Daily Clinicals e-newsletter in your email each
day for the latest news, information and much more on
SCM12 .
NATIONAL KIDNEY FOUNDATION STORE
Location: Conference Registration Area, Level 2
The NKF Store provides a broad array of up-to-date
educational materials and products for healthcare
professionals, kidney and transplant patients, and the
general public.
Stop by the NKF Store to….
• Browse and purchase our latest CKD-related tools,
materials and resources.
• Pick up free single copies of patient education
brochures.
• Buy SCM12 and “Love Your Kidneys” souvenirs and gifts
for colleagues, patients, and friends.
The NKF Store Hours are:
Tuesday 2:00pm – 8:00pm
Wednesday 7:00am – 6:00pm
Thursday 7:00am – 6:00pm
Friday 7:00am – 5:00pm
Saturday 7:00am – 5:00pm
37 37

38
GENERAL INFORMATION continued
MEMBERSHIP QUESTIONS?
NKF professional membership provides numerous benefits
for physicians, pharmacists, advanced practitioners, nurses,
technicians, dietitians, and social workers. Stop by the NKF
Booth located in the Exhibit Hall to learn more about how to
become a NKF member.
FELLOWS EVENT:
Career Choices in Nephrology/Fellows Reception
Held in association with Women in Nephrology
Saturday, May 12, 5:30pm – 7:00pm
Moderators: Linda Fried, MD, MPH, FNKF, and Heidi
Schaefer, MD, FNKF
Panelists:
Akhtar Ashfaq, MD
Jeffrey Giullian, MD
Timmy Lee, MD
David Leehey, MD
Kathleen Liu, MD, PhD, MAS
Career Choices in Nephrology is a special session perfect for
trainees in internal medicine and nephrology (of all genders)
who are trying to decide what career path to choose in
nephrology. The session will begin with a panel discussion
by individuals currently active in private practice, academic
medicine and industry. Learn why these individuals decided
on their career paths, their backgrounds, what they did to
secure their jobs, and if (and how) they would do it again
if they were starting over. After the panel discussion,
there will be time for questions and answers, followed by a
beer/wine reception with hors d’oeuvres. Come join us to
learn how others made career decisions and to meet your
colleagues and the SCM12 faculty.
NKF SCM12
THE LEARNING CONTINUES
Recordings
Most sessions will be recorded.* Mp3s will be available
following the meeting and sold in the Registration Area.
Please check the SCM12 website for additional information.
*Speaker permission must be granted in order to tape a session or a
particular speaker.
Faculty Slide Presentations
Final slide presentations* will be posted on the NKF
website in the weeks following the meeting and will be
made available to the registrants of SCM12. Attendees will
receive an email once the presentations are available.
*Presentations available with faculty permission only.
Follow Us on Facebook, Twitter, and Google+
For conference news, updates, and reminders
Questions? Comments? Write on our wall or tweet @NKFCLINICALS
Tweeting at SCM12? Use #NKFCLINICALS.

SPOTLIGHT ON OUR SPONSORS
The National Kidney Foundation gratefully acknowledges those Corporate Supporters who have helped the
Foundation further its mission of preventing kidney and urinary tract diseases, improving the health and wellbeing
of individuals and families affected by these diseases, and increasing the availability of all organs for
transplantation through our programmatic efforts. A percentage of funds raised are also directed toward the
Foundation’s research program.
The NKF wishes to recognize and thank the following Corporate Supporters:
Abbott
Affymax
Alaska Kidney Foundation
AMAG Pharmaceuticals
American Kidney Fund
Amerigroup
Amgen
Astellas
Baxter
Bayer Schering Pharma
Boehringer Ingelheim
Bristol-Myers Squibb
Chugai Pharmaceutical Co. Ltd
CM&D Pharma
Cranberry Marketing Committee
Daiichi Sanyo
Dialysis Patient Citizens
Dynavax
Embassy of United Arab Emerates
Fresenius Medical Care
Genentech
Genzyme
Hemosphere
NKF SCM12
Lab Corp
Litholink
Merck
Mitsubishi Tanabe Pharma
Musculoskeletal Transplant Foundation
Nephroceuticals
Novartis
Optum Health
Otsuka
Pentec Health
Pfizer
PharmaCosmos
Peking Union Medical College
Questcor
Reata Pharmaceuticals
Sanofi
Shire
Siemens
Sun Pharmaceutical Industries
Takeda
United Health Care
Vascular Access
Vifor International
39 39

40
SPECIAL BREAKFAST, LUNCH, & DINNER
CORPORATE SUPPORTED SYMPOSIA
THURSDAY, MAY 10
6:00am – 7:45am
Comprehensive Management of Mineral and Bone Disorders in
Advanced Chronic Kidney Disease
Supported by an educational donation provided by Amgen
12:00pm – 2:00pm
Bone-Intestinal-Vascular-Renal Axis: Modeling and Managing Calcium and
Phosphorus Disturbances in CKD
Supported by an educational grant from Sanofi
7:30pm – 9:30pm
Nobody Likes Rejection! Practical Guidance on Immunosuppression for 2012
Supported by an educational grant from Bristol-Myers Squibb
FRIDAY, MAY 11
6:00am – 7:45am
Anemia in CKD Stage 5: Balancing Morbidity, Mortality, and Quality of Life
Supported by an educational grant from Affymax, Inc. and Takeda Pharmaceuticals North
America, Inc.
SATURDAY, MAY 12
6:00am – 7:45am
Chronic Mild Hyponatremia Is Not Benign: Implications for Clinical Practice
Supported by an educational grant from Otsuka America Pharmaceutical, Inc.
NKF SCM12

DISCLOSURES of COMMERCIAL RELATIONSHIPS
The National Kidney Foundation is required by the
Accreditation Council for Continuing Medical Education
to disclose support or financial relationships between any
individuals in control of content and commercial entities for
all Continuing Medical Education (CME) activities.
The NKF sent a Disclosure Form to all planners and faculty
participating in the NKF 2012 Spring Clinical Meetings.
All individuals in control of content participating in a
National Kidney Foundation-accredited activity are
expected to disclose to the participants prior to the
educational activity the existence of any financial or other
relationships held by themselves, and/or family members,
with the manufacturer(s) of any commercial products(s)
or provider(s) of any commercial service(s) discussed in an
educational presentation.
Kenneth Abreo
Keli Adis
Anil Agarwal
Consultant/Scientific Advisor: Amgen,
Hospira, Novartis
Rajiv Agarwal
Enver Akalin
Consultant/Scientific Advisor: Genzyme,
Pfizer
Speaker’s Bureau: Novartis
Michael Allon
Consultant/Scientific Advisor: CorMedix
Tracy Anderson-Haag
Kenneth Andreoni
Gerald Appel
Akhtar Ashfaq
Arif Asif
Juan Carlos Ayus
George Bakris
Grant /Research Support: Forest, Novartis
Consultant/Scientific Advisor: Abbott,
Takeda, CVRx, Relapysa, Medtronic,
American Society of Hypertension,
National Kidney Foundation
Lynda Ball
Kyle Ballew
James Balow
Joanne Bargman
Speaker’s Bureau: DaVita Healthcare,
Baxter Healthcare, Amgen
Gerald Beathard
Full/Part-Time Employment: Lifeline
Vascular Access
Bryan Becker
Consultant/Scientific Advisor: Forward
Health Group
Marie Becker
Lorraine Bell
Deborah Benner
Full/Part-Time Employment: DaVita, Inc.
Laurie Benton
Judith Beto
Speaker’s Bureau: Amgen
Roy Bloom
Grant /Research Support: Novartis,
Astellas
Consultant/Scientific Advisor: Alexion,
Novartis, Lifecycle Pharma, Bristol Myers
Squibb
Carl Boethel
Steve Bogatz
W. Kline Bolton
Andrew Bomback
Grant / Research Support: Novartis
Marc Brazie
Patrick Brophy
Rebecca Brosch
Teri Browne
Speaker’s Bureau: Amgen
John Burnett
Consultant/Scientific Advisor: Nile
Pharmaceutical
Jerrilynn Burrowes
Mary Beth Callahan
Mona Calvo
NKF SCM12
The faculty member is also required to disclose to the
activity audience when an unlabeled use of a commercial
product, or an investigational use not yet approved for
any purpose, is discussed during an educational activity.
The intent of this disclosure is to provide attendees with
information prior to their participation in the educational
activity.
Individuals who have nothing to disclose are listed with no
information next to their name. Meeting participants may
also refer to the Session Chair introductory remarks for
each session for final listings of disclosures and off-label or
unapproved usages of a product.
Vito Campese
Katie E. Cardone
Grant /Research Support: Merck & Co.
Consultant/Scientific Advisor: Fresenius
Medical Care
Speaker’s Bureau: AZ Kidney Foundation,
American Nephrology Nurses’ Association
Other Financial or Material Support:
Fresenius Medical Care is spouse’s
employer
Hugh Carey
Juan Carrero
Grant/Research Support: Abbott
Laboratories
Ellen Case
Lee Cauble
Kerri Cavanaugh
Consultant/Scientific Advisor: UCB, Inc.
Michael Cervantes
Micah Chan
Grant/Research Support: Shire
Consultant/Scientific Advisor: Deltanoid
Lakhmir Chawla
Significant Financial Interest: Mako
Surgical, Inc.
Grant/Research Support: Eli Lilly &
Company, Astute Medical
Consultant/Scientific Advisor: Astute
Medical, NxStage Medical, DaVita
Medical, Gambro Medical, Alere Medical
Speaker’s Bureau: Covidien Medical,
NxStage Medical
Full/Part-Time Employment: ASN
Jianghua Chen
Alfred Cheung
41 41

42
DISCLOSURES of COMMERCIAL RELATIONSHIPS continued
Michael Choi
Grant/Research Support: Otsuka
Speaker’s Bureau: Paradigm Medical
Communications
Louise Clement
Carolyn Cochran
Significant Financial Interest: Various may
be included, based on fund manager’s
decisions
Lewis Cohen
Lisa Colaianni
Jill Cole
Full/Part-Time Employment: Greenfield
Health Systems, a division of Henry Ford
Health System
Allan Collins*
Danilo Concepcion
Consultant/Scientific Advisor: HD+
Luis Concepcion
Sandra Coorough
Daniel Coyne
Grant/Research Support: Abbott Renal
Care, Amgen
Consultant/Scientific Advisor: Abbott
Renal Care, Shire
Speaker’s Bureau: Abbott Renal Care
William Cushman
Grant/Research Support: Novartis
Consultant/Scientific Advisor: Takeda,
Daiichi-Sankyo, Novartis, Astra-Zeneca,
Merck, Omron
William Dager
Kristine D’Angelo David
Full/Part-Time Employment: Sigma-Tau
Pharmaceuticals
Ingemar Davidson
Connie Davis
Consultant/Scientific Advisor: Lucassin,
Bristol Myers Squibb
Jane Davis
Angela Degnan
Andrea DeKam
Sevag Demirjian
Consultant/Scientific Advisor: Covidien
Peter DeOreo
Consultant/Scientific Advisor: Arbor
Research Collaborative for Health
Maya Doyle
Amy Dwyer
Grant/Research Support: Bard Peripheral
Vascular, MedComp, Inc.
Kim English
Jessica Farrell
Lisa Farris
Harvey Feldman
Maria Ferris
Fernando Fervenza
Consultant/Scientific Advisor: Genentech,
Questcor Pharmaceutical, TEVA, Novartis
Frederic Finkelstein
Grant/Research Support: Amgen
Consultant/Scientific Advisor: Baxter
Healthcare, Orthobiotech
Catherine Firanek
Full/Part-Time Employment: Baxter
Healthcare Corp.
Agnes Fogo
Nancy Foley
Charles Foulks
Kelly Frank
Marion Franz
Barry Freedman
Linda Fried
Grant/Research Support: Merck, Reata
Melissa Fry
Trisha Fuhrman
Consultant/Scientific Advisor: Abbott
Full/Part-Time Employment: Coram
Healthcare, DCRX
Bina George-Figueroa
Michael Germain
Jeffrey Giullian
Consultant/Scientific Advisor: Otsuka
Pharmaceuticals
Speaker’s Bureau: Otsuka
Pharmaceuticals
Richard Glassock
Consultant/Scientific Advisor: Genentech,
Aspreva/Vifor, Novartis, Bio-Marin,
Bristol-Myers Squibb, Lilly, Mayo Clinic
Full/Part-Time Employment: UpToDate,
ASN
Joel Glickman
Consultant/Scientific Advisor: NxStage
Elaine Go
Christina Goalby
Thomas Golper
Consultant/Scientific Advisor: Baxter,
Affymax, Takeda, DaVita
Speaker’s Bureau: Baxter, Affymax,
Takeda, Fresenius Medical Care, DaVita
Janelle Gonyea
NKF SCM12
Simin Goral
Consultant/Scientific Advisor: Wyeth,
Bristol-Myers Squibb, Novartis, Otsuka,
Mitsubishi Pharma and Kureha
Corporation, Keryx Pharmaceuticals,
Roche, National Institutes of Health
Speaker’s Bureau: Novartis, Genzyme
Bonnie Greenspan
Consultant/Scientific Advisor: BBG
Consulting
Other Financial or Material Support:
Spouse is Medical Director of DaVita and
predecessor companies
Philip Gregory
Full/Part-Time Employment: Current/
Therapeutic Research Faculty
Stephen Grimm
Debra Gromo
Kim Gusse
Lisa Gutekunst
Consultant/Scientific Advisor: Genzyme
Speaker’s Bureau: Genzyme
Lisa Hall
Kevin Harned
Amber Harper
Other Financial or Material Support:
Spouse employee of DaVita and Fresenius
Medical Care
Full/Part-Time Employment: DaVita
Sarah Harper
Alexis Harris
Lori Hartwell
Jeanette Hasse
Rebecca Hays
Speaker’s Bureau: Amgen, Novartis,
Astellas
Aaron Herold
Jonathan Himmelfarb
Consultant/Scientific Advisor: Ardea
Biosciences, Bristol-Myers Squibb,
Thrasos, Aplagon
Sangeeta Hingorani
Diana Hlebovy
Full/Part-Time Employment: Fresenius
Medical Care, HemaMetric
Sue Hoekwater
R. Michael Hofmann
Consultant/Scientific Advisor: NxStage
Medical
Susan Hou

Andrew Howard
Consultant/Scientific Advisor: Fresenius
Medical Care
John Hubbard
Adriana Hung
Craig Hurwitz
Significant Financial Interest:
Visonex, LLC
Cathy Husser
Lesley Inker
Grant/Research Support: Gilead Sciences,
Inc., Pharmalink AB
Consultant/Scientific Advisor:
Oreixgen, Inc.
Joachim Ix
Sophie Jamal
Consultant/Scientific Advisor: Novartis,
Amgen, Warner-Chilcott, Genzyme, Shire
Speaker’s Bureau: Novartis, Amgen,
Warner-Chilcott, Genzyme, Shire
Aimee Jaremowicz
Speaker’s Bureau: Genzyme
Full/Part-Time Employment: Pentec Health
Charles Jennette
R. Allan Jhagroo
Kirsten Johansen
Rebecca Johnson
Grant/Research Support: Pfizer
Sharon Johnson
Stephanie Johnstone
Jessica Joseph
Peter Juergensen
Speaker’s Bureau: Amgen, Genzyme
Luis Juncos
Speaker’s Bureau: Gambro
Claudine Jurkovitz
Kamyar Kalantar-Zadeh
Grant/Research Support: Abbott, Shire
Consultant/Scientific Advisor: Abbott
Nutrition, Otsuka
Kamel Kamel
Judith Kari
Bertram Kasiske
Grant/Research Support: Genzyme,
Bristol-Myers Squibb, Merck-Sherring
Plough
Consultant/Scientific Advisor: LithoLink
(Labcorp)
Mary Pat Kelly
Kay Kendall
Jackie Kite
Stephen Knohl
Nina Kolbe
Speaker’s Bureau: Shire
Dawn Koonkongsatian
Jeffrey Kopp
Nelson Kopyt
Csaba Kovesdy
Grant/Research Support: Abbott,
Genzyme, Shire
Consultant/Scientific Advisor: Genzyme
Speaker’s Bureau: Abbott
Holly Kramer
Raymond Krediet
Grant/Research Support: 2010 Grant
support for study of peritoneal glycocalyx
Alison Kregness
Karen Kritsch
Dana Kumjian
Kathy Lahr
David Lammert
Carol Langford
Grant/Research Support: Genentech,
Bristol-Myers Squibb
Timothy Latimer
Timmy Lee
Consultant/Scientific Advisor: Proteon
Therapeutics
David Leehey
Janeen Leon
Mary Leonard
Thomas Lepetich
Marianna Leung
Nelson Leung
Grant/Research Support: Binding Site
Philip Li
Grant/Research Support: Baxter
Healthcare
Consultant/Scientific Advisor: Baxter
Healthcare
Mike Lilly
Anita Lipman
Kathleen Liu
Significant Financial Interest: Amgen,
Procter & Gamble
Grant/Research Support: Amgen, CMIC
Consultant/Scientific Advisor: Astute,
Cytopheryx
Charmaine Lok
Consultant/Scientific Advisor: Cormedix,
Gore
Speaker’s Bureau: Gore, Roche,
RMS Lifeline
Gloria Ramos-Lozano
Eileen MacFarlane
Full/Part-Time Employment: WellBound
of Mercer, Renal Ventures, Renal Center
of Brick
Hartmut Malluche
NKF SCM12
Barbara Weis Malone
Speaker’s Bureau: Novartis, Amgen
Bradley Manton
Kevin Martin
Consultant/Scientific Advisor: Abbott,
Shire, Cytochroma, Genzyme, KAI
Speaker’s Bureau: Abbott
Linda McCann
Consultant/Scientific Advisor: Amgen,
Genzyme
Speaker’s Bureau: Amgen, Genzyme
Full/Part-Time Employment: Genzyme
Maureen McCarthy
Melissa McCool
Significant Financial Interest: STI
Innovations
Officer/Director/Holder: STI Innovations
Full/Part-Time Employment: STI
Innovations
Peter McCullough
Matthew McDonough
Mary McKinney
Anthony Meade
Consultant/Scientific Advisor: Amgen
Speaker’s Bureau: Amgen, Baxter
Rajnish Mehrotra
Grant/Research Support: Baxter
Healthcare, DaVita
Speaker’s Bureau: Baxter Healthcare
Erica Meredith
Klemens Meyer
Consultant/Scientific Advisor: Dialysis
Clinic, Inc.
Officer/Director/Holder: Dialysis Clinic,
Inc.
Miriam Michael
Speaker’s Bureau: Genzyme
Officer/Director/Holder: American Renal
Associates
Rosemarie Miller
Tracy Greene Mintz
Sharon Moe
Grant/Research Support: Genzyme,
Amgen, Shire
Consultant/Scientific Advisor: Genzyme,
Amgen, Shire, Litholink, KAI, Novartis
Louise Moist
Consultant/Scientific Advisor: Roche,
Merck
Speaker’s Bureau: Merck
Jean Moody-Williams
Eileen Moore
Ranjani Moorthi
Stuart Mott
Bruce Mueller
Grant/Research Support: Cubist, Roche,
Amgen, Merck, Ortho
43 43

44
DISCLOSURES of COMMERCIAL RELATIONSHIPS continued
Mohanaram Narayanan
Danielle Nathan
Annette Needham
Christina Nelms
Sharon Nessim
Speaker’s Bureau: Baxter Healthcare,
Merck Frost
Shari Neul
Marianne Neumann
Mark Neumann
Vandana Niyyar
Tom Nolin
Linda Noto
Full/Part-Time Employment: Pentec
Health
Joyce O’Dea
Ann O’Hare
Jennifer O’Neill
Ali Olyaei
Paul Palevsky
Grant/Research Support: Spectral
Diagnostics
Consultant/Scientific Advisor: Sanofi,
Cytophryx
Alan Pao
Heather Paradis
Rulan Parekh
Grant/Research Support: Abbott
Chirag Parikh
Chhaya Patel
Priti Patel
Uptal Patel
Grant/Research Support: Merck & Co.,
Inc.
Consultant/Scientific Advisor: Amgen,
Daiichi Sankyo, Luitpold Pharma, Angion
Biomedica Corp., CSL Limited
Jessie Pavlinac
Danielle Peabody
Leanne Peace
Eileen Peacock
Mark Perazella
Cintia Perez
Pablo Pergola
Grant/Research Support: Reata
Pharmaceuticals
Consultant/Scientific Advisor: Reata
Pharmaceuticals
Gary Petingola
Jessica Phipps
Lynn Poole
Michael Powe
Megan Prescott
Lynn Puma
Susan Quaggin*
Alejandro Quiroga
Jai Radhakrishnan
Vernadette Ramos
Forest Rawls
Heather Reich
Grant/Research Support: Amgen Canada
James Riley
Kathy Riley
Eberhard Ritz
Grant/Research Support: Abbott, Daiichi-
Sankyo, Mitsubishi
Speaker’s Bureau: Abbott
Bruce Robinson
Grant/Research Support: Amgen, Kyowa
Hakko Kirin, Genzyme, Abbott
Irene Rosario
Alex Rosenblum
Mitchell Rosner
Consultant/Scientific Advisor: Gambro,
Opsona Pharmaceuticals, Astute Medical,
Johnson & Johnson
Jamie Ross
Significant Financial Interest: Hotspur
Technologies
Consultant/Scientific Advisor: Hotspur
Technologies, Bard, Covidien, Gore
Lainie Friedman Ross
Mario Rubin
George Saab
Bharat Sachdeva
Grant/Research Support: Bard Peripharal
Loay Salman
Anthony Samaha
Heidi Schaefer
Dori Schatell
Other Financial or Material Support: FMS,
NxStage, Amgen, Baxter, DaVita, Satellite,
DCC, DCI, Networks 8 & 13, Liberty, NKC,
Renal Advantage
Laura Schmidt
Jesse Schold
Wendy Schrag
Martin Schreiber
Speaker’s Bureau: Baxter Healthcare
Sarah Schuh
Nancy Scott
NKF SCM12
Dorry Segev
Consultant/Scientific Advisor: Sanofi
Speaker’s Bureau: Sanofi
Maritsa Serlemitsos-Day
Sanjeev Sethi
Amma Sewaah-Bonsu
Amit Sharma
Consultant/Scientific Advisor: Renal
Solution, Amgen, AMAG, Abbott
Speaker’s Bureau: Genzyme
Diana Shelkov
Paula Shelton
Michael Shlipak
Edward Siew
Consultant/Scientific Advisor: Alere, Inc.
Vernon Silva
Terri Silverman
Christopher Simon
Shane Simon
Full/Part-Time Employment: DaVita
Rachel Skumanich
Renata Sledge
Consultant/Scientific Advisor: Education
Committee, KDOQI
Full/Part-Time Employment: Elsevier,
National Kidney Foundation
Vivek Soi
Ulrech Specks
Grant/Research Support: Genentech/
BiogenIDEC
Consultant/Scientific Advisor: Genentech
Teri Spencer
John Sperati
David Spiegel
Grant/Research Support: Amgen,
Genentech, Keryx
Consultant/Scientific Advisor: Genzyme,
Amgen
Speaker’s Bureau: Amgen
Wendy St. Peter
Grant/Research Support: Amgen,
Genzyme, Shire, Abbott
Consultant/Scientific Advisor: Mitsubishi
Tanabe Pharma
Randall Starling
Consultant/Scientific Advisor: Novartis,
Thoratec, Medtronic, BioControl
Alison Steiber
Grant/Research Support: Sigma Tau
Pharmaceuticals, Inc., Genzyme, Inc.
Consultant/Scientific Advisor:
Nephroceuticals, Inc., Abbott,
Speaker’s Bureau: Sigma Tau
Pharmaceuticals, Inc., Pentech, Inc.

Peter Stenvinkel
Grant/Research Support: Amgen
Consultant/Scientific Advisor: Gambro,
Abbott, BMS
Brian Stephany
Stephanie Stewart
Kristin Stockard
Duane Sunwold
Marilyn Swartz
Lynda Szczech
Grant/Research Support: GSK
Consultant/Scientific Advisor: Gilead,
Roche, Affymax, Kureha, Astra-Zeneca,
Merck, AVI, Baxter
Speaker’s Bureau: FMC-NA, AMAG, Gilead
Harold Szerlip
Grant/Research Support: Spectral
Diagnostics, CytoPherx
Manjula Kurella Tamura
Consultant/Scientific Advisor: Amgen
W.H. Wilson Tang
Grant/Research Support: Abbott
Laboratories
Consultant/Scientific Advisor: Medtronic
Inc., St. Jude Medical
Eric Taylor
Victor Test
Ravi Thadhani
Grant/Research Support: Abbott
Laboratories
Consultant, Scientific Advisor: Fresenius
Medical Care-North America
Charuhas Thakar
Consultant/Scientific Advisor:
Cytopherx PSI Foundation, Novartis
Research Support: Reata
Charlie Thomas
Consultant/Scientific Advisor: Salt River
Pima-Maricopa Indian Community
Speaker’s Bureau: Novartis
Aliza Thompson
Raymond Townsend
Grant/Research Support: Novartis, NIH
ConsultantScientific Advisor; Pfizer
Speaker’s Bureau: ASH, ASN, AHA
Laura Troidle
Mandy Trolinger
Katherine Tuttle
Consultant/Scientific Advisor: Centocor, Eli
Lilly and Company
Aris Urbanes
Consultant/Scientific Advisor: Bard
Peripheral Vascular
Full/Part-Time Employment: DaVita
Tushar Vachharajani
Grant/Research Support: Tyco Healthcare
Suzann VanBuskirk
Joseph Vassalotti
Consultant/Scientific Advisor: CTI Clinical
Trials and Consulting Services
Speaker’s Bureau: Gore Creative
Technologies, Elsevier Health
Joseph Verbalis
Consultant/Scientific Advisor: Astellas,
CardioKine, Otsuka
Bradley Warady
Grant/Research Support: Baxter
Consultant/Scientific Advisor: Genzyme,
Abbott, Amgen, Fresenius
Richard Ward
Grant/Research Support: Gambro,
Rockwell Medical Technologies,
Consultant/Scientific Advisor: Fresenius,
Church & Dwight
Speaker’s Bureau: Fresenius
Sonia Washington
Amy Waterman
Emily Watson
Lawrence Weisberg
Grant/Research Support: Spectral
Diagnostics, Inc., Mitsubishi Tanabe
Pharma
Consultant/Scientific Advisor: Spectral
Diagnostics, Inc.
Catherine Wells
Speaker’s Bureau: Amgen
Adam Whaley-Connell
Karen Wiesen
Consultant/Scientific Advisor: Shire
Dawn Wilson
Cheryl Winterich
Alexander Wiseman
Consultant/Scientific Advisor: Wyeth,
Novartis, Gilead, Bristol-Myers Squibb,
Genzyme
Speaker’s Bureau: Wyeth, Novartis
Jay Wish
Consultant/Scientific Advisor: Watson,
AMAG, Amgen, Genzyme, Affymax
Speaker’s Bureau: Watson, AMAG,
Amgen, Genzyme
Beth Witten
Myles Wolf
William Wolfe
Karl Womer
Grant/Research Support: Bristol-Myers
Squibb
Jerry Yee
Consultant/Scientific Advisor: Amgen,
Otsuka, Takeda/Affymax, Genzyme,
Watson, Merck
Speaker’s Bureau: Amgen, Otsuka,
Takeda/Affymax, Genzyme
Alexander Yevzlin
NKF SCM12
Jana Zimmer
Troy Zimmerman
Kim Zuber
Patrice Zyry
45 45

46
NATIONAL KIDNEY FOUNDATION CONTINUING MEDICAL EDUCATION
PROGRAM MISSION STATEMENT
The mission of the National Kidney Foundation (NKF)
Continuing Medical Education Program is to provide
education for academic as well as private practitioners in
nephrology and other specialties/disciplines impacted by
kidney disease. These education activities are offered to
regional, national and international audiences.
PURPOSE:
To change clinical practice and improve patient outcomes
through education, information and the opportunity to
practice in a virtual clinical setting. To provide all members
of the kidney healthcare community with current, state of
the art scientific information on prevention, diagnosis and
treatment of chronic kidney disease (CKD) and urinary tract
diseases in order to improve the care of individuals with
CKD and those at risk for developing it.
CONTENT AREA:
Content areas span the scope of kidney disease and include:
risk factors, screening, diagnosis, staging, co-morbidities
and complications such as diabetes, hypertension,
cardiovascular disease, anemia, mineral and bone disorder
(MBD), chronic kidney disease, kidney failure, dialysis, acute
kidney injury, infectious diseases as they relate to kidney
disease, all aspects of kidney transplantation, and patient
safety issues. Selected topics are based on identified
need and gaps in physician knowledge, competence
and performance regarding the care and treatment of
individuals affected by kidney disease. Kidney Disease
Outcomes Quality (KDOQI) and Kidney Disease Improving
Global Initiatives (KDIGO) evidence based guidelines and the
latest peer-reviewed clinical science provide the foundation
for developing much of the content associated with best
practice, as do professional interests, expert opinions,
literature reviews and needs assessment data from patients
and caregivers that identify gaps in quality of care relative to
physician implementation of the science.
TARGET AUDIENCES:
Practicing physicians, residents, and fellows in nephrology
and other specialties including internal medicine, cardiology,
endocrinology, family practice, hospitalists; advanced
practitioners (physician assistants, nurse practitioners),
nurses, pharmacists and other disciplines in any setting who
care for individuals who are at increased risk for, or affected
by, kidney disease.
TYPES OF ACTIVITIES:
Activities are carefully designed to provide opportunities to
maximize learning and retention. Strategies to engage the
physician/other learners based on adult learning principles
along with critical thinking techniques to facilitate use of
higher order cognitive skills (reflection on what they know,
challenging assumptions, exploring/weighing alternatives)
are incorporated into all activities to facilitate application
of new learning and/or clinical strategies to patient care.
NKF SCM12
Teaching/learning methodologies include case study
presentation and discussion, virtual patient problemsolving,
question and answer, multi-media teaching/
learning tools, and others such as breakout sessions, small
group/individual exercises, depending on format (live or
enduring). Live activities include conferences, symposia,
courses, grand rounds, hands-on workshops, audience
response sessions, and debates. Enduring materials include
monographs, CD-ROMs and internet-based activities such as
webcasts and webinars.
EXPECTED RESULTS:
Expected results include improved physician knowledge,
competence and performance in order to maximize the
quality of care given to patients. Expected changes in care
focus on earlier identification of CKD and its risk factors and
use of evidence based treatment strategies to slow CKD
onset and reduce risk of CKD progression and development
of kidney failure and need for renal replacement therapy;
earlier and more up-to-date and evidence based treatment
of co-morbid conditions to avoid premature death from
cardiovascular disease and other complications; preemptive
kidney transplantation which yields better
outcomes than dialysis; improved patient safety relative
to drug dosing, medication therapies, quality of life and
early mortality. The expected results will be accomplished
through physician and other clinician education by providing
comprehensive educational activities that incorporate
up-to-date science, evidence based practice guidelines and
expert opinion; and by offering a variety of learning formats
to meet the diverse needs and preferences of learners.
Results/learning outcomes are evaluated immediately
post-participation by post-testing and feedback from
activity evaluations that ask learners about applicability of
the activity content to their scope/practice; commitment
to change; and how they plan to apply content to make
changes in clinical practice to improve patient outcomes.
A 3-6 month outcomes study collects data and measures
the resulting changes in knowledge acquisition, perception,
competency and behavior/clinical practices related to
activity content and learning objectives as well as identify
barriers to implementation. Indication by the learners of
the number of patients seen per week allows for projection
of potential beneficial impact of changes in practice on
patients. NKF’s data and other national screening and
mortality data will indicate trends over time in key CKD
patient outcomes metrics. This data will also help in
ongoing quality improvement of the CME Program.

PHYSICIAN & PHARMACIST PROGRAM
ACCREDITATION
The National Kidney Foundation is accredited by the
Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
CME CREDIT
The National Kidney Foundation designates this live activity
for a maximum of 30.0 AMA PRA Category 1 Credit(s) TM .
Physicians should claim only the credit commensurate with
the extent of their participation in the activity.
Note: Acquiring 30 .0 hours requires continuous participation
from Wednesday morning through Sunday morning. Many
participants opt for periodic breaks, which make their
reported credit hours somewhat less. Additional credits
are provided for courses requiring separate registration, as
noted below.
COURSE CREDITS
Transplant 7.0
Integrated Hemodialysis/Peritoneal Dialysis
Supported in part by Baxter Healthcare Corporation
8.0
Interventional Nephrology 7.5
In-kind support provided by GE
Healthcare, Inc., Covidien, and Bard.
Dialysis Unit Management 7.0
CKD Clinics 7.0
A Practical Approach to Renal Pathology 7.0
Glomerular Diseases: 8.0
Updates on Pathogenesis and Treatment
Supported by an educational grant from Questcor
Pharmaceuticals, Inc.
Cleveland Clinic Cardiorenal Update 4.0
PHARMACISTS
The University of Illinois at Chicago College of
Pharmacy is accredited by the Accreditation
Council for Pharmacy Education (ACPE) as a
provider of pharmacy continuing education.
Attendance at the entire knowledge-based program and
completion of the self-assessment questions and evaluation
form are prerequisites for receiving a statement of
continuing education credit for 28.5 contact hours (2.85
CEUs).
You will be notified via e-mail within 6 weeks of the program
date when your statement of pharmacy credit is available.
Please see the ACPE handout provided to you at registration
for a full list of approved sessions and ACPE Universal
Activity Numbers (UANs).
NKF SCM12
PRE-CONFERENCE COURSES
REQUIRED: Additional registration fee of $175 / $75 for
fellows and residents; $225 when registering for the
course only. Includes syllabus, breakfast, boxed lunch, and
CME/CE credits.
● TRANSPLANT
Wednesday, May 9
7:30am – 4:30pm
Course Director: Heidi Schaefer, MD, FNKF
Session 220, 7.0 credits
Target Audience: Designed for community nephrologists,
transplant nephrologists, nephrology fellows, transplant
coordinators, transplant pharmacists, and other professionals
involved in the care of the kidney transplant patient.
Course Description: This course offers the attendee a
comprehensive understanding of medical issues that affect
the kidney transplant recipient. Each lecture will begin with
a case presentation and the speaker will be asked to “work
through the case,” focusing on the topic at hand. At the
end of each session, the panel of speakers will be asked to
discuss additional cases. Audience participation
is encouraged.
Course Objectives: Upon completion of this course,
participants will be able to:
z Discuss common medical complications in the kidney
transplant recipient and describe appropriate treatment
strategies
z Be familiar with current and upcoming
immunosuppressive regimens
z Describe immunologic high risk transplants and discuss
current treatment protocols
z Determine how to manage the failed allograft
z Describe the role of dual organ transplantation in select
patient populations
PHYSICIAN
47 47

48
PHYSICIAN PROGRAM continued
Course Agenda:
TIME TOPIC FACULTY
7:30am – 8:00am Breakfast
Session I
8:00am – 8:30am Cardiovascular Evaluation of Kidney Transplant Recipients Mario Rubin, MD, FASN, FNKF
8:30am – 9:00am Role of Pancreas Transplant for Diabetic Patients Alexander Wiseman, MD, FACP
9:00am – 9:30am Malignancy and the Kidney Transplant Recipient Bertram Kasiske, MD
9:30am – 10:00am Panel Discussion
10:00am – 10:15am Break
Session II
10:15am – 10:45am Transplantation of the Sensitized Patient Enver Akalin, MD
10:45am – 11:15am Management of Transplant Glomerulopathy Simin Goral, MD
11:15am – 11:45am Panel Discussion
11:45am – 12:45pm Lunch
Session III
12:45pm – 1:15pm Acute Kidney Injury in the Transplant Recipient R. Michael Hofmann, MD
1:15pm – 1:45pm Use of Belatacept as Maintenance Immunosuppression Karl Womer, MD
1:45pm – 2:15pm Management of the Failed Allograft Juan Carlos Ayus, MD, FACP, FASN
2:15pm – 2:45pm Panel Discussion
2:45pm – 3:00pm Break
Session IV
3:00pm – 3:30pm Hepatitis and the Kidney Transplant Recipient Roy Bloom, MD
3:30pm – 4:00pm Liver-Kidney Transplant: Who, When, and Why Connie Davis, MD
4:00pm – 4:30pm Panel Discussion
NKF SCM12

● INTEGRATED HEMODIALYSIS/PERITONEAL
DIALYSIS
Supported in part by Baxter Healthcare Corporation
Wednesday, May 9
7:00am – 5:00pm
Course Director: Joanne Bargman, MD, FRCPC
Session 221, 8.0 credits
Target Audience: Designed for nephrologists, nephrology
fellows, advanced practitioners, and nephrology nurses.
Course Description: This course will deliver an integrated
and comprehensive approach to the physiologic
underpinnings and “nuts and bolts” of chronic dialysis
therapy. Approaches to the optimal management of
chronic dialysis patients with respect to extracellular fluid
volume control, solute removal, access complications, and
other infectious and non-infectious complications will be
discussed for both peritoneal and hemodialysis.
Course Agenda:
NKF SCM12
Course Objectives: Upon completion of this course,
participants will be able to:
z Identify the physics, physiology and techniques of
peritoneal dialysis and hemodialysis
z State the basis and practical application of dialysis dose
prescription in peritoneal and hemodialysis
z Know the infectious and noninfectious complications of
peritoneal and hemodialysis
z Describe the importance of proper access in both
peritoneal dialysis and hemodialysis and potential
complications of access problems
z Review special issues pertaining to dialysis in infants
and children
z Identify treatment-related complications in peritoneal
and hemodialysis and discuss potential treatment
strategies
TIME TOPIC FACULTY
7:00am – 7:30am Breakfast
7:30am – 7:45am Introduction – Why Are We Here? Joanne Bargman, MD, FRCPC
7:45am – 8:15am How Hemodialysis Works Daniel Coyne, MD
8:15am – 8:45am The Physiology of Peritoneal Dialysis Joanne Bargman, MD, FRCPC
8:45am – 9:15am Access in Hemodialysis Timmy Lee, MD, MSPH, FACP, FASN
9:15am – 9:45am PD Catheter Placement and Management Rajnish Mehrotra, MBBS, MD, FNKF
9:45am – 10:30am Hemodialysis Prescription, Adequacy, and Volume Control Daniel Coyne, MD
10:30am – 10:45am Break
10:45am – 11:30am Peritoneal Dialysis Prescription and Adequacy Sharon Nessim, MD
11:30am – 12:15pm Managing Ultrafiltration and Volume Control in Peritoneal Dialysis Rajnish Mehrotra, MBBS, MD, FNKF
12:15pm – 1:15pm Lunch
1:15pm – 1:45pm Prevention and Management of Infections in Hemodialysis Charmaine Lok, MD, MSc, FNKF
1:45pm – 2:15pm Prevention and Management of Infections in Peritoneal Dialysis Sharon Nessim, MD
2:15pm – 2:45pm Special Considerations in Infants and Children Bradley A. Warady, MD, FNKF
2:45pm – 3:15pm Non-Infectious Complications of Hemodialysis Thomas A. Golper, MD, FACP, FASN
3:15pm – 3:30pm Break
3:30pm – 4:00pm Non-Infectious Complications of Peritoneal Dialysis Joanne Bargman MD, FRCPC
4:00pm – 4:30pm Home Dialysis: Improved Quality of Life for Both Patient and Physician Thomas A. Golper, MD, FACP, FASN
4:30pm – 5:00pm Q&A and Evaluations
PHYSICIAN
49 49

50
PHYSICIAN PROGRAM continued
● INTERVENTIONAL NEPHROLOGY
In-kind support provided by GE Healthcare, Inc., Covidien,
and Bard
Wednesday, May 9
7:30am–5:15pm
Course Co-Directors: Loay Salman, MD, and
Amy Dwyer, MD, FACP
Session 222, 7.5 credits
Target Audience: Designed for clinical nephrologists,
nephrology fellows, advanced practitioners and other
healthcare professionals caring for patients with chronic
kidney disease.
Course Description: This course provides a well-rounded
education about hemodialysis access, peritoneal dialysis,
and ultrasound principles. The course will focus on vascular
access care as part of general nephrology practice. It
is also an introduction to a variety of interventional
and diagnostic procedures used by interventional
nephrologists to establish, monitor and maintain a
healthy and functional dialysis access. These procedures
include: diagnostic and ultrasound-guided renal biopsy,
placement of temporary and permanent central venous
catheters for hemodialysis, placement of peritoneal
dialysis catheters, vascular mapping, monitoring and
surveillance of vascular access, and salvage procedures for
failing or thrombosed arteriovenous fistulas and grafts. In
addition, hands-on training workshops focus on physical
exam of the vascular access, insertion of tunneled dialysis
catheters, percutaneous balloon angioplasty, mechanical
thrombectomy procedures, and ultrasound applications in
renal patients.
NKF SCM12
Course Objectives: Upon completion of this course,
participants will be able to:
z Recognize the anatomy of the vessels commonly used
for hemodialysis access
z Know the proper physical exam of a dialysis vascular
access
z Review the pre-operative evaluation for hemodialysis
vascular access placement
z Review vascular access surveillance techniques
z Identify the signs and symptoms of vascular access
dysfunction
z Differentiate the possibilities of hand ischemia by
patient history and physical exam
z Become familiar with basic interventional techniques
used to diagnose and treat vascular access dysfunction
z Become familiar with the techniques for peritoneal
catheter placement
z Identify the indications for renal artery imaging
z Become familiar with the tunneled catheter placement
procedure
z Recognize how to manage dialysis catheter dysfunction
z Review how to manage catheter-related bacteremia
z Determine the indications and appropriate patient
population for PD catheter placement
z Identify the possible uses of renal ultrasound
z Determine indications and contraindications for
renal biopsy
z Identify the role of a vascular access coordinator

Interventional Nephrology Course Agenda:
TIME TOPIC FACULTY
7:30am – 7:50am Continental Breakfast
7:50am – 7:55am Welcome and Introduction Loay Salman, MD
Amy Dwyer, MD, FACP
PLANNING AND PLACING A NEW ACCESS
7:55am – 8:00am ASDIN President’s Welcome Aris Urbanes, MD
8:00am – 8:15am Physical Exam of a Vascular Access Arif Asif, MD, FNKF
8:15am – 8:30am Vein Preservation 2012 Jamie Ross, MD
8:30am – 8:45am Vessel Mapping, When and How? Vandana Niyyar, MD
THE DYSFUNCTIONAL ACCESS
8:45am – 9:00am Access Surveillance, Should We Do It? Alexander Yevzlin, MD
9:00am – 9:15am Signs and Symptoms of Hemodialysis Access Dysfunction Kevin Harned, MD
9:15am – 9:30am Management of Access Dysfunction Aris Urbanes, MD
9:30am – 9:45am Is My New Fistula Ready? What Is an Immature Fistula? When Should
I Intervene?
NKF SCM12
Gerald Beathard, MD, PhD, FASN
9:45am – 10:00am Hand Ischemia: Physical Exam, Diagnosis, and Management Loay Salman, MD
10:00am – 10:15am The Failing Access: When Should I Send Patients for Secondary
Fistula?
10:15am – 10:25am Questions
10:25am –10:40am Break
DIALYSIS CATHETERS
Anil Agrawal, MD, FAHA, FASN, FASH
10:40am – 10:50am Tunneled Dialysis Catheter Insertion Amy Dwyer, MD, FACP
10:50am – 11:00am Tunneled Hemodialysis Catheter Dysfunction: How Do I Manage It? Anthony Samaha, MD
11:00am – 11:10am Tunneled Hemodialysis Catheter-Related Bacteremia: How Do I
Manage It?
RENAL IMAGING
Tushar Vachharajani, MD, FACP, FASN
11:10am – 11:25am Renal Ultrasound Vandana Niyyar, MD, FASN
11:25am – 11:40am Renal Biopsy Bharat Sachdeva, MD
11:40am – 11:55am Renal Artery Interventions:
When Should We Consider It?
11:55am – 12:00pm Questions
12:00pm – 1:00pm Lunch
PERITONEAL CATHETERS
Alexander Yevzlin, MD
1:00pm – 1:15pm Peritoneal Dialysis: Is It First Choice or Last Resort? Kenneth Abreo, MD
1:15pm – 1:30pm Peritoneal Dialysis Catheter Placement Bharat Sachdeva, MD
1:30pm – 1:45pm Non-Infectious Complications of PD Kenneth Abreo, MD
1:45pm – 2:00pm The Role of a Vascular Access Coordinator Paula Shelton, RN, BSN
2:00pm – 2:15pm Buttonholes: Should We Use Them? Arif Asif, MD, FNKF
2:15pm – 2:25pm Questions
2:25pm – 2:45pm Interesting Cases Loay Salman, MD, Amy Dwyer, MD, FACP
2:45pm – 3:00pm Assignments of Workshops and Break
3:00pm – 5:15pm WORKSHOPS
Potomac 3 Workshop A - Physical Exam Arif Asif, MD, FNKF, Kevin Harned, MD, Paula
Shelton, RN, BSN, Alexander Yevzlin, MD
Potomac 4 Workshop B - Renal Ultrasound Vandana Niyyar, MD, FASN, Kenneth Abreo,
MD, Bharat Sachdeva, MD
Potomac 5 Workshop C - Endovascular Techniques Anil Agrawal, MD, FNKF, Aris Urbanes, MD,
Gerald Beathard, MD, FASN
Potomac 6 Workshop D - Tunneled Catheter Placement Anthony Samaha, MD, Tushar Vachharajani,
MD, FACP, FASN, Jamie Ross, MD
PHYSICIAN
51 51

52
PHYSICIAN PROGRAM continued
● DIALYSIS UNIT MANAGEMENT
Wednesday, May 9
7:30am – 4:30pm
Course Director: Peter B. DeOreo, MD, FACP
Session 223, 7.0 credits
Target Audience: Designed for physicians, medical directors,
nurse managers, quality managers
NKF SCM12
Course Description: In the second performance year of
the QIP under the prospective payment system are we
learning anything? Are the oversight and expectations of
external regulators driving activity that is improving patient
outcomes? A diverse group of experts will review the
current regulatory environment and how successful facilities
integrate QAPI into the day-to-day care of their patients.
Objectives: Upon completion of this course, participants
will be able to align patient-centered care with regulatory
compliance and priority setting in the bundled environment.
Course Agenda:
TIME TOPIC FACULTY
7:30am – 8:00am Continental Breakfast
8:00am – 8:15am Welcome and Introduction Peter B. DeOreo, MD, FACP
8:15am – 9:00am Reading the Balance Sheet Cheryl Winterich, BS
9:00am – 9:45am Accountability: CMS, the Networks, and P4P Jay Wish, MD
9:45am – 10:30am Legal and Regulatory Issues James Riley, ESQ
10:30am – 10:45am Break
10:45am – 11:30am CMS Survey Judith Kari, MSSW, ACSW, LICSW
11:30am – 12:15pm Roadmap to EMR Optimization and a Data-Driven QAPI Program Craig Hurwitz, MD
12:15pm – 1:15pm Lunch
1:15pm – 2:00pm Using the Patient Experience of Care to Advance QAPI Klemens Meyer, MD
2:00pm – 2:45pm Home Dialysis Thomas Golper, MD, FACP, FASN
2:45pm – 3:30pm Management of the Dialysis Unit from a Technical Standpoint Richard Ward, PhD
3:30pm – 4:15pm Infection Control Update Priti Patel, MD
4:15pm – 4:30pm Evaluations

● A PRACTICAL APPROACH TO RENAL PATHOLOGY
Wednesday, May 9
7:30am – 5:00pm
Course Directors: Agnes Fogo, MD, and
Charmaine E. Lok, MD, MSc, FNKF
Session 224, 7.0 credits
Target Audience: Designed for nephrologists, nephrology
fellows, pathology fellows, and advanced practitioners.
Course Description: This course will deliver a practical,
integrated and comprehensive approach to the basics
of renal pathology. An approach to interpreting,
understanding, and applying the findings of renal pathology
will be taught and based on common yet challenging clinical
cases. A “hands-on” environment using virtual slides will be
combined with lectures and clinical discussion to provide
the participant with a well-rounded learning experience.
Key topics will cover a spectrum of diseases affecting
the native kidney, including glomerular, tubular and
vascular processes. Topics addressed will include diabetic
nephropathy, examples of immune complex disease,
NKF SCM12
differential of minimal change disease vs. FSGS, causes of
RPGN, monoclonal protein-related kidney disease, acute
tubular injury, and thrombotic microangiopathy. Virtual
slides and case histories will be distributed electronically in
advance for participants to study.
Course Objectives: Upon completion of this course,
participants will be able to:
z Gain a basic approach to interpreting renal pathology
z Identify key lesions differentiating selected glomerular,
tubular and vascular diseases
z Identify basic and distinguishing pathologic features
associated with common conditions
z Become familiar with histopathologic classification of
common glomerular diseases
z Recognize the implications of specific pathologic
findings for patient care
Course Agenda:
TIME TOPIC FACULTY
7:30am – 8:00am Breakfast
8:00am – 8:15am Introduction Agnes Fogo, MD
Charmaine E. Lok, MD, MSc, FNKF
8:15am – 9:00am Basic Approach to Renal Biopsy
Selected Stains and LM/IF/EM Findings
9:00am – 9:15am Biopsy of the Diabetic Patient
Clinical Indications
Charles Jennette, MD
Agnes Fogo, MD
Heather Reich, MD
Charmaine E. Lok, MD, MSc, FNKF
9:15am – 10:00am Biopsy Findings in the Diabetic Patient- Interactive Case-Based Study Charles Jennette, MD
Agnes Fogo, MD
10:00am – 10:15am Break
10:15am – 11:15am The Nephrotic Patient
Clinical Indications for Biopsy/Interactive Case-Based Study of Biopsy
Findings
11:15am – 12:15pm The Patient with SLE
Clinical Indications for Biopsy/Interactive Case-Based Study of Biopsy
Findings
12:15pm – 1:15pm Lunch
1:15pm – 2:30pm The Patient with RPGN
Clinical Indications for Biopsy/Interactive Case-Based Study of
Biopsy Findings
Heather Reich, MD
Charmaine E. Lok, MD, MSc, FNKF
Charles Jennette, MD
Agnes Fogo, MD
Heather Reich, MD
Charmaine E. Lok, MD, MSc, FNKF
Charles Jennette, MD
Agnes Fogo, MD
Heather Reich, MD
Charmaine E. Lok, MD, MSc, FNKF
Charles Jennette, MD
Agnes Fogo, MD
PHYSICIAN
53 53

54
PHYSICIAN PROGRAM continued
TIME TOPIC FACULTY
2:30pm – 2:45pm Break
2:45pm – 3:30pm The Patient with Monoclonal Gammopathy
Clinical Indications for Biopsy/Interactive Case-Based Study of Biopsy
Findings
3:30pm – 4:15pm The Patient with Acute Kidney Injury–Part 1
Clinical Indications for Biopsy/Interactive Case–
Based Study of Biopsy Findings
4:15pm – 4:45pm The Patient with Acute Kidney Injury–Part 2
Clinical Indications for Biopsy/Interactive Case-Based Study
of Biopsy Findings
NKF SCM12
Heather Reich, MD,
Charmaine E. Lok, MD, MSc, FNKF,
Charles Jennette, MD,
Agnes Fogo, MD
Heather Reich, MD,
Charmaine E. Lok, MD, MSc, FNKF,
Charles Jennette, MD,
Agnes Fogo, MD
Heather Reich, MD,
Charmaine E. Lok, MD, MSc, FNKF,
Charles Jennette, MD,
Agnes Fogo, MD
4:45pm – 5:00pm Summary Agnes Fogo, MD,
Charmaine E. Lok, MD, MSc, FNKF
● CKD CLINICS
Wednesday, May 9
7:30am – 5:00pm
Course Directors: Jerry Yee, MD, FACP, FASN, FNKF,
and Sandeep Soman, MD, FNKF
Session 225, 7.0 credits
Target Audience: Designed for nephrologists, fellows,
advanced practitioners, nurses, pharmacists, and clinic
administrators.
Course Description: This course is designed to offer
the attendee a complete understanding of the optimal
management of CKD and the needs for operationalizing a
CKD clinic. Management of various domains of CKD will be
discussed. The practical aspects of designing and operating
a CKD clinic will be reviewed. The attendee will get further
insight into incorporating various innovative care models
within the CKD clinic as well as utilizing technology in
effectively delivering optimal care for CKD patients.
Course Objectives: Upon completion of this course,
participants will be able to:
z Realize the need for a CKD clinic in their practice
domain matching local resources, and utilizing
guidelines to optimizing its efficiency
z Recognize some of the economic and business
principles of setting up and monitoring a CKD clinic and
optimizing billing
z Implement best practices in the management of
diabetes, hypertension, proteinuria and anemia, bone
and mineral disorder of CKD
z Recognize the importance of collaboration and
providing multidisciplinary resources in a CKD clinic
z Know what the patient expects from the CKD clinic
z Identify the benefits of adopting guidelines and
implementing technology including automation and
computerized clinical decision support system to
help with guideline adoption and adherence and
improve outcomes
z Use successful strategies to employ advanced
practitioners to achieve optimal results in the care of
CKD patients

CKD Clinics Course Agenda:
TIME TOPIC FACULTY
7:30am – 8:00am Breakfast
8:00am – 8:05am Introduction/Welcome Jerry Yee, MD, FACP, FASN, FNKF
8:05am – 8:45am Planning for a CKD Clinic—The Academic Perspective Nelson Kopyt, MD, FNKF
8:45am – 9:25am Planning for a CKD Clinic—The Private Practice and Rural Perspective Amit Sharma, MD, FACP, FASN
9:25am – 9:45am Break
9:45am – 10:25am C(ommunicating) Kidney Disease—Patient Perspective Lori Hartwell
10:25am – 11:10am Updates on CKD Management Michael J. Choi, MD, FNKF
11:10am – 11:50am Role of Advanced Practitioners in CKD Clinics Jane Davis, MSN, DNP, NP
11:50am – 12:00pm Questions
12:00pm – 1:00pm Lunch
1:00pm – 1:40pm The C(ollaborative)KD Clinic: Role of Nurses, Nutritionists, Social
Workers
NKF SCM12
W. Kline Bolton, MD
1:40pm – 2:10pm CKD Education Class Jill Cole, MSW, LMSW
2:10pm – 2:20pm Questions
2:20pm – 2:30pm Break
2:30pm – 3:10pm Information Technology in the CKD Clinic Vivek Soi, MD
3:10pm – 3:50pm Innovative Care Models for CKD Lawrence Weisberg, MD
3:50pm – 4:30pm Billing – Mini-Workshop Keli Adis, CCS-P
4:30pm – 5:00pm Wrap-Up Session/Q&A
● GLOMERULAR DISEASES: UPDATES ON
PATHOGENESIS AND TREATMENT
Supported by an educational grant from Questcor
Pharmaceuticals, Inc.
Wednesday, May 9
8:00am – 6:00pm
Course Directors: Fernando C. Fervenza, MD, PhD, FNKF,
and Michael J. Choi, MD, FNKF
Session 226, 8.0 credits
Target Audience: Designed for nephrologists, nephrology
fellows, advanced practitioners, pharmacists, and
nephrology nurses.
Course Description: In the last few years, a number of new
diagnostic and therapeutic tools have emerged. Practicing
nephrologists will greatly benefit by having an update
regarding their utility in the diagnosis and management
of patients with glomerular diseases. The course format
includes lectures, question-and-answer sessions, case-based
discussions, and panel sessions to review this evidence.
Faculty are composed of outstanding teachers who are
experts in their respective fields. The course should be of
special interest to nephrologists who deal with patients
with glomerular diseases or are looking for an update on
the subject.
Course Objectives: At the conclusion of this activity,
participants will be able to:
z Review current research and clinical findings in the
pathophysiology of glomerular diseases
z Examine novel diagnostic tools in glomerular diseases
z Identify current therapeutic options in glomerular
diseases
PHYSICIAN
55 55

56
PHYSICIAN PROGRAM continued
GN Course Agenda:
TIME TOPIC FACULTY
8:30am – 9:00am Minimal Change Disease Jai Radhakrishnan, MD
9:00am – 9:30am FSGS Jeffrey Kopp, MD
9:30am – 10:00am Kidney and Viral Infections Lynda A. Szczech, MD, MSCE, FNKF
10:00am – 10:30am Break
10:30am – 11:00am Membranous Nephropathy Fernando C. Fervenza, MD, PhD, FNKF
11:00am – 11:30am Membranoproliferative Glomerulonephritis Richard Glassock, MD,
11:30am – 12:00pm Monoclonal Gammopathies Nelson Leung, MD
12:00pm – 12:30pm Break
12:30pm – 1:30pm Working Lunch—Clinical Issues in MC, FSGS, MN, and MPGN All Morning Faculty
1:30pm – 2:00pm ANCA-Associated Vasculitis Ulrich Specks, MD
2:00pm – 2:30pm Lupus Nephritis James Balow, MD
2:30pm – 3:00pm Thrombotic Microangiopathies Susan Quaggin, MD
3:00pm – 3:30pm Break
3:30pm – 4:00pm IgA Nephropathy Gerald B. Appel, MD
4:00pm – 4:30pm Hereditary Nephropathies Agnes Fogo, MD
4:30pm – 6:00pm Clinical Issues in MG, ANCA, SLE, HUS/TTP, IgA Ulrich Specks, MD, Jim Balow, MD, Gerald B.
Appel, MD, and Fernando C. Fervenza, MD,
PhD, FNKF
● CLEVELAND CLINIC CARDIORENAL UPDATE
Wednesday, May 9
1:00pm – 5:30pm
Course Directors: Brian Stephany, MD, W.H. Wilson Tang,
MD, and Martin Schreiber, MD
Session 227, 4.0 credits
Target Audience: Designed for nephrologists, cardiologists,
and healthcare practitioners with an interest in cardiorenal
disease .
Course Description: This course is an interdisciplinary
collaboration aiming to address the increasing challenges
and concepts facing nephrologists and cardiologists with
regard to the interplay between heart failure syndrome
and acute or chronic kidney disease. The goal is to provide
a scientific forum to discuss the latest developments
and future directions in pathophysiology, diagnosis, and
management of concomitant cardiac and renal insufficiency.
.
NKF SCM12
Course Objectives: At the conclusion of this activity,
participants will be able to:
z Define our current understanding of the
pathophysiology of cardiorenal syndrome
z Discuss lessons learned from past and recent major
heart failure trials
z Discuss the approaches to diagnosis and utilization of
newer cardiac and renal markers to identify patients
with cardiorenal syndrome
z Examine both the standard therapeutic approaches and
innovative monitoring and treatment options for the
cardiorenal syndrome patient
z Review future areas of research in cardiorenal
syndrome

Cardiorenal Update Course Agenda:
TIME TOPIC FACULTY
1:00pm – 1:05pm Welcome and Introductions Brian Stephany, MD
Martin Schreiber, MD
1:05pm – 1:40pm Pathophysiology/Neurohormonal Disturbances of Cardiorenal
Syndrome/AKI
NKF SCM12
John Burnett, MD
1:40pm – 2:20pm Lessons Learned from Major Heart Failure Trials Randall Starling, MD, MPH
2:20pm – 3:00pm Novel Monitoring Strategies for Heart Failure Patients W.H. Wilson Tang, MD
3:00pm – 3:10pm Break
3:10pm – 3:50pm Usual and Novel Biomarkers in Cardiorenal Syndrome Uptal Patel, MD
3:50pm – 4:30pm Extracorporeal Strategies to Treat Cardiorenal AKI and Their
Consequences
Sevag Demirjian, MD
4:30pm – 5:10pm Management of Cardiac Abnormalities Eberhard Ritz, MD
5:10pm – 5:15pm Summation W.H. Wilson Tang, MD
5:15pm – 5:30pm Questions and Answers All Faculty
LUNCH WORKSHOPS
Separate Registration and Fee Required
An additional fee of $40 per workshop is required. Includes
a box lunch and CME credits. Tickets for these workshops
may be purchased at the NKF Ticket Sales Booth in the
Registration Area. Space is limited, so participation is
available on a first-come, first-served basis.
THURSDAY, MAY 10, 12:00PM – 2:00PM
● PRIMER ON REVIEWING CURRENT HIGH-IMPACT
RESEARCH STUDIES
Session 230
Chairs: Holly Kramer, MD, MPH, and Kerri Cavanaugh, MD,
MHS, FNKF
Presenters: Eric Taylor, MD, MSc, and
Holly Kramer, MD, MPH
Workshop Description: The information age has created
tremendous opportunities for expanding clinical research
and moving clinical science forward. However, clinicians
may feel overwhelmed and ill-equipped to evaluate and
interpret the majority of clinical research that is published,
and wonder whether findings in a particular study are
actually applicable to their patient population. This
workshop will provide clinicians with a few simple tools to
evaluate high-impact clinical research. The workshop will
be interactive and participants will be walked through the
evaluation process of a research study.
● ELECTROLYTES
Session 231
Presenters: Jerry Yee, MD, FACP, FASN, FNKF, and Harold
Szerlip, MD, FNKF
Workshop Description: Experts will present interesting
electrolyte cases and challenge the audience to diagnose
and choose the appropriate treatments. This is an excellent
review of renal pathophysiology. Attendees will gain a
better understanding of electrolyte disorders and review
mechanisms of electrolyte transport in the kidney.
● HOW TO SET UP A HOME HEMODIALYSIS PROGRAM
Supported by an educational grant from NxStage Medical, Inc.
Session 232
Chair: Thomas A. Golper, MD, FACP, FASN
Presenters: Joel Glickman, MD, Anita Lipman, BSN, MS,
CNN, and Aaron Herold, MSW, LICSW
Workshop Description: The recent (2011) prospective
payment structure has incented home dialysis. Newer
and easier hemodialysis equipment is available. Hence,
there may be a resurgence in all forms of home dialysis.
To succeed with a home dialysis program, one must
understand the process involved in training and maintaining
longitudinal care of these unique patients. Experience can
come from length and size of a program, so we will hear
from such experience as we describe the infrastructure
needs and care delivery processes for both home
hemodialysis as well as peritoneal dialysis.
PHYSICIAN
57 57

58
PHYSICIAN PROGRAM continued
● URINE MICROSCOPY
Session 233
Chairs: Linda Fried, MD, MPH, FNKF,
and Mark Perazella, MD, FNKF
Presenters: Paul Palevsky, MD, FNKF,
and Mark Perazella, MD, FNKF
Workshop Description: Urine microscopy is an important
component of the evaluation of patients with kidney
disease. A careful evaluation of urine can help narrow
the differential diagnosis in CKD and AKI, and can help
determine prognosis in AKI. As most urinalyses are now
done in central laboratories, nephrologist training and
comfort with this tool has decreased. This workshop will
start with a review of the approach to microscopy, and its
use in AKI and in differential diagnosis. Most of the time will
be devoted to cases with questions and answers to illustrate
important points.
● TOPICS IN INTERVENTIONAL NEPHROLOGY
Session 234
Chairs: Micah R. Chan, MD, MPH, FNKF,
and Charmaine E. Lok, MD, MSc, FNKF
Presenters: Micah R. Chan, MD, MPH, FNKF, Ingemar
Davidson, MD, PhD, Timmy Lee, MD, MSPH, FACP, FASN,
and Loay Salman, MD
Workshop Description: This workshop will provide a
practical and evidence-based review of topics current in
interventional nephrology. Leading experts in the field will
discuss catheter complications, translational research, and
the latest innovations, as well as access planning from a
surgical perspective. This will be a unique opportunity for
interactive learning between the audience and speakers.
● CRITICAL CARE NEPHROLOGY –
BASICS FOR THE PRACTICING NEPHROLOGIST
Session 235
Chair: Kathleen Liu, MD, PhD, MAS
Presenters: Kathleen Liu, MD, PhD, MAS, Ann O’Hare, MD,
and Edward Siew, MD
Workshop Description: This workshop will allow
participants to develop their knowledge and understanding
of the basic concepts of critical care relevant to nephrology
practice. Specific topics to be covered include fluid and
vasopressor management in shock, ventilator management,
and management issues related to critical illness and acute
kidney injury in elderly patients.
NKF SCM12
SATURDAY, MAY 12, 11:30AM – 1:00PM
● BOARD REVIEW
Session 236
Presenter: Harold Szerlip, MD, FNKF
Workshop Description: Test your knowledge of nephrology.
Come and see how you compare to your colleagues. During
this workshop you will have the opportunity to answer 30
Board-type questions that will cover a wide range of topics,
including electrolytes, acid-base, AKI, acute and chronic
dialysis, CKD management, and transplantation. Responses
will be anonymously tallied using an audience response
system. You are guaranteed to have fun and learn at the
same time!
● KIDNEY STONES 101
Session 237
Chairs: Stephen Knohl, MD, and R. Allan Jhagroo, MD
Presenters: R. Allan Jhagroo, MD, Kamel Kamel, MD,
FRCP(C), and Stephen Knohl, MD
Workshop Description: This workshop is designed to
provide an evidence-based background for recurrent kidney
stone prevention. Nutritional recommendations and their
true impact on kidney stone formation will be discussed.
Medical drug therapy will also be reviewed with regard
to stone formation. In addition, cases will be reviewed for
diagnosis and management by nutritional and medical
means.
● SECONDARY AND RESISTANT HYPERTENSION
Session 238
Chair: John Sperati, MD, MHS, FNKF
Presenters: Rajiv Agarwal, MD, FAHA, FASN, FASH, George
Bakris, MD, and Raymond Townsend, MD
Workshop Description: This workshop will address various
methods of blood pressure measurement to better identify
and treat patients with resistant hypertension. Utilizing this
knowledge, participants will then work through several case
scenarios with leading hypertension experts to refine the
participants’ ability to diagnose and manage patients with
secondary and resistant hypertension.

● IMPROVING LONG-TERM OUTCOMES IN KIDNEY
TRANSPLANT RECIPIENTS
Session 239
Chairs: Jianghua Chen, MD, and
Heidi M. Schaefer, MD, FNKF
Presenters: Sangeeta Hingorani, MD, MPH, Andrew Howard,
MD, FACP, and Alexander Wiseman, MD, FACP
Workshop Description: The focus of this workshop will be to
discuss ways to improve long-term outcomes in transplant
recipients. Attendees will obtain a better understanding of
how to transition patients from the transplant center back
to their community nephrologist. In addition, approaches
to the optimal management of bone marrow transplant
recipients who develop renal complications, and solid organ
transplant recipients with chronic kidney disease will be
addressed .
NKF SCM12
● WEIGHT LOSS MANAGEMENT IN CKD
Thank You
Session 240
Chair: Adam Whaley-Connell, DO, MSPH, FNKF, FASN
Presenters: Holly Kramer, MD, MPH, Kirsten Johansen, MD,
and Nina Kolbe, RD, CSR, LD
Workshop Description: Obesity continues to be a very
difficult problem that many patients with kidney disease
battle. This session provides healthcare providers a few
critical tools to facilitate weight loss in patients with kidney
disease. Experts in the fields of nutrition and exercise will
discuss methods to help patients lose weight through diet
and exercise. When diet and exercise fail, some patients
may proceed with bariatric surgery. Thus, it is imperative
that healthcare providers understand the pros and cons of
bariatric surgery for weight loss management.
to the Physician Host Committee for all of your help and support in promoting SCM12
James E. Balow, MD
Jonathan S. Bromberg, MD, PhD
Timothy E. Bunchman MD
Matthew Cooper, MD
Robert Fildes, MD
Lynt B. Johnson, MD
Jack Moore, Jr., MD, FACP
Asha Moudgil, MD
Dominic Raj, MD
Paul J. Scheel, Jr., MD
Matthew R. Weir, MD
PHYSICIAN
59 59

60
� Separate Registration and/or Fee Required
Wednesday, May 9
PHYSICIAN PROGRAM
TIME/ROOM SESSION # SESSION COURSE FACULTYDIRECTOR(S) NOTES CREDITS
7:30am – 4:30pm
Woodrow Wilson D
7:00am – 5:00pm
National Harbor 11
7:30am – 5:15pm
Potomac 1/2
7:30am – 4:30pm
Woodrow Wilson B
7:30am – 5:00pm
Chesapeake D
7:30am – 5:00pm
National Harbor 12
8:00am – 6:00pm
National Harbor 10
1:00pm – 5:30pm
Woodrow Wilson C
6:00pm – 6:30pm
Annapolis 1/2
Thursday, May 10
220 Transplant Heidi Schaefer, MD, FNKF � 7 .0
221 Integrated Hemodialysis/Peritoneal Dialysis Course
Supported in-part by Baxter Healthcare Corporation
NKF SCM12
Joanne Bargman,
MD, FRCPC
222 Interventional Nephrology
Loay Salman, MD
In-kind support provided by GE Healthcare, Inc., Covidien,
and Bard.
Amy Dwyer, MD, FACP
223 Dialysis Unit Management Peter B. DeOreo, MD,
FACP
224 A Practical Approach to Renal Pathology Agnes Fogo, MD
Charmaine Lok, MD,
MSc, FNKF
225 CKD Clinics Jerry Yee, MD, FNKF,
FACP, FASN
Sandeep Soman, MD, FNKF
226 Glomerular Diseases: Updates on Pathogenesis
Fernando C. Fervenza,
and Treatment
MD, PhD, FNKF
Supported by an educational grant from Questcor
Pharmaceuticals, Inc.
Michael J. Choi, MD, FNKF
227 Cleveland Clinic Cardiorenal Update Brian Stephany, MD
W.H. Wilson Tang, MD
Martin Schreiber, MD
100 NKF New Member Orientation NKF President
Lynda A. Szczech,
MD, MSCE, FASN, FNKF
� 8 .0
� 7 .5
� 7 .0
� 7 .0
� 7 .0
� 8 .0
� 4 .0
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
6:00am – 7:45am
Woodrow Wilson
Ballroom
8:00am – 9:30am
Maryland D
8:00am – 9:30am
Potomac D
800 Comprehensive Management of Mineral and Bone
Disorders in Advanced Chronic Kidney Disease
Supported by an educational donation provided by Amgen
Chair: Hartmut H.
Malluche, MD, FACP
When, Why, and How to Address Phosphate Retention Ravi Thadhani, MD, MPH
When to Consider Cinacalcet Csaba P. Kovesdy, MD,
FASN
Initiation and Limits of Vitamin D Kevin J. Martin, MB,
BCh, FACP
260 Quality Kidney Care: How Do You Measure Up? Chair: Paul Palevsky, MD,
FNKF
Clinical Performance Measurement – Are You Ready? Paul Palevsky, MD, FNKF
Drug Labeling and Physician Practice – The FDA Perspective Aliza Thompson, MD
Quality Measurement in CKD and ESRD – The CMS
Perspective
261 Overcoming Barriers for Choosing and Implementing
Home Dialysis
The Clinical and Financial Benefits of Home Dialysis
vs. In-Center
Jean Moody-Williams,
RN, MPP
Chairs: Rajnish Mehrotra,
MBBS, MD, FNKF, and
Raymond Krediet,
MD, PhD
Joel Glickman, MD
Debate: The Physician is the Main Barrier for Home Dialysis
Yes Thomas A. Golper, MD,
FACP, FASN
No Alfred Cheung, MD
1 .5
1 .5
1 .5

Thursday, May 10 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
8:00am – 9:30am
Potomac C
9:30am – 10:00am Break
10:00am – 11:30am
Potomac C
10:00am – 11:30am
National Harbor 4/5
12:00pm – 2:00pm
Woodrow Wilson
Ballroom
12:00pm – 2:00pm
National Harbor 11
12:00pm – 2:00pm
National Harbor 12
12:00pm – 2:00pm
National Harbor 13
12:00pm – 2:00pm
Potomac 1 - 3
262 Treatment of ANCA Vasculitis Chairs: Fernando C.
Fervenza, MD, PhD, FNKF,
and Michael J. Choi, MD,
FNKF
The Role of B Cell-Targeted Therapy Ulrech Specks, MD
Role of Cytoxan Carol Langford, MD, MHS
Role of Plasmapharesis Fernando C. Fervenza,
MD, PhD, FNKF
263 Understanding Blood Pressure Reduction in Kidney Disease Chairs: George Bakris,
MD, and Adam Whaley-
Connell, DO, MSPH, FASN,
FNKF
Targets for BP Control in the General Population, Diabetes,
and CKD
NKF SCM12
William Cushman, MD,
FACP, FAHA, FASH
Safety Issues in BP Management in CKD George Bakris, MD
Optimizing BP Control in CKD Patients: A Patient-Centered
Team-Based Approach
Wendy St. Peter, PharmD,
FCCP, FASN, FNKF, BCPS
264 Is Peritoneal Dialysis a Viable Long-Term Therapy? Chairs: Joanne Bargman,
MD, FRCPC, and Frederic
Finkelstein, MD, FNKF
Long-Term Outcomes with PD: Similar or Inferior to HD? Rajnish Mehrotra, MBBS,
MD, FNKF
Optimizing the PD Prescription for the Anuric Patient Joanne Bargman, MD,
FRCPC
Encapsulating Peritoneal Sclerosis: Should This Concern
Preclude Long-Term Use of PD?
801 Bone-Intestinal-Vascular-Renal Axis: Modeling and
Managing Calcium and Phosphorus Disturbances in CKD
Supported by an educational grant from Sanofi
Frederic Finkelstein, MD,
FNKF
Calcium Use in the Non-Nephrology Setting Sophie Jamal, MD, PhD,
FRCPC
A Reappraisal of Calcium Balance in Chronic Kidney Disease David Spiegel, MD
230 Workshop: Primer on Reviewing Current High-Impact
Research Studies
Chairs: Holly Kramer,
MD, MPH, and Kerri
Cavanaugh, MD, MHS,
FNKF
Threats to Clinical Research: Types of Bias and Examples Eric Taylor, MD, MSc
Interactive Review of Late-Breaking Clinical Research Results Holly Kramer, MD, MPH
231 Workshop: Electrolytes Jerry Yee, MD, FNKF, FASN,
FACP
Harold Szerlip, MD, FNKF
232 Workshop: How to Set Up a Home Hemodialysis Program
Supported by an educational grant from NxStage
Medical, Inc.
Chair: Thomas A. Golper,
MD, FACP, FASN
Practical Infrastructure Challenges Joel Glickman, MD
Comments from a Home Dialysis Nurse Anita Lipman, BSN ,MS,
CNN
The Psychosocial Impact of Home Dialysis Aaron Herold, MSW,
LICSW
233 Workshop: Urine Microscopy Chairs: Linda Fried, MD,
MPH, FNKF, and Mark
Perazella, MD, FNKF
Basics of Urine Microscopy: Cells, Casts, Crystals Mark Perazella, MD, FNKF
Case-Based Approach to Urine Microscopy Mark Perazella, MD, FNKF
Traditional Urinary Biomarkers Paul Palevsky, MD, FNKF
1 .5
1 .5
1 .5
1 .5
� 2 .0
� 2 .0
� 2 .0
� 2 .0
PHYSICIAN
61 61

� Separate Registration and/or Fee Required
62
Thursday, May 10 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
12:00pm – 2:00pm
Potomac 4/5
12:00pm – 2:00pm
Potomac 6
2:00pm – 2:30pm Break
2:30pm – 3:30pm
Potomac A/B
3:30pm – 4:00pm Break
4:00pm – 5:30pm
Potomac C
4:00pm – 5:30pm
Maryland D
4:00pm – 5:30pm
Potomac D
234 Workshop: Topics in Interventional Nephrology Chairs: Micah R. Chan,
MD, MPH, FNKF and
Charmaine E. Lok, MD,
MSc, FNKF
Preventing and Treating Catheter Complications
Infectious Loay Salman, MD
Non-Infectious Micah R. Chan, MD, MPH,
FNKF
Innovation in Interventional Nephrology: Translating
Technology to Practice
Doing the Right Thing From a Surgical Perspective: From
Assessment to Cannulation
235 Workshop: Critical Care Nephrology – Basics for the
Practicing Nephrologist
NKF SCM12
Timmy Lee, MD, MSPH,
FACP, FASN
Ingemar Davidson, MD,
PhD
Chair: Kathleen Liu, MD,
PhD, MAS
Fluids and Vasopressor Management in Shock Kathleen Liu, MD, PhD,
MAS
Ventilator Management: What the Nephrologist Needs
to Know
Edward Siew, MD
Critical Illness and AKI in the Elderly Ann O’Hare, MD
265 NKF Presidential Address: The Person and the Policy Lynda A. Szczech, MD,
MSCE, FASN, FNKF
Shaul G. Massry Distinguished Lecture: Translating Biology
and Observations into Human Trials: The New Era of
CKD-MBD
Ravi Thadhani, MD, MPH
266 KDOQI Commentary on the KDIGO AKI Guidelines Chair: Paul Palevsky, MD,
FNKF
Definition of AKI Charuhas V. Thakar, MD,
FNKF
Prevention and Treatment of AKI Lakhmir Chawla, MD
Contrast-Induced AKI Paul Palevsky, MD, FNKF
Renal Replacement Therapy Kathleen Liu, MD, PhD,
MAS
Pediatric Issues Patrick Brophy, MD
267 Coping and Depressive Symptoms in Advanced Kidney
Disease
Chairs: Frederic
Finkelstein, MD, FNKF,
and Megan Prescott,
MSW, LCSW
Identification and Evaluation/Assessments of Depression Frederic Finkelstein, MD, FNKF
Non-Pharmacologic Approaches for Treating Depression in
Kidney Disease
Stephanie Johnstone, MSW,
LCSW
Pharmacologic Therapies for Depression in Kidney Disease Tracy Anderson-Haag,
PharmD, BCPS
268 Increasing Living Kidney Donation Chair: Susan Hou, MD,
FACP
Pay It Forward Programs: A Story of Success Susan Hou, MD, FACP
Ethical Considerations for Living Donation Rebecca Hays, MSW,
APSW, NSW-C
Desensitization Enver Akalin, MD
6:00pm – 7:30pm Opening Ceremonies and Reception in the Exhibit Hall –
Visit Posters*/Exhibits
� 2 .0
� 2 .0
1 .0
1 .5
1 .5
1 .5

Thursday, May 10 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
7:30pm – 9:30pm
Woodrow Wilson
Ballroom
Friday, May 11
804 Nobody Likes Rejection! Practical Guidance on
Immunosuppression for 2012
Supported by an educational grant from Bristol-Myers Squibb
From Clinical Practice to Clinical Guidelines: The Evolution of
Recommendations in Immunosuppressant Therapies
Outcomes in Immunosuppression Therapies:
A Case Study Model
A Team Approach to Managing Immunosuppression:
The Central Role of the Empowered Patient
NKF SCM12
Ali Olyaei, PharmD
Erika Meredith, PharmD
Rebecca Hayes, MSW,
APSW, NSW-C
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
6:00am – 7:45am
802 Anemia in CKD Stage 5: Balancing Morbidity, Mortality, and
1 .5
Woodrow Wilson
Quality of Life
Ballroom
Supported by an educational grant from Affymax, Inc. and
Takeda Pharmaceuticals North America, Inc.
Evaluation and Management of Hemoglobin Variability Jay Wish, MD
Individualization of Therapy for Anemia Csaba P. Kovesdy, MD,
FASN
Analyzing Emerging Treatment Data for Patients with
Anemia of ESRD
7:00am – 8:00am Continental Breakfast in Exhibit Hall –
Visit Posters*/Exhibits
8:00am – 8:30am
Potomac D
8:30am – 10:00am
Potomac D
8:30am – 10:00am
Potomac C
10:00am – 10:30am Break
10:30am – 12:00pm
Potomac A
Anil Agarwal, MD, FNKF
290 Changing Access to Kidney Replacement Modalities Chair: Joseph Vassalotti,
MD, FASN, FNKF
End the Wait for Kidney Transplantation Bryan N. Becker, MD,
MMM, FNKF
Access to Dialysis Care in the Bundled Environment Allan J. Collins, MD, FACP
269 Current and Future Approaches to Renal Protection
through Blood Pressure Control
Review of the Topic in Context of BP Control in Kidney
Disease
Baroreceptor Modulation for Treating Refractory
Hypertension Renal Denervation
Chairs: George Bakris, MD,
and Joseph Vassalotti, MD,
FASN, FNKF
Rajiv Agarwal, MD, FAHA,
FASN, FASH
Vito Campese, MD
Renal Denervation George Bakris, MD
270 The Management of CKD-MBD Chair: Bradley A. Warady,
MD, FNKF
Clinical Assessment of Bone Mineral Status in Adults
and Children
Mary Leonard, MD, MSCE
PTH or FGF-23: When to Measure One, the Other, or Both Myles Wolf, MD, MMSC
Realistic Dietary Strategies to Control Phosphorus in CKD/
ESRD
Lisa Gutekunst, MSEd, RD,
CSR, CDN
271 Controversies in Organ Allocation Chair: Heidi Schaefer, MD,
FNKF
The History and Evolution of the Kidney Organ
Allocation System
Kenneth Andreoni, MD
Racial, Gender, and Ethnic Disparities in Organ Allocation Jesse Schold, PhD
The Role of Age in Organ Allocation: Is it Discriminatory? Lainie Friedman Ross, MD
1 .5
0 .5
1 .5
1 .5
1 .5
PHYSICIAN
63 63

� Separate Registration and/or Fee Required
64
Friday, May 11 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
10:30am – 12:00pm
Potomac C
10:30am – 12:00pm
Potomac D
272 Update on Selected Glomerular Diseases Chairs: Fernando C.
Fervenza, MD, PhD, MPH,
FNKF, and Philip K.T. Li,
MD, FRCP, FACP, FNKF
Have We Made Progress in the Management of
Lupus Nephritis?
NKF SCM12
Gerald B. Appel, MD
Membranoproliferative Glomerulonephritis Sanjeev Sethi, MD, PhD
Current Management Strategies of FSGS Jeffrey Kopp, MD
273 Treatment Options For Advanced Kidney Disease in Older
Adults
When Is It Appropriate to Recommend Initiation of Chronic
Dialysis in Older Adults?
What Is Conservative Therapy and When Should This Be
Considered?
When Is It Appropriate to Recommend Referral for
Transplantation in an Older Adult?
12:00pm – 2:00pm Break in the Exhibit Hall (Lunch Served 12:15pm – 1:15pm)—
Visit Posters*/Exhibits
2:00pm – 3:30pm
Potomac A
2:00pm – 3:30pm
Potomac D
3:30pm – 4:00pm Break
4:00pm – 5:30pm
National Harbor 13
4:00pm – 5:30pm
Potomac A
Chairs: Ann O’Hare, MD,
and Charmaine E. Lok,
MD, MSc, FNKF
Manjula Kurella Tamura,
MD, MPH
Michael Germain, MD
Dorry Segev, MD, PhD
275 Literature Review Chair: Harold Szerlip, MD,
FNKF
Hypertension Raymond Townsend, MD
Transplant Bryan N. Becker, MD,
MMM, FACP, FNKF
CKD Rajiv Agarwal, MD, FAHA,
FASN, FASH
276 Solving Drug Dosing Dilemmas Chairs: Wendy St. Peter,
PharmD, FCCP, FASN,
FNKF, BCPS, and Bruce
Mueller, PharmD, FCCP,
FASN, FNKF
Approach for Drug Dosage Adjustments in an Era of
Standardized Creatinine, Equation Overload, and Real
Patients
Rethinking How We Determine Drug Removal in Patients
Requiring CRRT
Managing Systemic Anticoagulation in Kidney Failure:
Frequently Asked Questions
Thomas Nolin, PharmD,
PhD, FCCP
Bruce Mueller, PharmD,
FCCP, FASN, FNKF
William Dager, PharmD,
BCPS
277 The Challenges of Being an Adolescent Chair: Bradley A. Warady,
MD, FNKF
I Don’t Like Being Different From My Friends! Angela Degnan, MSW,
LCSW, LSCSW
Individualizing the Prevention/Treatment of Non-Adherence Rebecca Johnson, PhD
Transition – The Mandate for Pediatric and Adult Medicine
Collaboration
Lorraine Bell, MD, FRCPC
278 Key Controversies in Hemodialysis Vascular Access Chairs: Charmaine E. Lok,
MD, MSc, FNKF, and Alfred
Cheung, MD
Debate: Fistula First…To Do What?
Succeed (as Primary Access) Jay Wish, MD
Fail (to be used for HD) Michael Allon, MD
Debate: Access Surveillance: Is It Really Necessary?
Yes Jay Wish, MD
No Louise Moist, MD, MSc,
FRCPC
1 .5
1 .5
1 .5
1 .5
1 .5
1 .5

Friday, May 11 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
6:00pm – 7:30pm Networking Reception in the Exhibit Hall –
Visit Posters*/Exhibits
Saturday, May 12
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
6:00am – 7:45am
803 Chronic Mild Hyponatremia Is Not Benign: Implications for Chair: Joseph G. Verbalis,
1 .5
Woodrow Wilson
Clinical Practice
MD
Ballroom
Supported by an educational grant from Otsuka America
Pharmaceutical, Inc.
Adverse Effects of Chronic Mild Hyponatremia Joseph G. Verbalis, MD
Applicability of Vasopressin Antagonists in the Management
of Chronic Mild Hyponatremia
Case Studies: Diagnosis and Effective Management of
Chronic Mild Hyponatremia
8:00am – 9:00am Continental Breakfast Served in the Exhibit Hall –
Visit Posters*/Exhibits
9:30am – 11:00am
Potomac C
9:30am – 11:00am
Potomac A
9:30am – 11:00am
Potomac B
11:00am – 11:30am Break
11:30am – 1:00pm
National Harbor 3
11:30am – 1:00pm
National Harbor 10
279 Healthcare Access in the Kidney Early Evaluation Program:
Implications on Outcomes
NKF SCM12
Mitchell Rosner, MD, FACP
Mitchell Rosner, MD, FACP
Chairs: Adam Whaley-
Connell, DO, MSPH,
FASN, FNKF, and Peter
McCullough, MD, MPH,
FACC, FACP, FNKF
Access to Healthcare in KEEP® Andrew Bomback, MD,
MPH
KEEP: The Role of Healthcare Access in Risk Factor Control Claudine Jurkovitz, MD,
MPH
KEEP: The Role of Healthcare Access on Mortality George Saab, MD
280 AKI After Major Surgery Chair: Charuhas V. Thakar,
MD, FNKF
Epidemiology of Post-Operative AKI Charuhas V. Thakar, MD,
FNKF
Biomarkers: A Case for Early Diagnosis of AKI Chirag Parikh, MD, PhD
Prevention and Treatment of Post-Operative AKI Jonathan Himmelfarb, MD
281 Changing CKD Care Through Collaborative Care Chairs: Wendy St.
Peter, PharmD, FCCP,
FASN, FNKF, BCPS, and
Charmaine E. Lok, MD,
MSc, FNKF
Evolving Models of Care Bryan N. Becker, MD,
MMM, FACP, FNKF
Translating Successful Canadian Collaborative Care CKD
Models to the U.S. – Possible or Mission Impossible?
Marianna Leung, PharmD,
BSc
Implementing a Collaborative Care Model in the U.S. Adam Whaley-Connell,
DO, MSPH, FASN, FNKF
236 Workshop: Board Review Harold Szerlip, MD, FNKF � 1 .5
237 Workshop: Kidney Stones 101 Chairs: Stephen Knohl,
MD, and R. Allan Jhagroo,
MD
Nutrition: Myths and Manipulation R. Allan Jhagroo, MD
Medications and Maximizing Outcomes Kamel Kamel, MD, FRCPC
Putting It Together: Cases Stephen Knohl, MD
� 1 .5
1 .5
1 .5
1 .5
PHYSICIAN
65 65

� Separate Registration and/or Fee Required
66
Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
11:30am – 1:00pm
National Harbor 11
11:30am – 1:00pm
Potomac 3
11:30am – 1:00pm
Chesapeake D/E
1:00pm – 1:30pm Break
1:30pm – 3:00pm
Potomac B
1:30pm – 3:00pm
Potomac A
3:00pm – 3:30pm Break
3:30pm – 5:00pm
Potomac A
238 Workshop: Secondary and Resistant Hypertension Chair: John Sperati, MD,
MHS, FNKF
Alternative Methods of Blood Pressure Measurement:
Implications for Resistant Hypertension
NKF SCM12
Rajiv Agarwal, MD, FAHA,
FASN, FASH
Cases Raymond Townsend, MD
239 Workshop: Improving Long-Term Outcomes in Kidney
Transplant Recipients
The Role of the Community Nephrologist and Ancillary
Providers in the Care of Transplant Recipients: How to
Transition Smoothly
Chairs: Heidi Schaefer,
MD, FNKF, and Jianghua
Chen, MD
Andrew Howard, MD,
FACP
Renal Complications of Bone Marrow Transplantation Sangeeta Hingorani, MD,
MPH
Epidemiology and Management of CKD Following Solid
Organ Transplantation
Alexander Wiseman, MD,
FACP
240 Workshop: Weight Loss Management in CKD Chair: Adam Whaley-
Connell, DO, MSPH, FASN,
FNKF
Diet Nina Kolbe, RD, CSR, LD
Exercise Kirsten Johansen, MD
Surgical Holly Kramer, MD, MPH
282 Relevance of CKD Guidelines to Older Adults Chairs: Ann O’Hare, MD,
and Charmaine E. Lok,
MD, MSc, FNKF
Proposed Changes to the Classification System for CKD Lesley Inker, MD, MS
Debate: Do Current and Proposed CKD Definitions Make
Sense in Older Adults?
Yes Michael Shlipak, MD,
MPH, FNKF
No Richard J. Glassock, MD
283 Novel Effects of Vitamin D in Patients with Kidney Disease Chairs: Joachim Ix, MD,
and Ravi Thadhani, MD,
MPH
Vitamin D and Cardiovascular Disease Ravi Thadhani, MD, MPH
Vitamin D and Proteinuria Rajiv Agarwal, MD, FAHA,
FASN, FASH
Musculoskeletal Sharon Moe, MD, FASN,
FACP, FAHA
284 Diabetes Debate
Chairs: Linda Fried,
MD, MPH, FNKF, and
Charmaine E. Lok, MD,
MSc, FNKF
What Should Goal HgbA1c Be in CKD and ESRD? Katherine Tuttle, MD,
FASN, FACP
Debate: Glycated Albumin is a Superior Method to Assess
Glycemic Control in Diabetic ESRD Patients
Pro Barry Freedman, MD
Con Kamyar Kalantar-Zadeh,
MD, PhD, MPH, FNKF
� 1 .5
� 1 .5
� 1 .5
1 .5
1 .5
1 .5

Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
3:30pm – 5:00pm
Potomac C
5:30pm – 7:00pm
Maryland C
Sunday, May 13
285 The Impact of Bundling on Clinical Practice Chair: Lynda A. Szczech,
MD, MSCE, FASN, FNKF
Changes in Practice Patterns and Laboratory Values Bruce Robinson, MD, MS,
FACP
Changes in Anemia Management and Anticipated Effects on
Patient Outcomes
The Administrative Challenges of Implementing Oral Meds
into The Bundle
NKF SCM12
Lynda A. Szczech, MD,
MSCE, FASN, FNKF
Jay Wish, MD
102 Fellows Reception/Career Choices in Nephrology Moderators: Linda Fried,
MD, MPH, FNKF, and Heidi
Schaefer, MD, FNKF
Panelists:
Akhtar Ashfaq, MD
Jeff Giullian, MD
Timmy Lee, MD
David Leehey, MD
Kathleen Liu, MD, PhD, MAS
TIME/ROOM SESSION # SESSION FACULTY NOTES CREDITS
8:00am – 9:30am
286 Implications of Dietary Additives in Kidney Disease Chairs: Linda Fried, MD,
1 .5
Potomac C
MPH, FNKF, and Janeen
Leon, MS, RD, LD
8:00am – 9:30am
Potomac A
9:30am – 10:00am Break
10:00am – 11:30am
Potomac C
10:00am – 11:30am
Potomac D
11:30am Meeting Adjourns
High Fructose Corn Syrup Adam Whaley-Connell,
DO, MSPH, FASN, FNKF
Sodium Alan Pao, MD
Phosphorus Additives Janeen Leon, MS, RD, LD
287 Renal Replacement Therapy in AKI Chair: Jonathan
Himmelfarb, MD
Timing and Modality of Acute Therapy Kathleen Liu, MD, PhD,
MAS
Drug Dosing in Acute Therapies Bruce Mueller, PharmD,
FCCP, FASN, FNKF
Intensity of RRT in AKI: How Much is Enough? Jonathan Himmelfarb, MD
288 Symptom Management Tips in Advanced CKD/ESRD Chairs: Ann O’Hare, MD,
and Kerri Cavanaugh, MD,
MHS, FNKF
Prevalence and Evaluation of Symptoms: Sleep Disorders,
Pruritus, Pain
Kerri Cavanaugh, MD,
MHS, FNKF
Non-Pharmacologic Management Gary Petingola, RSW, BA,
BSW
Pharmacologic Management Marianna Leung, PharmD,
BSc
289 CVD in CKD and ESRD Chairs: Rulan Parekh,
MD, FASN, and Peter
Stenvinkel, MD, PhD
*A MAXIMUM OF 1.0 CREDIT ONLY WILL BE AWARDED FOR POSTER SESSIONS.
Prevention of Sudden Cardiac Death in the Dialysis Patient Rulan Parekh, MD, FASN
Cardiorenal Syndrome – Evaluation and Management Luis Juncos, MD
Management of Atrial Fibrillation in CKD and Dialysis Peter McCullough, MD,
MPH, FACC, FACP, FNKF
1 .5
1 .5
1 .5
1 .5
PHYSICIAN
67 67

68
ADVANCED PRACTITIONER PROGRAM
PLANNING COMMITTEE
Amma Sewaah-Bonsu, DNP, NP-C
Program Chair
Nephrology Associates of Central Florida
Orlando, FL
Laurie E. Benton, PhD, MPAS, BS, PA-C, RN
Program Co-Chair
Scott & White Hospital
Temple, TX
Mandy Trolinger, MS, RD, PA-C
Denver Nephrology
Denver, CO
Sonia Washington, MSN, ARNPBC
Florida Hospital, Orlando Campus
Orlando, FL
HOST COMMITTEE
Lynn Poole, FNP-BC
McLean, VA
Kim Zuber, MS, PA-C
Metropolitan Nephrology
Alexandria, VA
PROGRAM GOAL
To improve patient outcomes by enhancing the advanced
practitioners’ knowledge base and skills that affect their
clinical practice in nephrology.
CONTINUING EDUCATION INFORMATION
PHYSICIAN ASSISTANTS
AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 Credit(s)
from organizations accredited by ACCME or a recognized
state medical society. Physician assistants may receive a
maximum of 30.0 hours of Category I credit for completing
this program .
NKF SCM12
NURSE PRACTITIONERS
This program is approved for 27.7 contact hours
of continuing education (which includes 9.7 hours
pharmacology) by the American Academy of Nurse
Practitioners. Program ID 1203120.
This program was planned in accordance with AANP CE
Standards and Policies and AANP Commercial Support
Standards.
Pre-Conference Courses
COURSE CONTACT HOURS PROGRAM ID
Nephrology 201
7 .75
1203110
for Advanced
Practitioners
(3.5 Pharm)
Foundations of
Nutrition Practice
for Kidney Disease
(Strategies I)
8 .0 1202050
Transplant 7 .0
(1.4 Pharm)
1202051
Integrated
8 .0
1202053
Hemodialysis /
Peritoneal Dialysis
Supported in
part by Baxter
Healthcare
Corporation
(2.5 Pharm)
Interventional
Nephrology
In-kind support
provided by GE
Healthcare,Inc.,
Covidien, and
Bard.
7 .3 1202063
Dialysis Unit
Management
7 .0 1203105
CKD Clinics 7 .1 1202052

PRE-CONFERENCE COURSES
REQUIRED: Separate registration fee of $125 ($175 when
registering for the course only); includes syllabus, light
breakfast, boxed lunch and CME/CE credits. Participation
is limited.
● NEPHROLOGY 201 FOR ADVANCED PRACTITIONERS
Wednesday, May 9
7:30am – 5:30pm
Course Directors: Laurie E. Benton, PhD, MPAS, BS, PA-C,
RN, and Amma Sewaah-Bonsu, DNP, NP-C
Session 620, 7.75 contact hours (3.5 Pharm)
Target Audience: Designed for physician assistants and
nurse practitioners in the field of nephrology.
Course Description: Whether you are new to nephrology
or a seasoned advanced practitioner (AP), Nephrology 201
has information to meet current AP professional needs. The
program will begin with lectures that are fundamental to
the practice of nephrology from the unique perspective of
the AP and then later divide into two tracks which represent
the most common areas of nephrology AP practice:
the acute care and chronic settings.
NKF SCM12
Course Objectives: Upon completion of this course,
participants will be able to:
z Evaluate the common causes of electrolyte disturbances
in the chronic kidney disease patient population
z Discuss the role of glomerulonephropathies in
multisystem disorders
z Recognize the hidden dangers in pharmacology as it
relates to the CKD/ESRD patient
z Identify and discuss the treatment of primary care
issues in the nephrology patient
z Describe the epidemiology and pathophysiology of
bone mineral disease in the CKD/ESRD patient and the
role of biophosphonate therapy in this population
z Recognize the conditions and disorders under which
fluid resuscitation is necessary and which fluid choice is
best
z Describe which patient conditions require rapid
response intervention and the AP role
z Describe common issues that arise in the dialysis unit
and their interventions
z Evaluate HD/PD treatment plans and under which
circumstances adjustments are needed
z Discuss the basic principles of kidney transplantation
and transplant medications and complications.
Course Agenda:
TIME TOPIC FACULTY
7:30am – 8:00am Continental Breakfast
8:00am – 8:15am Welcome and Introductions Amma Sewaah-Bonsu, DNP, NP-C, and Kim
Zuber, MS, PA-C
8:15am – 9:00am Electrolyte Disturbances: CKD-ESRD Charles Foulks, MD
9:00am – 9:45am GN in Multisystem Disorders: SLE, Wegner’s, Amyloidosis Hugh Carey, MD
9:45am – 10:00am Break
10:00am – 11:00am Pharmacology: Hidden Dangers Maritsa Serlemitsos-Day, PharmD
11:00am – 12:00pm Treating Primary Care Issues in the Nephrology Patient Barbara Weis Malone, FNP, RN, CFNP
Mandy Trolinger, MS, RD, PA-C
12:00pm – 1:00pm Lunch
1:00pm – 2:00pm MBD in the CKD-ESRD Patient/Using Biophosphonates in the
CKD-ESRD Patient
TIME TRACK ONE: ACUTE CARE
Room: National Harbor 4
2:15pm – 3:15pm AKI
Miriam Michael, MD
3:15pm – 3:30pm Break
3:30pm – 4:30pm When, What, and Why:
Fluid Resuscitation in the Acute Setting
Luis Concepcion, MD
4:30pm – 5:30pm Rapid Response
Victor Test, MD, FACP
Peter Juergensen, PA-C
TRACK TWO: DIALYSIS
Room: National Harbor 2
Troubleshooting Dialysis Issues
Kim Zuber, MS, PA-C
HD/PD Prescription:
When to Stay and When to Change
Laura Troidle, BS, PA-C
Transplant Essentials
Mohanaram Narayanan, MD, FASN
ADVANCED PRACTITIONER
69 69

70
ADVANCED PRACTITIONER PROGRAM continued
● FOUNDATIONS OF NUTRITION PRACTICE FOR
KIDNEY DISEASE (STRATEGIES I)
Wednesday, May 9, 7:30am – 5:15pm
Session 520, 8.0 contact hours
See page 87 for course details. Separate registration and
fee required.
● TRANSPLANT
Wednesday, May 9, 7:30am – 4:30pm
Session 220, 7.0 contact hours (1.4 Pharm)
See page 47 for course details. Separate registration and
fee required.
● INTEGRATED HEMODIALYSIS/
PERITONEAL DIALYSIS
Wednesday, May 9, 7:00am – 5:00pm
Session 221, 8.0 contact hours (2.5 Pharm)
See page 49 for course details. Separate registration and
fee required.
● INTERVENTIONAL NEPHROLOGY
Wednesday, May 9, 7:30am – 5:15pm
Session 222, 7.3 contact hours
See page 50 for course details. Separate registration and
fee required.
● DIALYSIS UNIT MANAGEMENT
Wednesday, May 9, 7:30am – 4:30pm
Session 223, 7.0 contact hours
See page 52 for course details. Separate registration and
fee required.
● CKD CLINICS
Wednesday, May 9, 7:30am – 5:00pm
Session 225, 7.1 contact hours
See page 54 for course details. Separate registration and
fee required.
NKF SCM12
LUNCH WORKSHOPS
REQUIRED: Separate registration fee of $40.00; includes a
box lunch and CME/CE credits. Participation is limited to
75, so register early.
THURSDAY, MAY 10, 12:00PM – 2:00PM
● TROUBLE SHOOTING DIABETIC DILEMMAS
Session 630
Presenter: Marc Brazie, MD
Workshop Description: This interactive session will focus
on patients with diabetes and kidney disease. Specific
topics will include: when is the right time to start on insulin,
make changes to the patients’ oral medication regimen
and/or refer them to an endocrinologist. Learn about the
differences when working with the “in” versus the “out”
patient. This workshop is designed specifically to be an
interactive and comprehensive case review of managing
patients with diabetes and their comorbidities. To get even
more out of this session, bring your most difficult diabetic/
nephrology questions for group discussion.
● ELECTROLYTES
Session 231
Presenters: Jerry Yee, MD, FACP, FASN, FNKF, and Harold
Szerlip, MD, FNKF
See page 57 for workshop description.
● URINE MICROSCOPY
Session 233
Chairs: Linda Fried, MD, MPH, FNKF, and Mark Perazella,
MD, FNKF
Presenters: Paul Palevsky, MD, FNKF, and Mark Perazella,
MD, FNKF
See page 58 for workshop description.
● TOPICS IN INTERVENTIONAL NEPHROLOGY
Session 234
Chairs: Micah R. Chan, MD, MPH, FNKF, and Charmaine E.
Lok, MD, FNKF
Presenters: Micah R. Chan, MD, MPH, FNKF, Ingemar
Davidson, MD, PhD, Timmy Lee, MD, MSPH, FACP, FASN, and
Loay Salman, MD
See page 58 for workshop description.

SATURDAY, MAY 12, 11:30AM - 1:00PM
● PHYSICAL ASSESSMENT
Session 530
Presenter: Mary Pat Kelly, MS, RD, RN, RNP
See page 89 for workshop description.
● SECONDARY AND RESISTANT HYPERTENSION
Session 238
Chair: John Sperati, MD, MHS, FNKF
Presenters: Rajiv Agarwal, MD, FAHA, FASN, FASH, George
Bakris, MD, and Raymond Townsend, MD
See page 58 for workshop description.
● IMPROVING LONG-TERM OUTCOMES IN KIDNEY
TRANSPLANT RECIPIENTS
Session 239
Chairs: Jianghua Chen, MD, MPH, and Heidi M. Schaefer,
MD, FNKF
Presenters: Sangeeta Hingorani, MD, MPH, Andrew Howard,
MD, FACP, and Alexander Wiseman, MD, FACP
See page 59 for workshop description.
NKF SCM12
ADVANCED PRACTITIONER PROGRAM
ADVANCED PRACTITIONER
71 71

72
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Wednesday, May 9
ADVANCED PRACTITIONER PROGRAM
TIME/ROOM SESSION # SESSION COURSE FACULTYDIRECTOR(S) NOTES
CONTACT
CREDITS HOURS
7:30am – 5:30pm
620 Nephrology 201 for Advanced Practitioners Laurie E. Benton, PhD, �ù 7 .75
National Harbor 2
MPAS, BS, PA-C, RN, and
(3 .5
Amma Sewaah-Bonsu,
MSN, NP-C
Pharm)
7:30am – 4:30pm
Woodrow Wilson D
7:00am – 5:00pm
National Harbor 11
7:30am – 5:15pm
Potomac 1/2
7:30am – 4:30pm
Woodrow Wilson B
7:30am – 5:00pm
National Harbor 12
7:30am – 5:15pm
Chesapeake 4
6:00pm – 6:30pm
Annapolis 1/2
6:30pm – 7:30pm
Potomac Terrace
Thursday, May 10
220 Transplant Heidi Schaefer, MD, FNKF �¬ 7 .0
(1 .4
Pharm)
221 Integrated Hemodialysis/Peritoneal Dialysis Joanne Bargman, MD,
FRCPC
222 Interventional Nephrology
In-kind support provided by GE Healthcare, Inc., Covidien,
and Bard.
NKF SCM12
Loay Salman, MD
Amy Dwyer, MD, FACP
223 Dialysis Unit Management Peter B. DeOreo, MD,
FACP
225 CKD Clinics Jerry Yee, MD, FNKF,
FACP, FASN
Sandeep Soman, MD,
FNKF
520 Foundations of Nutrition Practice for Kidney Disease
(Strategies I)
Louise Clement, MS, RD,
CSR, LD
100 NKF New Member Orientation NKF President Lynda
A. Szczech, MD, MSCE,
FASN, FNKF
NKF Council Executive
Committees
678 Council of Advanced Practitioners Networking Reception –
All Are Welcome!
�¬ 8 .0
(2 .5
Pharm)
�¬ 7 .3
�¬ 7 .0
�¬ 7 .1
�ù 8 .0
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
6:00am – 7:45am
Woodrow Wilson
800 Comprehensive Management of Mineral and Bone
Disorders in Advanced Chronic Kidney Disease
Chair: Hartmut H.
Malluche, MD, FACP
¬ 1 .5
Ballroom
Supported by an educational donation provided by Amgen
8:00am – 9:30am
National Harbor 10
8:00am – 9:30am
National Harbor 13
9:30am – 10:00am Break
10:00am – 11:30am
National Harbor 3
When, Why, and How to Address Phosphate Retention Ravi Thadhani, MD, MPH
When to Consider Cinacalcet Csaba P. Kovesdy,
MD, FASN
Initiation and Limits of Vitamin D Kevin J. Martin, MB, BCh,
FACP
660 Hospital Rounds and Pain Management 1 .5
Nephrology Hospital Rounds/Grand Rounds for the AP Luis Concepcion, MD
Pain Management in the CKD/ESRD Patient Mohanaram Narayanan,
MD, FASN
662 The Ultimate Hyper-Update: Hypertension and Hyper-
Coagulation
Where’s Aldo: Aldosterone and Hypertension Update Harvey Feldman, MD
Hyper-Coag Update: Dx and Rx Dana Kumjian, MD
661 Metabolic Panel Made Easy Charles Foulks, MD ù 1 .5
ù¬
1 .5

Thursday, May 10 continued
NKF SCM12
ADVANCED PRACTITIONER PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
10:00am – 11:30am 563 Prioritizing Nutrition Therapy for Diabetes Care Marion Franz, MS,
ù 1 .5
National Harbor 10
RD, CDE
10:00am – 11:30am 485 Meeting the Quality Assessment and Performance
Bonnie Greenspan, RN, ù 1 .5
Potomac D
Improvement Challenge
BSN, MBA
Rosemarie Miller, RN
Beth Witten, MSW,
ACSW, LSCSW
11:30am – 12:00pm Break
12:00pm – 2:00pm
Woodrow Wilson
Ballroom
12:00pm – 2:00pm
National Harbor 10
12:00pm – 2:00pm
National Harbor 12
12:00pm – 2:00pm
Potomac 1 - 3
12:00pm – 2:00pm
Potomac 4/5
2:00pm – 2:30pm Break
2:30pm – 3:30pm
Potomac A/B
801 Bone-Intestinal-Vascular-Renal Axis: Modeling and
Managing Calcium and Phosphorus Disturbances in CKD
Supported by an educational grant from Sanofi
A Reappraisal of Calcium Balance in Chronic Kidney Disease David Spiegel, MD
Calcium Use in the Non-Nephrology Setting Sophie Jamal, MD, PhD,
FRCPC
¬ 1 .5
630 Workshop: Trouble Shooting Diabetic Dilemmas Marc Brazie, MD � 2 .0
231 Workshop: Electrolytes Jerry Yee, MD, FNKF,
FASN, FACP
Harold Szerlip, MD, FNKF
233 Workshop: Urine Microscopy Chairs: Linda Fried, MD,
MPH, FNKF, and Mark
Perazella, MD, FNKF
Basics of Urine Microscopy: Cells, Casts, and Crystals Mark Perazella, MD, FNKF
Case-Based Approach to Urine Microscopy Mark Perazella, MD, FNKF
Traditional Urinary Biomarkers Paul Palevsky, MD, FNKF
234 Workshop: Topics in Interventional Nephrology
Preventing and Treating Catheter Complications
Chairs: Micah R. Chan,
MD, MPH, FNKF, and
Charmaine E. Lok, MD,
MSc, FNKF
Infectious Loay Salman, MD
Non-Infectious Micah R. Chan, MD, MPH,
FNKF
Innovation in Interventional Nephrology: Translating
Timmy Lee, MD, MSPH,
Technology to Practice
FACP, FASN
Doing the Right Thing From a Surgical Perspective: From Ingemar Davidson, MD,
Assessment to Cannulation
PhD
265 NKF Presidential Address: The Person and the Policy Lynda A. Szczech, MD,
MSCE, FASN, FNKF
Shaul G. Massry Distinguished Lecture:
Translating Biology and Observations into Human Trials: The
New Era of CKD-MBD
3:30pm – 4:00pm Break
4:00pm – 5:30pm
Potomac C
Ravi Thadhani, MD, MPH
266 KDOQI Commentary on the KDIGO AKI Guidelines Chair: Paul Palevsky, MD,
FNKF
Definition of AKI Charuhas V. Thakar, MD,
FNKF
Prevention and Treatment of AKI Lakhmir Chawla, MD
Contrast-Induced AKI Paul Palevsky, MD, FNKF
Renal Replacement Therapy Kathleen Liu, MD, PhD, MAS
Pediatric Issues Patrick Brophy, MD
�¬ 2 .0
�¬ 2 .0
�¬ 2 .0
¬ù 1 .0
¬ 1 .5
ADVANCED PRACTITIONER
73 73

74
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Thursday, May 10 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
4:00pm – 5:30pm
267 Coping and Depressive Symptoms in Advanced Kidney Chairs: Frederic
¬ 1 .5
Maryland D
Disease
Finkelstein, MD, FNKF,
and Megan Prescott,
LCSW
4:00pm – 5:30pm
Maryland C
Identification and Evaluation/Assessments of Depression Frederic Finkelstein, MD,
FNKF
Non-Pharmacologic Approaches for Treating Depression in
Kidney Disease
NKF SCM12
Stephanie Johnstone,
MSW, LCSW
Pharmacologic Therapies for Depression in Kidney Disease Tracy Anderson-Haag,
PharmD, BCPS
381 Collaborating to Improve Infection Control Outcomes Teri Spencer, RN
Kelly Frank, RN, BSN
Judith Kari, MSSW, ACSW,
LICSW
6:00pm – 7:30pm Opening Ceremonies and Reception in the Exhibit Hall –
Visit Posters*/Exhibits
7:30pm – 9:30pm
Woodrow Wilson
Ballroom
Friday, May 11
804 Nobody Likes Rejection! Practical Guidance on
Immunosuppression for 2012
Supported by an educational grant from Bristol-Myers Squibb
From Clinical Practice to Clinical Guidelines: The Evolution of
Recommendations in Immunosuppressant Therapies
Outcomes in Immunosuppression Therapies:
A Case Study Model
A Team Approach to Managing Immunosuppression: The
Central Role of the Empowered Patient
Ali Olyaei, PharmD
Erika Meredith, PharmD
Rebecca Hays, MSW,
APSW, NSW-C
ù 1 .5
¬ 1 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
6:00am – 7:45am
802 Anemia in CKD Stage 5: Balancing Morbidity, Mortality, and
¬ 1 .5
Woodrow Wilson
Quality of Life
Ballroom
Supported by an educational grant from Affymax, Inc. and
Takeda Pharmaceuticals North America, Inc.
Evaluation and Management of Hemoglobin Variability Jay Wish, MD
Individualization of Therapy for Anemia Csaba P. Kovesdy, MD,
FASN
Analyzing Emerging Treatment Data for Patients with
Anemia of ESRD
7:00am – 8:00am Continental Breakfast in Exhibit Hall –
Visit Posters*/Exhibits
8:00am – 8:30am
Potomac D
8:30am – 10:00am
Potomac D
8:30am – 10:00am
National Harbor 2
10:00am – 10:30am Break
Anil Agarwal, MD, FNKF
290 Changing Access to Kidney Replacement Modalities Chair: Joseph Vassalotti,
MD, FASN, FNKF
End the Wait For Kidney Transplantation Bryan N. Becker, MD,
MMM, FNKF
Access to Dialysis Care in the Bundled Environment Allan J. Collins, MD, FACP
269 Current and Future Approaches to Renal Protection
Through Blood Pressure Control
Review of the Topic in Context of BP Control in Kidney
Disease
Chairs: George Bakris,
MD, and Joseph
Vassalotti, MD, FASN,
FNKF
Rajiv Agarawal, MD,
FAHA, FASN, FASH
Baroreceptor Modulation for Treating Refractory
Hypertension
Vito Campese, MD
Renal Denervation George Bakris, MD
663 Tough Nuts to Crack: Case Studies in HIVAN/HTN/GN and
the Path that Solves It
Miriam Micheal, MD
Alexis Harris, MD
¬ 0 .5
¬ 1 .5
1 .5

Friday, May 11 continued
NKF SCM12
ADVANCED PRACTITIONER PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
10:30am – 12:00pm
National Harbor 3
664 Feet Don’t Fail Me Now! Diabetic Foot Care and Update:
Evaluations and Complications
Kyle Ballew, DPM ù 1 .5
10:30am – 12:00pm
National Harbor 2
665 The Liver, Heart, Lung, and Kidney Connection 1 .5
Heptorenal/Cardiorenal: Pathogenesis and Diagnosis Peter Juergensen, PA-C
Pulmonary Hypertension in Renal Disease Victor Test, MD
12:00pm – 2:00pm Break in the Exhibit Hall (Lunch Served 12:15pm – 1:15pm)
– Visit Posters*/Exhibits
2:00pm – 3:30pm
National Harbor 10
666 Renal Anatomy Game Show John Hubbard, PhD, PT 1 .5
3:30pm – 4:00pm Break
4:00pm – 5:30pm
Potomac 4/5
4:00pm – 5:30pm
National Harbor 10
667 Kidney Preservation and Problem Management 1 .5
OSA/RLS Kim English, MSN, RN,
FNP
Preserving Residual Renal Function in ESRD: The AP’s role Catherine Wells, DNP,
ACNP, CNN-NP
668 ABCs of ABG Carl Boethel, MD 1 .5
6:00pm – 7:30pm Networking Reception in the Exhibit Hall –
Visit Posters*/Exhibits
Saturday, May 12
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
6:00am – 7:45am
803 Chronic Mild Hyponatremia Is Not Benign: Implications for Chair: Joseph G. Verbalis, ¬ 1 .5
Woodrow Wilson
Clinical Practice
MD
Ballroom
Supported by an educational grant from Otsuka America
Pharmaceutical, Inc.
Adverse Effects of Chronic Mild Hyponatremia Joseph G. Verbalis, MD
Applicability of Vasopressin Antagonists in the Management Mitchell Rosner, MD, FACP
of Chronic Mild Hyponatremia
Case Studies: Diagnosis and Effective Management of Mitchell Rosner, MD, FACP
Chronic Mild Hyponatremia
8:00am – 9:00am Continental Breakfast Served in the Exhibit Hall – Visit
Posters*/Exhibits
9:30am – 11:00am
Potomac C
9:30am – 11:00am
National Harbor 4/5
11:00am – 11:30am Break
11:30am – 1:00pm
National Harbor 2
279 Healthcare Access in the Kidney Early Evaluation Program:
Implications on Outcomes
Chairs: Adam Whaley-
Connell, DO, MSPH,
FASN, FNKF, and Peter
McCullough, MD, MPH,
FACC, FACP, FNKF
Access to Healthcare in KEEP® Andrew Bomback, MD,
MPH
KEEP: The Role of Healthcare Access in Risk Factor Control Claudine Jurkovitz, MD,
MPH
KEEP: The Role of Healthcare Access on Mortality George Saab, MD
¬ù 1 .5
669 Pharmacology for the Provider 1 .5
Prescription and OTC Meds: Side Effects, Adverse Drug
Reactions and Interactions in Frequently Used Medications
Katie E. Cardone, PharmD,
BCACP
Herbal and Supplemental Medications Barbara Weis Malone,
FNP, RN, CFNP
530 Workshop: Physical Assessment Mary Pat Kelly, MS, RD,
RN, RNP
�ù 1 .5
ADVANCED PRACTITIONER
75 75

76
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
11:30am – 1:00pm 238 Workshop: Secondary and Resistant Hypertension Chair: John Sperati, MD, �¬ 1 .5
National Harbor 11
MHS, FNKF
11:30am – 1:00pm
Potomac 3
1:00pm – 1:30pm Break
1:30pm – 3:00pm
National Harbor 10
1:30pm – 3:00pm
National Harbor 12
3:00pm – 3:30pm Break
3:30pm – 5:00pm
Potomac 3
3:30pm – 5:00pm
Potomac 1/2
Sunday, May 13
Alternative Methods of Blood Pressure Measurement:
Implications for Resistant Hypertension
NKF SCM12
Rajiv Agarwal, MD, FAHA,
FASN, FASH
Cases George Bakris, MD
Raymond Townsend, MD
239 Workshop: Improving Long-Term Outcomes in Kidney
Transplant Recipients
The Role of the Community Nephrologist and Ancillary
Providers in the Care of Transplant Recipients: How to
Transition Smoothly
Chairs: Heidi Schaefer,
MD, FNKF, and Jianghua
Chen, MD
Andrew Howard, MD,
FACP
Renal Complications of Bone Marrow Transplantation Sangeeta Hingorani, MD,
MPH
Epidemiology and Management of CKD Following Solid
Organ Transplantation
Alexander Wiseman, MD,
FACP
�¬ 1 .5
670 Dermal to Dental in Renal 1 .5
Dermatological Disorders Kathy Riley, MSBC, PA-C
Dental and Oral Issues in CKD/ESRD Patients Stephen Grimm, DDS
671 Computer Word Made Easy: Understanding MS Word David Lammert, BMEd,
MM
672 Just Sign Here: Contract Negotiations for Advanced
Practitioners
Michael Powe, BS
Kim Zuber, MS, PA-C
Lisa Farris, DNP, CRNP
673 Is It Nephrotic or Nephritic? Peter Juergensen, PA-C 1 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS HOURS
8:00am – 9:30am
675 Transplant Treatment and Update Annette Needham, MSN,
2 .0
National Harbor 2
NP-C, CNN-NP, CCTC
8:00am – 9:30am
Potomac A
9:30am – 10:00am Break
10:00am – 11:30am
Potomac D
11:30am Meeting Adjourns
287 Renal Replacement Therapy in AKI Chair: Jonathan
Himmelfarb,MD
Timing and Modality of Acute Therapy Kathleen Liu, MD, PhD,
MAS
Drug Dosing in Acute Therapies Bruce Mueller, PharmD,
FCCP, FASN, FNKF
Intensity of RRT in AKI: How Much is Enough? Jonathan Himmelfarb, MD
289 CVD in CKD and ESRD Chairs: Rulan Parekh,
MD, FASN, and Peter
Stenvinkel, MD, PhD
Prevention of Sudden Cardiac Death in the Dialysis Patient Rulan Parekh, MD, FASN
Cardiorenal Syndrome – Evaluation and Management Luis Juncos, MD
Management of Atrial Fibrillation in CKD and Dialysis Peter McCullough, MD,
MPH, FACC, FACP, FNKF
*A MAXIMUM OF 1.0 CONTACT HOUR ONLY WILL BE AWARDED FOR POSTER SESSIONS.
1 .5
1 .5
¬ 1 .5
¬ 1 .5

NEPHROLOGY NURSE & TECHNICIAN PROGRAM
PLANNING COMMITTEE
Debra Gromo, RN, CNN
Program Chair
Fresenius Medical Care –
North America
Santa Rosa, CA
Laura Schmidt, RN, BSN, CNN, MHR
Program Co-Chair
Renal Ventures
Los Lunas, NM
Danilo B. Concepcion, CHT, CCHT, CBNT
St. Joseph Hospital
Orange, CA
Eileen MacFarlane, BSN, RN, CNN
WellBound of Mercer
Hamilton, NJ
Sheila Nelson
Fresenius Medical Care –
North America
Stockton, CA
Cintia Perez, RN
Saint Joseph Hospital
Orange, CA
Marilyn D. Swartz, RN, MSN
National Kidney Foundation
New York, NY
Patrice A. Zyry, BSN, RN, CNN
Belmont Dialysis
Farmingdale, NJ
HOST COMMITTEE
Debbie Cote, RN, BSN, CNN
University of Virginia
Verona, VA
Sarah Harper, CCHT
UVA Lynchburg Dialysis
Lynchburg, VA
Cathy Husser, BS, MEd, RN, CNN
UVA Lynchburg Dialysis
Lynchburg, VA
NKF SCM12
NEPHROLOGY NURSE AND TECHNICIAN PROGRAM
PROGRAM GOAL
To improve patient outcomes by enhancing nephrology
nurses’ and technicians’ knowledge base and skills that
will have a direct impact on clinical practice in a variety
of settings.
CONTINUING EDUCATION INFORMATION
The National Kidney Foundation (OH-337, 12/12/2012) is
an approved provider of continuing nursing education by
the Ohio Nurses Association (OBN-001-91), an accredited
approver by the American Nurses Credentialing Commission
on Accreditation.
This activity will provide up to 26.0 contact hours.
The following pre-conference courses have been approved:
COURSE CONTACT HOURS
Vascular Access 3 .75
Explore Transplant 6 .0
Nephrology 201 for
7 .75
Advanced Practitioners
Transplant 7 .0
Integrated Hemodialysis/
8 .0
Peritoneal Dialysis
Supported in part by
Baxter Healthcare Corporation
Interventional Nephrology
7 .3
In-kind Support provided by GE
Healthcare, Inc., Covidien, and Bard.
Dialysis Unit Management 7 .0
CKD Clinics 7 .1
NEPHROLOGY NURSE & TECHNICIAN
77 77

78
NEPHROLOGY NURSE & TECHNICIAN continued
PRE-CONFERENCE COURSES
REQUIRED: Separate registration fee of $60 ($90 when
registering for the course only); includes syllabus, light
breakfast, boxed lunch and CE contact hours. Participation
is limited.
● VASCULAR ACCESS: THE TEAM APPROACH TO
OPTIMAL SELECTION AND OUTCOMES
Wednesday, May 9
1:00pm – 5:00pm
Course Directors: Marianne Neumann RN, CNN, and
Terri Silverman RN, CNN
Session 320, 3.75 contact hours
Target Audience: Healthcare professionals interested in
management of vascular access outcomes
NKF SCM12
Course Description: This session will explain the history
and goals of the Fistula First Breakthrough Initiative and
enhance the attendee’s knowledge of the roles of members
of the facility vascular access team.
Course Objectives: Upon completion of this course,
participants will be able to:
z Recognize the message of the Fistula First Breakthrough
Initiative
z Discuss the role of the vascular access manager in
reaching access goals
z Discuss the roles of the nephrologist and surgeon on
the vascular access team
z Describe a Catheter Reduction Initiative which will
lead to lower bloodstream infection rates and lower
hospitalization rates
Course Agenda:
TIME TOPIC FACULTY
1:00pm – 1:15pm The Fistula First Breakthrough Initiative: Where We’ve Been and
Where We’re Going
Marianne Neumann, RN,CNN
1:15pm – 1:45pm The Role of the Vascular Access Manager in Unit Outcomes Marianne Neumann, RN,CNN
1:45pm – 2:30pm Systemic Barriers to Optimal Hemodialysis Access Jay Wish, MD
2:30pm – 2:45pm Break
2:45pm – 3:30pm The Surgeon’s Role on the Vascular Access Team Mike Lilly, MD
3:30pm – 4:15pm Catheter Reduction Initiative Alex Rosenblum, BS, RN, CNN
4:15pm – 4:45pm Group Discussion and Questions Panel
4:45pm – 5:00pm Wrap Up/Evaluations
REQUIRED: Separate registration fee of $125 ($175
when registering for the course only); includes syllabus,
light breakfast, boxed lunch and CE credits. Participation
is limited.
● EXPLORE TRANSPLANT
10:00am–5:00pm
Session 420, 6.0 contact hours
See page 96 for course details.
● NEPHROLOGY 201 FOR ADVANCED PRACTITIONERS
7:30am – 5:30pm
Session 620, 7.75 contact hours
See page 68 for course details.
REQUIRED: Additional registration fee of $175; $225
when registering for the course only. Includes syllabus,
breakfast, boxed lunch, and CME/CE credits.
● TRANSPLANT
7:30am – 4:30pm
Session 220, 7.0 contact hours
See page 47 for course details.
● INTEGRATED HEMODIALYSIS/PERITONEAL DIALYSIS
7:00am – 5:00pm
Session 221, 8.0 contact hours
See page 49 for course details.

● INTERVENTIONAL NEPHROLOGY
7:30am – 5:15pm
Session 222, 7.3 contact hours
See page 50 for course details.
● DIALYSIS UNIT MANAGEMENT
7:30am – 4:30pm
Session 223, 7.0 contact hours
See page 52 for course details.
● CKD CLINICS
7:30am – 5:00pm
Session 225, 7.1 contact hours
See page 54 for course details.
NKF SCM12
TECHNICIAN DAY
THURSDAY, MAY 10
NEPHROLOGY NURSE AND TECHNICIAN PROGRAM
8:00am – 5:30pm
Session 322, 5.5 contact hours
Description: Technicians are invited to attend a full day of
interactive sessions that will discuss the importance of their
role in the kidney healthcare team. Technician day sessions
can be recognized with a “²” in the Nurse and Technician
Program .
NEPHROLOGY NURSE & TECHNICIAN
79 79

80
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils ² Technician Day Session
Wednesday, May 9
NEPHROLOGY NURSE & TECHNICIAN
TIME/ROOM SESSION # SESSION COURSE FACULTYDIRECTOR(S) NOTES
CONTACT
CREDITS
HOURS
7:30am – 5:30pm
620 Nephrology 201 for Advanced Practitioners Laurie E. Benton, PhD, �ù 7 .75
National Harbor 2
MPAS, BS, PA-C, RN
Amma Sewaah-Bonsu,
DNP, MSN, NP-C
7:30am – 4:30pm
Woodrow Wilson D
7:00am – 5:00pm
National Harbor 11
7:30am – 5:15pm
Potomac 1/2
7:30am – 4:30pm
Woodrow Wilson B
7:30am – 5:00pm
National Harbor 12
10:00am – 5:00pm
Chesapeake 7/8
1:00pm – 5:00pm
Chesapeake 9
6:00pm – 6:30pm
Annapolis 1/2
6:30pm – 7:30pm
Riverview Terrace
Thursday, May 10
220 Transplant Heidi Schaefer, MD, FNKF �¬ 7 .0
221 Integrated Hemodialysis/Peritoneal Dialysis Joanne Bargman, MD,
FRCPC
222 Interventional Nephrology
In kind support provided by GE Healthcare, Inc., Covidien,
and Bard.
NKF SCM12
Loay Salman, MD
Amy Dwyer, MD, FACP
223 Dialysis Unit Management Peter B. DeOreo, MD,
FACP
225 CKD Clinics Jerry Yee, MD, FNKF, FACP,
FASN
Sandeep Soman, MD,
FNKF
420 Explore Transplant Amy D. Waterman, PhD
Christina Goalby, MSW
320 Vascular Access Marianne Neumann, RN, CNN
Terri Silverman, RN, CNN
100 NKF New Member Orientation NKF President Lynda A.
Szczech, MD, MSCE,
FASN, FNKF
NKF Council Executive
Committees
101 Healthcare Professionals Welcome Reception ù
�¬ 8 .0
�¬ 7 .3
�¬ 7 .0
�¬ 7 .1
�ù 6 .0
� 3 .75
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
6:00am – 7:45am
800 Comprehensive Management of Mineral and Bone
Chair: Hartmut H.
¬ 1 .5
Woodrow Wilson
Disorders in Advanced Chronic Kidney Disease
Malluche, MD, FACP
Ballroom
Supported by an educational donation provided by Amgen
8:00am – 9:30am
Potomac 1 - 3
8:00am – 9:30am
Potomac 4/5
8:00am – 9:30am
Potomac D
When, Why, and How to Address Phosphate Retention Ravid Thadhani, MD, MPH
When to Consider Cinacalcet Csaba P. Kovesdy, MD,
FASN
Initiation and Limits of Vitamin D Kevin J. Martin, MB, BCh,
FACP
360 What’s Wrong With This Picture? Diana Shelkov, CHT ² 1 .5
361 Before Disaster Strikes – Emergency Preparedness Dawn Koonkongsatian,
RN, CNN, MSN, Ed
261 Overcoming Barriers for Choosing and Implementing Home
Dialysis
The Clinical and Financial Benefits of Home Dialysis
vs. In-Center
Chairs: Rajnish Mehrotra,
MBBS, MD, FNKF, and
Raymond Krediet, MD, PhD
Joel Glickman, MD
Debate: The Physician is the Main Barrier for Home Dialysis
Yes Thomas A. Golper, MD,
FACP, FASN
No Alfred Cheung, MD
ù¬
1 .5
¬ 1 .5

Thursday, May 10 continued
NKF SCM12
NEPHROLOGY NURSE AND TECHNICIAN PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
9:30am – 10:00am Break
10:00am – 11:30am
National Harbor 2
10:00am – 11:30am
National Harbor 13
10:00am – 11:30am
Potomac D
10:00am – 11:30am
National Harbor 3
10:00am – 11:30am
Potomac C
12:00pm – 2:00pm
Maryland A
2:00pm – 2:30pm Break
2:30pm – 3:30pm
Potomac A/B
3:30pm – 4:00pm Break
4:00pm – 5:30pm
Potomac C
4:00pm – 5:30pm
National Harbor 12
4:00pm – 5:30pm
National Harbor 13
4:00pm – 5:30pm
Maryland C
362 How Do I Say That? Putting Professional Information into
Practice
Thomas Lepetich,
MSW, LCSW
363 What Do All Those Numbers Mean? Water Room 101 Heather Paradis, CHT ² 1 .5
485 Meeting the Quality Assessment and Performance
Improvement Challenge
Bonnie Greenspan, RN,
BSN, MBA
Rosemarie Miller, RN
Beth Witten, MSW, ACSW,
LSCSW
1 .5
ù 1 .5
661 Metabolic Panel Made Easy Charles Foulks, MD ù 1 .5
263 Understanding Blood Pressure Reduction in Kidney Disease Chairs: George Bakris,
MD, and Adam Whaley-
Connell, DO, MSPH, FASN,
FNKF
Targets for BP Control in the General Population, Diabetes,
and CKD
William Cushman, MD,
FACP, FAHA, FASH
Safety Issues in BP Management in CKD George Bakris, MD
Optimizing BP Control in CKD Patients: A Patient-Centered
Team-Based Approach
382 Council of Nephrology Nurses and Technicians Luncheon –
All Are Welcome!
Wendy St. Peter, PharmD,
FCCP, FASN, FNKF, BCPS
265 NKF Presidential Address: The Person and the Policy Lynda A. Szczech, MD,
MSCE, FASN, FNKF
Shaul G. Massry Distinguished Lecture: Translating Biology
and Observations into Human Trials: The New Era of
CKD-MBD
Ravi Thadhani, MD, MPH
266 KDOQI Commentary on the KDIGO AKI Guidelines Chair: Paul Palevsky, MD,
FNKF
Definition of AKI Charuhas V. Thakar, MD,
FNKF
Prevention and Treatment of AKI Lakhmir Chawla, MD
Contrast-Induced AKI Paul Palevsky, MD, FNKF
Renal Replacement Therapy Kathleen Liu, MD, PhD,
MAS
Pediatric Issues Patrick Brophy, MD
364 Water Room Workshop Danilo Concepcion, CHT,
CCHT, CBNT
Heather Paradis, CHT
Forest Rawls, CCHT, CHT
368 Transition From the Pediatric Unit to an Adult Facility Vernadette Ramos, CCLS
Maria Ferris, MD, MPH,
PhD
381 Collaborating to Improve Infection Control Outcomes Teri Spencer, ADN, RN
Kelly Frank, RN, BSN
Judith Kari, MSSW, ACSW,
LICSW
6:00pm – 7:30pm Opening Ceremonies and Reception in the Exhibit Hall –
Visit Posters*/Exhibits
¬ 1 .5
¬ù² 1 .0
¬ù 1 .5
² 1 .5
1 .5
ù 1 .5
NEPHROLOGY NURSE & TECHNICIAN
81 81

82
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Thursday, May 10 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
7:30pm – 9:30pm
804 Nobody Likes Rejection! Practical Guidance on
¬ 1 .5
Woodrow Wilson
Immunosuppression for 2012
Ballroom
Supported by an educational grant from Bristol-Myers Squibb
Friday, May 11
From Clinical Practice to Clinical Guidelines: The Evolution of
Recommendations in Immunosuppressant Therapies
Outcomes in Immunosuppression Therapies:
A Case Study Model
A Team Approach to Managing Immunosuppression: The
Central Role of the Empowered Patient
NKF SCM12
Ali Olyaei, PharmD
Erika Meredith, PharmD
Rebecca Hays, MSW,
APSW, NSW-C
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
6:00am – 7:45am
802 Anemia in CKD Stage 5: Balancing Morbidity, Mortality, and
¬ 1 .5
Woodrow Wilson
Quality of Life
Ballroom
Supported by an educational grant from Affymax, Inc. and
Takeda Pharmaceuticals North America, Inc.
Evaluation and Management of Hemoglobin Variability Jay Wish, MD
Individualization of Therapy for Anemia Csaba P. Kovesdy, MD,
FASN
Analyzing Emerging Treatment Data for Patients with
Anemia of ESRD
7:00am – 8:00am Continental Breakfast in Exhibit Hall – Visit Posters*/
Exhibits
8:00am – 8:30am
Potomac D
8:30am – 10:00am
National Harbor 12
8:30am – 10:00am
National Harbor 11
8:30am – 10:00am
Potomac D
8:30am – 10:00am
Potomac C
10:00am – 10:30am Break
10:30am – 12:00pm
National Harbor 12
Anil Agarwal, MD, FNKF
290 Changing Access to Kidney Replacement Modalities Chair: Joseph Vassalotti,
MD, FASN, FNKF
End the Wait For Kidney Transplantation Bryan N. Becker, MD,
MMM, FNKF
Access to Dialysis Care in the Bundled Environment Allan J. Collins, MD, FACP
365 CKD 101 and Treatment Options: Introduction to Home
Therapies
Anita Lipman, BSN, MS,
CNN
¬ 0 .5
383 CROWNWeb Matthew McDonough, MS 1 .5
269 Current and Future Approaches to Renal Protection
Through Blood Pressure Control
Review of the Topic in Context of BP Control in Kidney
Disease
Baroreceptor Modulation for Treating Refractory
Hypertension
Chairs: George Bakris, MD,
and Joseph Vassalotti,
MD, FASN, FNKF
Rajiv Agarawal, MD, FAHA,
FASN, FASH
Vito Campese, MD
Renal Denervation George Bakris, MD
270 The Management of CKD-MBD Chair: Bradley A. Warady,
MD, FNKF
Clinical Assessment of Bone Mineral Status in Adults and
Children
Mary Leonard, MD, MSCE
PTH or FGF-23: When to Measure One, the Other, or Both Myles Wolf, MD, MMSC
Realistic Dietary Strategies to Control Phosphorus in CKD/
ESRD
Lisa Gutekunst, MSEd, RD,
CSR, CDN
1 .5
¬ 1 .5
¬ 1 .5
366 Armed and Educated 1 .5
Home Hemo Basics Eileen MacFarlane, RN,
BSN, CNN
PD Basics Catherine Firanek, MBA,
BSN

Friday, May 11 continued
NKF SCM12
NEPHROLOGY NURSE AND TECHNICIAN PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
10:30am – 12:00pm 367 As the Bugs Come Marching In: Lesser-Known Infections Eileen Peacock, MSN, RN,
1 .5
National Harbor 13
CNN, CIC, CPHQ, CLNC
10:30am – 12:00pm
National Harbor 3
10:30am – 12:00pm
Potomac D
664 Feet Don’t Fail Me Now! Diabetic Foot Care and Update:
Evaluations and Complications
273 Treatment Options For Advanced Kidney Disease in
Older Adults
When Is It Appropriate to Recommend Initiation of Chronic
Dialysis in Older Adults?
What Is Conservative Therapy and When Should This Be
Considered?
When Is It Appropriate to Recommend Referral for
Transplantation in an Older Adult?
12:00pm – 2:00pm Break in the Exhibit Hall (Lunch Served 12:15pm – 1:15pm)
– Visit Posters*/Exhibits
2:00pm – 3:30pm
National Harbor 4/5
3:30pm – 4:00pm Break
4:00pm – 5:30pm
National Harbor 12
4:00pm – 5:30pm
National Harbor 4/5
4:00pm – 5:30pm
National Harbor 13
Kyle Ballew, DPM ù 1 .5
Chairs: Ann O’Hare, MD,
and Charmaine E. Lok,
MD, MSc, FNKF
Manjula Kurella Tamura,
MD, MPH
Michael Germain, MD
Dorry Segev, MD, PhD
369 Cannulation Workshop Lynda Ball, RN, MSN, CNN
Marianne Neumann, RN,
CNN
Terri Silverman, RN, CNN
Stuart Mott, BA, BS
370 Save My Lifeline: Assessment, Techniques, and
Complications
Kim Zuber, MS, PA-C
Lynn Poole, FNP-BC
¬ 1 .5
371 Palliative Care – Help Me Die with Dignity Lewis Cohen, MD ù 1 .5
277 The Challenges of Being an Adolescent Chair: Bradley A. Warady,
MD, FNKF
I Don’t Like Being Different Than My Friends! Angela Degnan, MSW,
LCSW, LSCSW
Individualizing the Prevention/Treatment of Non-Adherence Rebecca Johnson, PhD
Transition – The Mandate for Pediatric and Adult Medicine
Collaboration
6:00pm – 7:30pm Networking Reception in the Exhibit Hall –
Visit Posters*/Exhibits
Saturday, May 12
Lorraine Bell, MD
1 .5
1 .5
¬ù 1 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
6:00am – 7:45am
803 Chronic Mild Hyponatremia Is Not Benign: Implications for Chair: Joseph G. Verbalis, ¬ù 1 .5
Woodrow Wilson
Clinical Practice
MD
Ballroom
Supported by an educational grant from Otsuka America
Pharmaceutical, Inc.
Adverse Effects of Chronic Mild Hyponatremia Joseph G. Verbalis, MD
Applicability of Vasopressin Antagonists in the Management
of Chronic Mild Hyponatremia
Case Studies: Diagnosis and Effective Management of
Chronic Mild Hyponatremia
8:00am – 9:00am Continental Breakfast Served in the Exhibit Hall –
Visit Posters*/Exhibits
9:30am – 11:00am
National Harbor 2
372 We Need More Sugar: How Do We Get the Excellence Back
in Our Customer Service?
Mitchell Rosner, MD, FACP
Mitchell Rosner, MD, FACP
Alison Kregness, RN, CNN 1 .5
NEPHROLOGY NURSE & TECHNICIAN
83 83

84
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
9:30am – 11:00am
National Harbor 13
384 Cracking the Code to Buttonhole Survival Stuart Mott, BA, BS 1 .5
9:30am – 11:00am
Potomac C
11:15am – 12:45pm
Potomac 1/2
11:15am – 12:45pm
Chesapeake B/C
12:45pm – 1:30pm Break
1:30pm – 3:00pm
Chesapeake B/C
1:30pm – 3:00pm
Maryland 1/2
1:30pm – 3:00pm
Potomac A
3:00pm – 3:30pm Break
3:30pm – 5:00pm
National Harbor 3
3:30pm – 5:00pm
National Harbor 4/5
3:30pm – 5:00pm
National Harbor 10
3:30pm – 5:00pm
Potomac A
3:30pm – 5:00pm
Potomac C
279 Healthcare Access in the Kidney Early Evaluation Program:
Implications on Outcomes
NKF SCM12
Chairs: Adam Whaley-
Connell, DO, MSPH,
FASN, FNKF, and Peter
McCullough, MD, MPH,
FACC, FACP, FNKF
Access to Healthcare in KEEP® Andrew Bomback, MD,
MPH
KEEP: The Role of Healthcare Access in Risk Factor Control Claudine Jurkovitz, MD,
MPH
KEEP: The Role of Healthcare Access on Mortality George Saab, MD
373 “It Takes Two to Tango” Learning How to Dance in the
Dialysis Facility – IDT Approach to Dealing with the
Challenging Patient
374 Protecting Everyone: Hand Hygiene, Gloves, and Patient
Information
375 Hypotension, Hypertension, and Sodium – What Do These
All Have in Common?
376 Handing Off Your Patient – Continuum of Care/
Medication Reconciliation
Cathy Husser, BS, RN,
MEd, CNN
Sarah Harper, CCHT
Alison Kregness, RN, CNN
Danilo Concepcion,
CCHT,CHT, CBNT
Diana Hlebovy, RN, BSN,
CHN, CNN
Elaine Go, RN, NP, MSN,
CNN
283 Novel Effects of Vitamin D in Patients with Kidney Disease Chairs: Joachim Ix, MD,
and Ravi Thadhani, MD,
MPH
Vitamin D and Cardiovascular Disease Ravi Thadhani, MD, MPH
Vitamin D and Proteinuria Rajiv Agarwal, MD, FAHA,
FASN, FASH
Musculoskeletal Sharon Moe, MD, FASN,
FACP, FAHA
¬ù 1 .5
1 .5
1 .5
1 .5
1 .5
¬ 1 .5
377 Basic Training: The “Battle” to Understand Hepatitis B Labs Nancy Foley, RN, CNN 1 .5
378 Laughter in the Workplace Mary McKinney, MSW,
MPA, LCSW, ACSW
468 Boundaries and Social Media Lisa Hall, MSSW, LICSW ù 1 .5
284 Diabetes Debate Chairs: Linda Fried,
MD, MPH, FNKF, and
Charmaine E. Lok, MD,
MSc, FNKF
What Should Goal HgbA1c Be in CKD and ESRD? Katherine Tuttle, MD,
FASN, FACP
Debate: Glycated Albumin is a Superior Method to Assess
Glycemic Control in Diabetic ESRD Patients
Pro Barry Freedman, MD
Con Kamyar Kalantar-Zadeh,
MD, PhD, MPH, FNKF
285 The Impact of Bundling on Clinical Practice Chair: Lynda A. Szczech,
MD, MSCE, FASN, FNKF
Changes in Practice Patterns and Laboratory Values Bruce Robinson, MD, MS,
FACP
Changes in Anemia Management and Anticipated Effects on
Patient Outcomes
The Administrative Challenges of Implementing Oral Meds
into The Bundle
Lynda A. Szczech, MD,
MSCE, FNKF
Jay Wish, MD
1 .5
¬ù 1 .5
¬ 1 .5

Sunday, May 13
NKF SCM12
NEPHROLOGY NURSE AND TECHNICIAN PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES
CONTACT
CREDITS
HOURS
8:00am – 9:30am
379 Fluid Management: The 5th Vital Sign Diana Hlebovy, RN, BSN, ù 1 .5
National Harbor 11
CHN, CNN
8:00am – 9:30am
National Harbor 12/13
8:00am – 9:30am
Potomac C
9:30am – 10:00am Break
10:00am – 12:00pm
National Harbor 10
10:00am – 11:30am
Potomac C
10:00am – 11:30am
Potomac D
12:00pm Meeting Adjourns
380 Handing Off the Torch: Career Leadership Development Suzann VanBuskirk, BSN,
RN, CNN
286 Implications of Dietary Additives in Kidney Disease Chairs: Linda Fried, MD,
MPH, FNKF, and Janeen
Leon, MS, RD, LD
High Fructose Corn Syrup Adam Whaley-Connell,
DO, MSPH, FASN, FNKF
Sodium Alan Pao, MD
Phosphorus Additives Janeen Leon, MS, RD, LD
580 IDT Panel Discussion of Fluid Management of Patients Cathy Husser, BS, RN,
MEd, CNN
Sarah Harper, CCHT
Mary Pat Kelly, MS, RD,
RN, RNP
Cooking Demo: Low-Salt Cooking Equals Flavor Chef Duane Sunwold
288 Symptom Management Tips in Advanced CKD/ESRD Chairs: Ann O’Hare, MD,
and Kerri Cavanaugh, MD,
MHS, FNKF
Prevalence and Evaluation of Symptoms: Sleep Disorders,
Pruritus, and Pain
Kerri Cavanaugh, MD,
MHS, FNKF
Non-Pharmacologic Management Gary Petingola, RSW, BA,
BSW
Pharmacologic Management Marianna Leung, PharmD,
BSc
289 CVD in CKD and ESRD Chairs: Rulan Parekh, MD,
MS, and Peter Stenvinkel,
MD, PhD
Prevention of Sudden Cardiac Death in the Dialysis Patient Rulan Parekh, MD, MS
Cardiorenal Syndrome – Evaluation and Management Luis Juncos, MD
Management of Atrial Fibrillation in CKD and Dialysis Peter McCullough, MD,
MPH, FACC, FACP, FNKF
*A MAXIMUM OF 1.0 CONTACT HOUR ONLY WILL BE AWARDED FOR POSTER SESSIONS.
1 .5
¬ 1 .5
ù 2 .0
¬ 1 .5
¬ 1 .5
NEPHROLOGY NURSE & TECHNICIAN
85 85

86
RENAL and CLINICAL DIETITIAN PROGRAM
PLANNING COMMITTE
Aimee Jaremowicz, RD, LDN
Program Chair
Pentec Health, Inc.
Chicago Ridge, IL
Marie Becker, MS, RD, LDN
Program Co-Chair
DaVita Central
Orlando Dialysis
Orlando, FL
Louise Clement, MS, RD, CSR, LD
Fresenius Medical Care
Lubbock, TX
Kristine D’Angelo David, RD
Sigma-Tau
Pharmaceuticals, Inc.
Gaithersburg, MD
Janelle Gonyea, BS, RD, LD
Mayo Clinic
Dialysis System
Rochester, MN
Chhaya Patel, MA, RD, CSR
DaVita Inc.
Walnut Creek, CA
Irene M. Rosario, RD, LDN
DaVita Winter Park
Hemodialysis
Winter Park, FL
Jana Zimmer, RD, LD, BS
DaVita Weslaco
Rancho Viejo, TX
NKF SCM12
HOST COMMITTEE
Wendy Caesar-Gibbs, RD, LDN
Walter Reed Army Hospital
Lanham, MD
Sharon Kennedy, RD, LDN
Independent Dialysis Foundation
Baltimore, MD
Karen Marino, RD, LDN
DaVita, Inc.
Owings Mills, MD
Maryann Thornton, RD, LDN
Independent Dialysis Foundation
Baltimore, MD
Stephanie Yacob, RD, LD
Fort Washington, MD
CONTINUING EDUCATION INFORMATION
The National Kidney Foundation is a
Continuing Professional Education (CPE)
Accredited Provider with the Commission
on Dietetic Registration (CDR). Registered
dietitians (RDs) and Dietetic Technicians,
Registered (DTRs) will receive up to 36.5
continuing professional education units
(CPEUs) for completion of this program/
material .

PRE-CONFERENCE COURSES
REQUIRED: Separate registration fee of $125 ($175
when registering for a course only); includes syllabus,
light breakfast, boxed lunch and CPEUs. Participation
is limited.
● FOUNDATIONS OF NUTRITION PRACTICE FOR
KIDNEY DISEASE (STRATEGIES I)
Wednesday, May 9
7:30am – 5:15pm
Course Director: Louise Clement, MS, RD, CSR, LD
Session 520, 8.0 CPEUs
Target Audience: This course is designed for dietitians who
are new to renal nutrition, as well as for dietitians who work
in non-renal settings but wish to strengthen their overall
knowledge in this dynamic area.
Course Description: Strengthen fundamental knowledge
of renal nutrition! Understand medical nutrition therapy
in bone management, hemodialysis, peritoneal dialysis,
anemia, and treating malnutrition. Interact with experts in
kinetic modeling, micronutrient requirements, and nutrition
assessment. Participants will gain a solid foundation to
practice as entry-level nutrition specialists in the dialysis
setting or in other practice settings with chronic kidney
disease, and end-stage kidney disease in particular.
NKF SCM12
RENAL AND CLINICAL DIETITIAN PROGRAM
Course Objectives: Upon completion of this activity,
participants will be able to:
z Describe normal bone metabolism and resulting
alterations in CKD
z Discuss physiology and transport in peritoneal dialysis,
the guidelines to meet the nutrient requirements in PD,
and special considerations
z List available CKD programs and resources, including
CMS, quality initiatives, and ESRD Networks
z Review kinetic modeling in hemodialysis, the process
of anemia management, and the treatment of
malnutrition
z Discuss the unique vitamin requirements of patients
in CKD 5 by status assessment, recommendations, and
knowledge of available products
z Describe the process of nutrition assessment in the
dialysis population
Course Agenda:
TIME TOPIC FACULTY
7:50am – 8:00am Welcome and Introductions Louise Clement, MS, RD, CSR, LD
8:00am – 9:00am Nutrition Guidelines for Hemodialysis Janelle Gonyea, BS, RD, LD
9:00am – 10:00am Treating Malnutrition Trisha Fuhrman, MS, RD, LD, FADA
10:00am – 10:15am Break
10:15am – 11:15am Overview of Bone and Mineral Disease Linda McCann, RD, CSR, LD
11:15am – 12:00pm MNT in Peritoneal Dialysis Karen Wiesen, MS, RD, LD
12:00pm – 12:45pm Lunch
12:45pm – 1:15pm Introduction to CKD Programs Karen Wiesen, MS, RD, LD
1:15pm – 2:00pm Kinetic Modeling Lee Cauble, RN, BSN, BSB
2:00pm – 2:30pm Anemia Management Louise Clement, MS, RD, CSR, LD
2:30pm – 3:00pm Vitamin Requirements in CKD 5 Louise Clement, MS, RD, CSR, LD
3:00pm – 3:15pm Break
3:15pm – 4:15pm Nutrition Assessment Deborah Benner, MA, RD, CSR
4:15pm – 5:00pm Case Studies Louise Clement, MS, RD, CSR, LD
5:00pm – 5:15pm Q&A/Evaluations
RENAL AND CLINICAL DIETITIAN
87 87

88
RENAL and CLINICAL DIETITIAN continued
● ADVANCED PRACTICE IN RENAL NUTRITION:
UPDATE 2012 (STRATEGIES II)
Wednesday, May 9
7:30am – 4:00pm
Course Director: Alison Steiber, PhD, RD, LD
Session 521, 7.5 CPEUs
Target Audience: Designed for seasoned dietitians.
Course Description: Designed to integrate new research
into clinical practice, and foster critical thinking strategies
to improve nutrition status of patients with chronic kidney
disease. This course will promote interactive learning that
will result in changes in practice which will ultimately
improve patient outcomes. This will be achieved by
NKF SCM12
integrating research with clinical practice. Topics for
presentation and discussion include: inflammation: causes
and impact on nutritional status; Exercise: the research
and the clinical application; reducing metabolic acidosis:
potentially an inexpensive and effective intervention, and
designer oral supplements: can they reduce inflammation?
Course Objectives: Upon completion of this activity,
participants will be able to:
z Describe research results and techniques in which those
results can be integrated into clinical practice
z Identify and reduce or ameliorate inflammation in
patients with chronic kidney disease
Course Agenda:
TIME TOPIC FACULTY
7:30am Breakfast
8:00am – 8:30am Welcome from the Leadership Alison Steiber, PhD, RD, LD
Lisa Gutekunst, MSEd, RD, CSR, CDN
Aimee Jaremowicz, RS, LDN
8:30am – 9:30am Introduction to Inflammation: Causes, Biomarkers, and Impact on
Nutrition and Mortality
Juan Carrero, PharmD, PhD, MBA
9:30am – 10:10am Inflammation: Translating Research into Clinical Practice Alison Steiber, PhD, RD, LD
10:10am – 11:00am Promoting Anabolism/Reducing Inflammation in
Chronic Kidney Disease: Overview
Adriana Hung, MD, MPH
11:00am – 11:45am Exercise for People with CKD Anthony Meade, BSc, MND, APD
11:45am – 1:00pm Lunch
1:00pm – 2:00pm Anti-inflammatory Nutrition Support Kamyar Kalantar-Zadeh, MD, PhD, MPH,
FNKF
2:00pm – 3:30pm Interventions to Reduce Inflammation and Promote Anabolism
Fatty Acids – Omega 3 and Beyond Juan Carrero, PharmD, PhD, MBA
Vegetarian Diet: Impact on pH and Serum Phosphorus Ranjani Moorthi, MD, MPH, MS
Bardoxolone Pablo Pergola, MD, PhD
Anti-Oxidant Nutrients & Molecules Alison Steiber, PhD, RD, LD
3:30pm – 4:00pm Concluding Remarks and Evaluations

LUNCH WORKSHOPS
REQUIRED: Separate registration fee of $40. Includes box
lunch and CPEUs. Participation is limited so register early.
SATURDAY, MAY 12, 11:30AM – 1:00PM
PHYSICAL ASSESSMENT
Session 530
Presenter: Mary Pat Kelly, MS, RD, RN, RNP
Workshop Description: This workshop will focus on
nutrients that have the potential for deficiency or excess
in dialysis patients. Each nutrient will be reviewed in
relation to dietary intake, medical history/comorbid
conditions, dialysis therapy, physical signs and symptoms,
laboratory indices, and interactions with drugs or other
nutrients. Participants will complete this workshop with an
enhanced understanding of nutrient assessment that can be
extrapolated to other nutrients of interest.
NKF SCM12
RENAL AND CLINICAL DIETITIAN PROGRAM
WEIGHT LOSS MANAGEMENT IN CKD
Session 240
Chair: Adam Whaley-Connell, DO, MSPH, FNKF, FASN
Presenters: Holly Kramer, MD, MPH, Kirsten Johansen, MD,
and Nina Kolbe, RD, CSR, LD
See page 59 for workshop description.
RENAL AND CLINICAL DIETITIAN
89 89

90
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Wednesday, May 9
RENAL and CLINICAL DIETITIAN
TIME/ROOM SESSION # SESSION COURSE FACULTYDIRECTORS NOTES CPEUs
7:30am – 5:15pm
Chesapeake 4
7:30am – 4:00pm
National Harbor 3
6:00pm – 6:30pm
Annapolis 1/2
6:30pm – 7:30pm
Riverview Terrace
Thursday, May 10
520 Foundations of Nutrition Practice for Kidney Disease
(Strategies I)
521 Advanced Practice in Renal Nutrition: Update 2012
(Strategies II)
NKF SCM12
Louise Clement, MS, RD,
CSR, LD
Alison Steiber, PhD, RD,
LD
100 NKF New Member Orientation NKF President Lynda A.
Szczech, MD, MSCE, FASN,
FNKF
NKF Council Executive
Committees
101 Healthcare Professionals Welcome Reception ù
�ù 8 .0
�ù 7 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
6:00am – 7:45am
800 Comprehensive Management of Mineral and Bone
Chair: Hartmut H.
¬ù 1 .5
Woodrow Wilson
Disorders in Advanced Chronic Kidney Disease
Malluche, MD, FACP
Ballroom
Supported by an educational donation provided by Amgen
8:00am – 9:30am
National Harbor 11
8:00am – 9:30am
National Harbor 3
9:30am – 10:00am Break
10:00am – 11:30am
National Harbor 10
10:00am – 11:30am
National Harbor 3
10:00am – 11:30am
Potomac C
10:00am – 11:30am
Potomac D
11:30am – 12:00pm Break
12:00pm – 2:00pm
Maryland C
2:00pm – 2:30pm Break
When, Why, and How to Address Phosphate Retention Ravi Thadhani, MD, MPH
When to Consider Cinacalcet Csaba P. Kovesdy, MD,
FASN
Initiation and Limits of Vitamin D Kevin J. Martin, MB, BCh,
FACP
560 Use of Inorganic Phosphorus Ingredients in Food
Processing: The Good, the Bad, and the Ugly
ù¬
Mona Calvo, PhD 1 .5
561 Obesity: The Problem and Some Treatment Options Maureen McCarthy,
MPH, RD, CSR, LD
Nina Kolbe, RD, CSR, LD
563 Prioritizing Nutrition Therapy for Diabetes Care Marion Franz, MS, RD, CDE ù 1 .5
661 Metabolic Panel Made Easy Charles Foulks, MD ù
263 Understanding Blood Pressure Reduction in Kidney Disease Chairs: George Bakris,
MD, and Adam Whaley-
Connell, DO, MSPH, FASN,
FNKF
Targets for BP Control in the General Population, Diabetes,
and CKD
William Cushman, MD,
FACP, FAHA, FASH
Safety Issues in BP Management in CKD George Bakris, MD
Optimizing BP Control in CKD Patients: A Patient-Centered
Team-Based Approach
485 Meeting the Quality Assessment and Performance
Improvement Challenge
583 Council on Renal Nutrition Networking Luncheon ––
All are Welcome!
Wendy St. Peter, PharmD,
FCCP, FASN, FNKF, BCPS
Bonnie Greenspan, RN,
BSN, MBA
Rosemarie Miller, RN
Beth Witten, MSW ACSW,
LSCSW
1 .5
¬ 1 .5
ù 1 .5
Judith Beto, PhD, RD, FADA 0 .5

Thursday, May 10 continued
NKF SCM12
RENAL AND CLINICAL DIETITIAN PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
2:30pm – 3:30pm
Potomac A/B
3:30pm – 4:00pm Break
4:00pm – 5:30pm
National Harbor 4/5
4:00pm – 5:30pm
Potomac C
4:00pm – 5:30pm
Maryland D
4:00pm – 5:30pm
Maryland C
265 NKF Presidential Address: The Person and the Policy Lynda A. Szczech, MD,
MSCE, FASN, FNKF
Shaul G. Massry Distinguished Lecture: Translating Biology
and Observations into Human Trials: The New Era of CKD-
MBD
564 Joel D. Kopple Award Presentation
Interaction of Lipids and Inflammation in Health and Chronic
Kidney Disease
Ravi Thadhani, MD, MPH
Accepting on behalf of
Nathan W. Levin, MD,
FACP: Jerrilynn Burrowes,
PhD, RD , LDN
George Kaysen, MD, PhD
266 KDOQI Commentary on the KDIGO AKI Guidelines Chair: Paul Palevsky, MD,
FNKF
Definition of AKI Charuhas V. Thakar, MD,
FNKF
Prevention and Treatment of AKI Lakhmir Chawla, MD
Contrast-Induced AKI Paul Palevsky, MD, FNKF
Renal Replacement Therapy Kathleen Liu, MD, PhD,
MAS
Pediatric Issues Patrick Brophy, MD
267 Coping and Depressive Symptoms in Advanced Kidney
Disease
Chairs: Frederic
Finkelstein, MD, FNKF,
and Megan Prescott,
MSW, LCSW
Identification and Evaluation/Assessments of Depression Frederic Finkelstein, MD,
FNKF
Non-Pharmacologic Approaches for Treating Depression in
Kidney Disease
Stephanie Johnstone,
MSW, LCSW
Pharmacologic Therapies for Depression in Kidney Disease Tracy Anderson-Haag,
PharmD, BCPS
381 Collaborating to Improve Infection Control Outcomes Teri Spencer, RN, ADN
Kelly Frank, RN, BSN
Judith Kari, MSSW, ACSW,
LICSW
6:00pm – 7:30pm Opening Ceremonies and Reception in the Exhibit Hall –
Visit Posters*/Exhibits
7:30pm – 9:30pm
Woodrow Wilson
Ballroom
Friday, May 11
804 Nobody Likes Rejection! Practical Guidance on
Immunosuppression for 2012
Supported by an educational grant from Bristol-Myers Squibb
From Clinical Practice to Clinical Guidelines: The Evolution of
Recommendations in Immunosuppressant Therapies
Outcomes in Immunosuppression Therapies:
A Case Study Model
A Team Approach to Managing Immunosuppression:
The Central Role of the Empowered Patient
Ali Olyaei, PharmD
Erika Meredith, PharmD
Rebecca Hayes, MSW,
APSW, NSW-C
¬ù 1 .0
1 .5
¬ 1 .5
¬ 1 .5
ù 1 .5
¬ 1 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
6:00am – 7:45am
802 Anemia in CKD Stage 5: Balancing Morbidity, Mortality, and
¬ 1 .5
Woodrow Wilson
Quality of Life
Ballroom
Supported by an educational grant from Affymax, Inc. and
Takeda Pharmaceuticals North America, Inc.
Evaluation and Management of Hemoglobin Variability Jay Wish, MD
Individualization of Therapy for Anemia Csaba P. Kovesdy, MD,
FASN
Analyzing Emerging Treatment Data for Patients with
Anemia of ESRD
Anil Agarwal, MD, FNKF
RENAL AND CLINICAL DIETITIAN
91 91

� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
92
Friday, May 11 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
7:00am – 8:00am Continental Breakfast in the Exhibit Hall –
Visit Posters*/Exhibits
8:00am – 8:30am
Potomac D
8:30am – 10:00am
National Harbor 10
8:30am – 10:00am
Potomac C
10:00am – 10:30am Break
10:30am – 12:00pm
National Harbor 11
10:30am – 12:00pm
National Harbor 10
10:30am – 12:00pm
Potomac D
290 Changing Access to Kidney Replacement Modalities Chair: Joseph Vassalotti,
MD, FASN, FNKF
End the Wait for Kidney Transplantation Bryan N. Becker, MD,
MMM, FNKF
Access to Dialysis Care in the Bundled Enviornment Allan J. Collins, MD, FACP
565 MNT for CKD: Evolution of the Process Carolyn Cochran,
RD, LD, MS, CDE
Jessie Pavlinac, RD, CSR,
LD
270 The Management of CKD-MBD Chair: Bradley A. Warady,
MD, FNKF
Clinical Assessment of Bone Mineral Status in Adults
and Children
NKF SCM12
Mary Leonard, MD, MSCE
PTH or FGF-23: When to Measure One, the Other, or Both Myles Wolf, MD, MMSC
Realistic Dietary Strategies to Control Phosphorus in
CKD/ESRD
Lisa Gutekunst, MSEd, RD,
CSR, CDN
¬ 0 .5
1 .5
¬ 1 .5
566 Focusing on the Positives: Mg++ and Ca++ in CKD David Spiegel, MD 1 .5
567 Legal Aspects for the Renal Dietitian: Ethical Considerations Sharon Johnson, JD, MS,
RD, LD
273 Treatment Options For Advanced Kidney Disease in Older
Adults
When Is It Appropriate to Recommend Initiation of Chronic
Dialysis in Older Adults?
What Is Conservative Therapy and When Should This Be
Considered?
When Is It Appropriate to Recommend Referral for
Transplantation in an Older Adult?
12:00pm – 2:00pm Break in the Exhibit Hall (Lunch Served 12:15pm – 1:15pm)
– Visit Posters*/Exhibits
2:00pm – 3:30pm
National Harbor 3
2:00pm – 3:30pm
National Harbor 13
3:30pm – 4:00pm Break
4:00pm – 5:30pm
National Harbor 2
4:00pm – 5:30pm
National Harbor 11
4:00pm – 5:30pm
National Harbor 13
Chairs: Ann O’Hare, MD,
and Charmaine E. Lok,
MD, MSc, FNKF
Manjula Kurella Tamura,
MD, MPH
Michael Germain, MD
Dorry Segev, MD, PhD
568 Metabolic Implications of Pica and Behavioral Interventions Karen Wiesen, MS, RD, LD
Shari Neul, PhD
569 Research on a Shoe String: Pursuing the Possible Jerrilyn Burrowes, PhD,
RD, CDN
Does DM or Transporter Type Influence Response to IPN? Eileen Moore, CNSD,
RD, LD
Anthropometry in an Irish Hemodialysis Unit Jennifer O’Neil, RD
570 Influences of Nutrition and Inflammatory Factors on
Anemia in CKD-5 Dialysis
571 Management of the Patient with Liver Disease in
Nephrology
Amit Sharma, MD, FACP,
FASN
Jeanette Hasse, PhD, RD,
FADA, CNSC
277 The Challenges of Being an Adolescent Chair: Bradley A. Warady,
MD, FNKF
I Don’t Like Being Different From My Friends! Angela Degnan, MSW,
LCSW, LSCSW
Individualizing the Prevention/Treatment of Non-Adherence Rebecca Johnson, PhD
Transition – The Mandate for Pediatric and Adult Medicine
Collaboration
6:00pm – 7:30pm Networking Reception in the Exhibit Hall –
Visit Posters*/Exhibits
Lorraine Bell, MD, FRCPC
1 .5
¬ 1 .5
1 .5
1 .5
1 .5
1 .5
¬ 1 .5

Saturday, May 12
NKF SCM12
RENAL AND CLINICAL DIETITIAN PROGRAM
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
6:00am – 7:45am
Woodrow Wilson
Ballroom
803 Chronic Mild Hyponatremia Is Not Benign: Implications for
Clinical Practice
Supported by an educational grant from Otsuka America
Pharmaceutical, Inc.
Chair: Joseph G. Verbalis,
MD
Adverse Effects of Chronic Mild Hyponatremia Joseph G. Verbalis, MD
Applicability of Vasopressin Antagonists in the Management
of Chronic Mild Hyponatremia
Case Studies: Diagnosis and Effective Management of
Chronic Mild Hyponatremia
8:00am – 9:00am Continental Breakfast Served in the Exhibit Hall –
Visit Posters*/Exhibits
9:30am – 11:00am
Potomac C
9:30am – 11:00am
National Harbor 11
9:30am – 11:00am
Potomac 1/2
279 Healthcare Access in the Kidney Early Evaluation Program:
Implications on Outcomes
Mitchell Rosner, MD,
FACP
Mitchell Rosner, MD,
FACP
Chairs: Adam Whaley-
Connell, DO, MSPH,
FASN, FNKF, and Peter
McCullough, MD, MPH,
FACC, FACP, FNKF
Access to Healthcare in KEEP® Andrew Bomback, MD,
MPH
KEEP: The Role of Healthcare Access in Risk Factor Control Claudine Jurkovitz, MD,
MPH
KEEP: The Role of Healthcare Access on Mortality George Saab, MD
572 Bundling Update and the RD Linda McCann, RD, CSR
Mark Neumann, MS
573 The Best Losers: Weight Loss in CKD and
Transplant Patients
¬ù 1 .5
¬ 1 .5
1 .5
Karen Kritsch, PhD, RD 1 .5
11:00am – 11:30am Break
11:15am – 12:45pm
National Harbor 4/5
574 Personality Disorders/Dealing with Difficult Patients Shari Neul, PhD 1 .5
11:30am – 1:00pm
530 Workshop: Physical Assessment Mary Pat Kelly, MS, RD, �ù 1 .5
National Harbor 2
RN, RNP
11:30am – 1:00pm
Chesapeake D/E
1:00pm – 1:30pm Break
1:30pm – 3:00pm
National Harbor 13
1:30pm – 3:00pm
Potomac 1/2
1:30pm – 3:00pm
National Harbor 2
3:00pm – 3:30pm Break
3:30pm – 5:00pm
National Harbor 12
3:30pm – 5:00pm
National Harbor 13
240 Workshop: Weight Loss Management in CKD Chair: Adam Whaley-
Connell, DO, MSPH, FASN,
FNKF
Diet Nina Kolbe, RD, CSR, LD
Exercise Kirsten Johansen, MD
Surgical Holly Kramer, MD, MPH
575 Peritoneal Dialysis: Nutritional Consequences and
Interventions
576 Putting the “Kid” in Kidney: Pediatric CKD Christina Nelms, MS,
RD, CSP, CNSC, LD
�¬ 1 .5
Linda Noto, RD, BS 1 .5
577 Helping Patients Stretch Their Food Budget Rebecca Brosch, RD, LD, BS 1 .5
578 Home Hemo/In-Center Nocturnal Dialysis and Nutrition Kathy Lahr, RD
Shane Simon, MBA
Chhaya Patel, MA, RD, CSR
562 Not All Proteins are Created Equal Joyce O’Dea, RD, CSR 1 .5
1 .5
1 .5
RENAL AND CLINICAL DIETITIAN
93 93

94
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils
Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
3:30pm – 5:00pm
Potomac A
Sunday, May 13
284 Diabetes Debate
NKF SCM12
Chairs: Linda Fried,
MD, MPH, FNKF, and
Charmaine E. Lok, MD,
MSc, FNKF
What Should Goal HgbA1c Be in CKD and ESRD? Katherine Tuttle, MD,
FASN, FACP
Debate: Glycated Albumin is a Superior Method to Assess
Glycemic Control in Diabetic ESRD Patients
Pro Barry Freedman, MD
Con Kamyar Kalantar-Zadeh,
MD, MPH, PhD, FNKF
¬ 1 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES CPEUs
8:00am – 9:30am
379 Fluid Management: The 5th Vital Sign Diana Hlebovy, RN, BSN, ù 1 .5
National Harbor 11
CHN, CNN
8:00am – 9:30am
Potomac C
9:30am – 10:00am Break
10:00am – 11:30am
National Harbor 11
10:00am – 12:00pm
National Harbor 10
12:00pm Meeting Adjourns
286 Implications of Dietary Additives in Kidney Disease Chairs: Linda Fried, MD,
MPH, FNKF, and Janeen
Leon, MS, RD, LD
High Fructose Corn Syrup Adam Whaley-Connell,
DO, MSPH, FASN, FNKF
Sodium Alan Pao, MD
Phosphorus Additives Janeen Leon, MS, RD, LD
582 How to Avoid Drug-Supplement Interactions Philip J. Gregory, PharmD,
FACN
580 IDT Panel Discussion of Fluid Management of Patients Cathy Husser, RN, BS,
MEd, CNN
Sarah Harper, CCHT
Mary Pat Kelly, MS, RD,
RN, RNP
*A MAXIMUM OF 1.0 CPEU ONLY WILL BE AWARDED FOR POSTER SESSIONS.
Cooking Demo: Low-Salt Cooking Equals Flavor Chef Duane Sunwold
¬ 1 .5
1 .5
ù 2 .0

NEPHROLOGY SOCIAL WORKER PROGRAM
PLANNING COMMITTEE
Rebecca Hays, MSW, APSW, NSW-C
Program Chair
University of Wisconsin
Hospital and Clinics
Madison, WI
Kristin Stockard, MSW, LICSW, NSW-C
Program Co-Chair
Seattle’s Children’s Hospital and
Regional Medical Center
Seattle, WA
Andrea Dekam, MSW, LMSW
Continuing Education Coordinator
University of Michigan Dialysis
Livonia, MI
Sandra Coorough, ACSW, LCSW, NSW-C
Phoenix Children’s Hospital
Kid’s Kidney Center
Phoenix, AZ
Jessica Farrell, MSW, LCSW, NSW-C
Duke University Medical Center
Durham, NC
Melissa Fry, MSW, CAPSW
Mile Bluff Medical Center
Mauston, WI
Megan R. Prescott, MSW, LCSW
University of Colorado Hospital
Aurora, CO
Vernon Silva, MSW, LCSW, NSW-C
Kidney Dialysis Center of
West Los Angeles
Los Angeles, CA
Christopher Simon, MSW, LCSW-C
Independent Dialysis Foundation, Inc.
Baltimore MD
NKF SCM12
HOST COMMITTEE
Denise J. Collins, MSSW, LCSW-C, LICSW, NSW-C
Kaiser Permanente
Rockville, MD
Kevin Ceckowski, MSW, LICSW
Walter Reed
National Military Medical Center
Bethesda, MD
LaKeisha R. Jackson, MSW
DaVita, Inc.
District Heights, MD
Elizabeth Jones, MSW, LCSW
DaVita Sterling
Sterling, VA
Phyllis Oresky, MSW
Holy Cross Hospital Dialysis
Silver Spring, MD
Amanda Wilson, LGSW
DaVita Renal Care of Lanham
Lanham, MD
Dawn Wilson, MSW, ACSW, LCSW, NSW-C
DaVita of Covington
Covington, VA
CONTINUING EDUCATION INFORMATION
The National Kidney Foundation Council of Nephrology
Social Workers, Provider #1014, is approved as a provider
for social work continuing education by the Association
of Social Work Boards (ASWB) www.aswb.org, through
the Approved Continuing Education (ACE) program. The
National Kidney Foundation Council of Nephrology Social
Workers maintains responsibility for the program. Social
workers participating in this activity will receive up to 36.5
continuing education clock hours.
Licensed social workers should contact their individual
jurisdiction to review current continuing education
requirements for licensure renewal.
NEPHROLOGY SOCIAL WORKER
95 95

96
NEPHROLOGY SOCIAL WORKER
PROGRAM GOALS
At the conclusion of this program, participants will be able to:
z Gain the knowledge and skills for outcomes-oriented
clinical nephrology social work practice
z Identify biopsychosocial variables affecting chronic
kidney disease patients and their families
z Learn skills to ameliorate and address biopsychosocial
variables affecting kidney disease patients and their
families
z Address issues of diversity among chronic kidney
disease patients and healthcare professionals
z Practice ethical social work with renal, dialysis, and
transplant patients and families
This program is NSW-C approved. All Social Work Ethics
courses will be accepted for NSW-C re-certification.
PRE-CONFERENCE COURSES
REQUIRED: Separate registration fee of $125 ($175 when
registering for a course only); includes syllabus, breakfast
and CE clock hours. Participation is limited, so register early.
● EXPLORE TRANSPLANT
Wednesday, May 9, 10:00am – 5:00pm
Course Directors: Amy D. Waterman, PhD, and Christina
Goalby, MSW
Session 420, 6.5 CE clock hours
NKF SCM12
Target Audience: Designed for nephrology social workers,
nurses, technicians, and advanced practitioners.
Course Description: Explore Transplant has partnered with
national ESRD Networks and NKF on a quality improvement
initiative to help improve transplant education in dialysis
centers. To date, over 1000 dialysis providers have
participated. Through this award-winning program, dialysis
providers will be trained how to help their patients make
informed transplant choices. The program outlines the risks
and benefits of transplantation and living donation, and
helps patients decide whether transplant is personally right
for them. Upon completion of this training, each participant
will have increased transplant knowledge and will have
designed a transplant education plan for his/her clinic(s)
that supports the new CMS CfC transplantation regulations.
In addition, each participant will receive copies of the
Explore Transplant educational videos and print materials in
English and Spanish for dissemination to their patients.
Course Objectives: Upon completion of this course,
participants will be able to:
z Enhance their transplant knowledge
z Gain experience delivering the Explore Transplant
education program
z Design a transplant education plan for their clinic that
supports the new CMS CfC transplantation regulations
Course Agenda:
TIME TOPIC FACULTY
10:00am – 10:15am Welcome and Introductions Amy D. Waterman, PhD
Christina Goalby, MSW
10:15am – 10:45am In the Trenches Christina Goalby, MSW
10:45am – 12:15pm Foundations of Explore Transplant Amy D. Waterman, PhD
12:15pm – 12:30pm Break
12:30pm – 1:30pm Meeting One: Exploring Transplant Amy D. Waterman, PhD
1:30pm – 2:30pm Working Lunch and Transplant Expert Panel Panel
2:30pm – 2:45pm Break
2:45pm – 3:45pm Meetings Two and Three: Kidney Recipients’ Transplant Experiences
and Living Donor’s Donation Experiences
Amy D. Waterman, PhD
3:45pm – 4:30pm Meeting Four: Deciding What to Do
4:30pm – 5:00pm Best Practices: Developing Your Facilities’ Explore Transplant Plan Christina Goalby, MSW

REQUIRED: Separate registration fee of $60 ($90 when
registering for a course only); includes syllabus, box lunch
and CE credits. Participation is limited, so register early.
● SYMPTOM-TARGETED INTERVENTION (STI)
Wednesday, May 9
1:00pm – 5:00pm
Course Directors: Melissa McCool, MSW, LCSW, and Renata
Sledge, MSW, LCSW
Session 421, 4.0 CE clock hours
Target Audience: Designed for nephrology social workers.
NKF SCM12
Course Description: Participants will learn how to
incorporate STI into their daily practice to decrease
depressive symptoms in their patients. This course will
use didactic training, experiential exercises, role playing
and film.
Course Objectives: Upon completion of this course,
participants will be able to:
z Identify depression in dialysis patients
z Define principles of STI, its evolution, and why it is
uniquely suited to dialysis centers
z Learn specific STI interventions and apply specific
techniques to their practice
Course Agenda:
TIME TOPIC FACULTY
1:00pm - 1:15pm Why Address Depression? Renata Sledge, MSW, LCSW
1:15pm - 1:30pm STI Model Melissa, McCool, MSW, LCSW
1:30pm - 1:45pm Practice Outcome Evaluation Renata Sledge, MSW, LCSW
1:45pm - 2:30pm Cognitive Interventions Renata Sledge, MSW, LCSW
Melissa McCool, MSW, LCSW
2:30pm - 3:15pm Behavioral Interventions Renata Sledge, MSW, LCSW
Melissa McCool, MSW, LCSW
3:15pm - 4:00pm Mindfulness Interventions Renata Sledge, MSW, LCSW
Melissa McCool, MSW, LCSW
4:00pm - 5:00pm Barriers and Integration into Practice Renata Sledge, MSW, LCSW
Melissa McCool, MSW, LCSW
NEPHROLOGY SOCIAL WORKER
97 97

98
� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils � Ethics Session
Wednesday, May 9
NEPHROLOGY SOCIAL WORKER
TIME/ROOM SESSION # SESSION COURSE FACULTYDIRECTOR(S) NOTES
10:00am – 5:00pm
Chesapeake 7/8
1:00pm – 5:00pm
National Harbor 5
6:00pm – 6:30pm
Annapolis 1/2
6:30pm – 7:30pm
Riverview Terrace
Thursday, May 10
420 Explore Transplant Amy D. Waterman, PhD
Christina Goalby, MSW
421 Symptom-Targeted Intervention (STI) Melissa McCool, MSW,
LCSW
Renata Sledge, MSW, LCSW
100 NKF New Member Orientation NKF President Lynda A.
Szczech, MD, MSCE, FASN,
FNKF
NKF Council Executive
Committees
101 Healthcare Professionals Welcome Reception ù
TIME/ROOM SESSION # SESSION FACULTY NOTES
6:00am – 7:45am
Woodrow Wilson
Ballroom
8:00am – 9:30am
National Harbor 4/5
9:30am – 10:00am Break
10:00am – 11:30am
Potomac D
10:00am – 11:30am
National Harbor 11
10:00am – 11:30am
National Harbor 12
11:30am – 12:00pm Break
12:00pm – 2:00pm
Maryland B
2:00pm – 2:30pm Break
2:30pm – 3:30pm
Potomac A/B
3:30pm – 4:00pm Break
800 Comprehensive Management of Mineral and Bone
Disorders in Advanced Chronic Kidney Disease
Supported by an educational donation provided by Amgen
NKF SCM12
Chair: Hartmut H.
Malluche, MD, FACP
When, Why, and How to Address Phosphate Retention Ravi Thadhani, MD, MPH
When to Consider Cinacalcet Csaba P. Kovesdy, MD,
FASN
Initiation and Limits of Vitamin D Kevin J. Martin, MB, BCh,
FACP
460 Successful Practice With Seniors Tracy Greene Mintz, MA,
MSW, LCSW
485 Meeting the Quality Assessment and Performance
Improvement Challenge
Bonnie Greenspan, RN,
BSN, MBA
Rosemarie Miller, RN
Beth Witten, MSW, ACSW,
LSCSW
CE CLOCK
HOURS
�ù 6 .5
� 4.0
ù¬
CE CLOCK
HOURS
¬ 1 .5
1 .5
ù 1 .5
461 Two Models for Staff Training – Teamwork and Boundaries 1 .5
Staff Satisfaction and Team Development Emily Watson, MSW
Boundaries Amber Harper, MSW,
LCSW, NSW-C
463 Helping School-Age Kids Adapt 1 .5
School Re-entry Lynn Puma, LCSW
Why Camp Matters Maya Doyle, MSW, ABD,
LCSW
486 Council of Nephrology Social Workers Luncheon –
All Are Welcome!
265 NKF Presidential Address: The Person and the Policy Lynda A. Szczech, MD,
MSCE, FASN, FNKF
Shaul G. Massry Distinguished Lecture: Translating Biology
and Observations into Human Trials: The New Era of
CKD-MBD
Ravi Thadhani, MD, MPH
¬ù 1 .0

Thursday, May 10 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
4:00pm – 5:30pm
National Harbor 3
4:00pm – 5:30pm
Maryland D
4:00pm – 5:30pm
Potomac D
NKF SCM12
CE CLOCK
HOURS
462 Nephrology Social Work 101: Strengths-Based Lens 1 .5
Chronic Disease Adjustment Steve Bogatz, MBA, MSW,
LCSW, FMS
Cultural Awareness Toolkit Gloria Lozano Ramos,
MPA, MSW, ACSW
267 Coping and Depressive Symptoms in Advanced Kidney
Disease
Chairs: Frederic
Finkelstein, MD, FNKF, and
Megan Prescott, LCSW
Identification and Evaluation/Assessments of Depression Frederic Finkelstein, MD,
FNKF
Non-Pharmacologic Approaches for Treating Depression in
Kidney Disease
Stephanie Johnstone,
LCSW
Pharmacologic Therapies for Depression in Kidney Disease Tracy Anderson-Haag,
PharmD, BCPS
268 Increasing Living Kidney Donation Chair: Susan Hou, MD,
FACP
Pay It Forward Programs: A Story of Success Susan Hou, MD, FACP
Ethical Considerations for Living Donation Rebecca Hays, MSW,
APSW, NSW-C
Desensitization Enver Akalin, MD
6:00pm – 7:30pm Opening Ceremonies and Reception in the Exhibit Hall –
Visit Posters*/Exhibits
7:30pm – 9:30pm
Woodrow Wilson
Ballroom
Friday, May 11
804 Nobody Likes Rejection! Practical Guidance on
Immunosuppression for 2012
Supported by an educational grant from Bristol-Myers Squibb
From Clinical Practice to Clinical Guidelines: The Evolution of
Recommendations in Immunosuppressant Therapies
Outcomes in Immunosuppression Therapies:
A Case Study Model
A Team Approach to Managing Immunosuppression: The
Central Role of the Empowered Patient
Ali Olyaei, PharmD
Erika Meredith, PharmD
Rebecca Hays, MSW,
APSW, NSW-C
TIME/ROOM SESSION # SESSION FACULTY NOTES
6:00am – 7:45am
Woodrow Wilson
Ballroom
802 Anemia in CKD Stage 5: Balancing Morbidity, Mortality,
and Quality of Life
Supported by an educational grant from Affymax, Inc. and
Takeda Pharmaceuticals North America, Inc.
Evaluation and Management of Hemoglobin Variability Jay Wish, MD
Individualization of Therapy for Anemia Csaba P. Kovesdy, MD, FASN
Analyzing Emerging Treatment Data for Patients with
Anemia of ESRD
7:00am – 8:00am Continental Breakfast in Exhibit Hall –
Visit Posters*/Exhibits
8:00am – 8:30am
Potomac D
Anil Agarwal, MD, FNKF
290 Changing Access to Kidney Replacement Modalities Chair: Joseph Vassalotti,
MD, FASN
End the Wait for Kidney Transplantation Bryan N. Becker, MD,
MMM, FNKF
Access to Dialysis Care in the Bundled Environment Allan J. Collins, MD, FACP
¬ù 1 .5
¬ 1 .5
¬ 1 .5
CE CLOCK
HOURS
¬ 1 .5
¬ 0 .5
NEPHROLOGY SOCIAL WORKER
99 99

� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils � Ethics Session
100
Friday, May 11 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
8:30am – 10:00am
National Harbor 4/5
8:30am – 10:00am
Potomac 1 - 3
10:00am – 10:30am Break
10:30am – 12:00pm
National Harbor 4/5
10:30am – 12:00pm
Potomac 1 - 3
10:30am – 12:00pm
Potomac A
NKF SCM12
CE CLOCK
HOURS
465 Managing Challenging Events as a Team 1 .5
Mental Illness in the Dialysis Setting Megan Prescott, MSW,
LCSW
Critical Incident Debriefing Jackie Kite, MSW, LICSW
476 Transplant Let-Down Prevention and Intervention 1 .5
Post-Transplant Let-Down and Strategies to Cope Sarah Schuh, MSW, LICSW
Challenging Reentry: Rethinking Rehab Mary Beth Callahan,
MSSW, ACSW, LCSW
464 Social Work Role in Medical Ethics Committees Timothy Latimer, MSSW,
LCSW
Ellen Case, MSW, LISW
477 Impact of Policy Changes on Patients Troy Zimmerman
Nancy Scott, RN
271 Controversies in Organ Allocation Chair: Heidi Schaefer, MD,
FNKF
The History and Evolution of the Kidney Organ
Allocation System
Kenneth Andreoni, MD
Racial, Gender, and Ethnic Disparities in Organ Allocation Jesse Schold, PhD
The Role of Age in Organ Allocation: Is it Discriminatory? Lainie Friedman Ross, MD
12:00pm – 2:00pm Break in the Exhibit Hall (Lunch Served 12:15pm–1:15pm)
– Visit Posters*/Exhibits
2:00pm – 3:30pm
Potomac C
2:00pm – 3:30pm
National Harbor 11
3:30pm – 4:00pm Break
4:00pm – 5:30pm
Potomac 1 - 3
4:00pm – 5:30pm
National Harbor 4/5
4:00pm – 5:30pm
National Harbor 13
� 1 .5
1 .5
¬ 1 .5
470 Self-Care for the Helper 1 .5
Coping with Loss Jackie Kite, MSW, LICSW
Mindful Meditation Gary Petingola, RSW, BA,
BSW
471 Ethics and Policy � 1 .5
UNOS Ethics Committee Work Kay Kendall,
MSW, LISW, ACSW, CCTSW
Ethics and Policy for Social Workers Charlie Thomas, MSW,
LCSW, ACSW
472 Transplant Recipient-Donor Contact 1 .5
Interventions to Improve Process Lisa Colaianni
Clinical Impact for Recipients Danielle Peabody, MSW,
LICSW
371 Palliative Care – Help Me Die with Dignity Lewis Mitchel Cohen, MD ù 1 .5
277 The Challenges of Being an Adolescent Chair: Bradley A. Warady,
MD, FNKF
I Don’t Like Being Different From My Friends! Angela Degnan, MSW,
LCSW, LSCSW
Individualizing the Prevention/Treatment of Non-Adherence Rebecca Johnson, PhD
Transition – The Mandate for Pediatric and Adult Medicine
Collaboration
6:00pm – 7:30pm Networking Reception in the Exhibit Hall –
Visit Posters*/Exhibits
Lorraine Bell, MD, FRCPC
¬ù 1 .5

Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
6:00am – 7:45am
Woodrow Wilson
Ballroom
803 Chronic Mild Hyponatremia Is Not Benign: Implications for
Clinical Practice
Supported by an educational grant from Otsuka America
Pharmaceutical, Inc.
NKF SCM12
Chair: Joseph G. Verbalis,
MD
Adverse Effects of Chronic Mild Hyponatremia Joseph G. Verbalis, MD
Applicability of Vasopressin Antagonists in the Management
of Chronic Mild Hyponatremia
Case Studies: Diagnosis and Effective Management of
Chronic Mild Hyponatremia
8:00am – 9:00am Continental Breakfast Served in the Exhibit Hall –
Visit Posters*/Exhibits
8:30am – 9:30am
Potomac 3
9:30am – 11:00am
Potomac C
9:30am – 11:00am
National Harbor 3
9:30am – 11:00am
National Harbor 12
11:00am – 11:30am Break
11:30am – 12:30pm
National Harbor 13
11:30am – 12:30pm
National Harbor 12
12:30pm – 1:30pm Break
1:30pm – 3:00pm
National Harbor 4/5
1:30pm – 3:00pm
National Harbor 11
3:00pm – 3:30pm Break
Mitchell Rosner, MD, FACP
Mitchell Rosner, MD, FACP
473 Guided Tour of Posters Teri Browne, PhD,
MSW, LSW
Steve Bogatz, MSW, MBA,
LCSW
279 Healthcare Access in the Kidney Early Evaluation Program:
Implications on Outcomes
Chairs: Adam Whaley-
Connell, DO, MSPH,
FASN, FNKF, and Peter
McCullough, MD, MPH,
FACC, FACP, FNKF
Access to Healthcare in KEEP® Andrew Bomback, MD,
MPH
KEEP: The Role of Healthcare Access in Risk Factor Control Claudine Jurkovitz, MD,
MPH
KEEP: The Role of Healthcare Access on Mortality George Saab, MD
CE CLOCK
HOURS
¬ù 1 .5
� 1 .0
¬ù 1 .5
474 Practicing Clinical Work in a Business Culture 1 .5
Making Social Work Resonate with the
Business-Minded Leader
Stephanie Stewart, MSW,
LICSW, MBA, NSW-C
Walking in Management’s Shoes Leanne Peace, MSW,
LCSW, MHA
475 Work at the Forefront 1 .5
CNSW Research Project: African American Attitudes Towards
Kidney Transplant
Bradley Manton, MSW
Online Community Building (Living with Cystinosis) Maya Doyle, MSW, ABD,
LCSW
467 Developing a 12-Month Education Plan Jessica Phipps, MSW, LSW 1 .0
484 Staffing and Patient Outcomes William Wolfe, MSW 1 .0
478 Psychosocial Status and Key Patient Health Indicators 1 .5
Social Support and Psychosocial Factors Teri Browne,
PhD, MSW, LSW
KDQOL Goal Setting Vernon Silva, MSW, LCSW,
NSW-C
479 Acknowledging Patient Health Decline 1 .5
Social Work Role Wendy Funk Schrag, MSW,
LMSW, ACSW
New Ways to Frame Advance Medical Directives Sue Hoekwater, LMSW,
MSW
NEPHROLOGY SOCIAL WORKER
101 101

� Separate Registration and/or Fee Required ¬ Joint with Physicians ù Joint with Councils � Ethics Session
102
Saturday, May 12 continued
TIME/ROOM SESSION # SESSION FACULTY NOTES
3:30pm – 5:00pm
National Harbor 2
3:30pm – 5:00pm
National Harbor 10
3:30pm – 5:00pm
National Harbor 11
Sunday, May 13
466 PedsQL Data Interpretation and Goal Setting Kristin Stockard, MSW,
LICSW, NSW-C
Sandra Coorough, MSSA,
ACSW, LCSW, NSW-C
NKF SCM12
CE CLOCK
HOURS
468 Boundaries and Social Media Lisa Hall, MSSW, LICSW ù� 1 .5
469 Impact of ESRD on Women’s Body Image and Sexuality Dori Schatell, MS 1 .5
482 Maximizing Nephrology Social Work Skill Set
CE CLOCK
HOURS
1 .5
TIME/ROOM SESSION # SESSION FACULTY NOTES
8:00am – 9:30am
Potomac 4 - 6
8:00am – 9:30am
Potomac 1 - 3
9:30am – 10:00am Break
10:00am – 11:30am
Potomac 1 - 3
10:00am – 11:30am
Potomac C
11:30am Meeting Adjourns
Shaping and Mentoring the New Nephrology Social Worker Michael Cervantes,
MSW, LCSW, NSW-C
Concrete and Clinical Skills: Happy Together Thomas Lepetich,
MSW, LCSW
483 Fostering Community Collaboration 1 .5
Coalition Building and Strategic Partnerships Lisa Hall, MSSW, LICSW
Building Rural Transportation Networks – Strategies For
Buy-In and Engagement
Dawn Wilson, ACSW,
LCSW, NSW-C
480 Challenges of Transplanting Teens Kimberly Gusse, MSW,
LMSW, ACSW
Alejandro Quiroga, MD
288 Symptom Management Tips in Advanced CKD/ESRD Chairs: Ann O’Hare, MD,
and Kerri Cavanaugh, MD,
MHS, FNKF
Prevale3nce and Evaluation of Symptoms: Sleep Disorders,
Pruritus, and Pain
Kerri Cavanaugh, MD,
MHS, FNKF
Non-Pharmacologic Management Gary Petingola, RSW, BA,
BSW
Pharmacologic Management Marianna Leung, PharmD,
BSc
*A MAXIMUM OF 1.0 CE CLOCK HOURS ONLY WILL BE AWARDED FOR POSTER SESSIONS.
1 .5
� 1 .5
¬ 1 .5

FELLOWSHIP OF THE
NATIONAL KIDNEY FOUNDATION INDUCTEES
Congratulations and thank you for all you do to improve the lives of patients with kidney disease!
Konstantin Abramov, MD, FNKF
Anjali Acharya, MBBS, FNKF
Alok Agrawal, MD, FNKF
Anil Agarwal, MD, FNKF
Ayoola Akinbamowo, MD, FNKF
Fadel Alrowaie, MD, FNKF
Ehteshamul Anjum, MD, FNKF
Jose Arruda, MD, FNKF
Arif Asif, MD, FNKF
Rasheed Balogun, MD, FNKF
George Bayliss, MD, FNKF
Bryan Becker, MD, FNKF
Gavin Becker, MD, FNKF
Mary Behren, MD, FNKF
Jeffrey Berns, MD, FNKF
Geoffrey Block, MD, FNKF
Joseph Bonventre, MD, PhD, FNKF
Robert Brown, MD, FNKF
Wendy Brown, MD, MPH, FNKF
Kellie Calderon, MD, FNKF
Laurence Carroll, MD, FNKF
Kerri Cavanaugh, MD, FNKF
Micah Chan, MD, FNKF
Daranee Chewaproug, DO, FNKF
Michael Choi, MD, FNKF
Tejas Desai, MD, FNKF
Shannon Doyle, MD, FNKF
Fernando Fervenza, MD, FNKF
Jeffrey Fink, MD, FNKF
Frederic Finkelstein, MD, FNKF
Jurgen Floege, MD, FNKF
Chester Fox, MD, FNKF
Linda Fried, MD, FNKF
Masafumi Fukagawa, MD, FNKF
Susan Furth, MD, PhD, FNKF
Kumar Gaurav, MD, FNKF
Charles George, MD, FNKF
Stuart Goldstein, MD, FNKF
Larry Greenbaum, MD, PhD, FNKF
Azzour Hazzan, MD, FNKF
Nasser Hebah, MD, FNKF
Joanna Hudson, PharmD, FNKF
Kunitoshi Iseki, MD, FNKF
Bernard Jaar, MD, FNKF
Tazeen Jafar, MD, FNKF
Kenar Jhaveri, MD, FNKF
Kamyar Kalantar-Zadeh, MD, FNKF
Ayman Karkar, MD, FNKF
Richard Kasama, MD, FNKF
Bertram Kasiske, MD, FNKF
Frederick Kaskel, MD, PhD, FNKF
Pranay Kathuria, MD, FNKF
Paul Kellerman, MD, FNKF
Nelson Kopyt, MD, FNKF
Christina Lankhorst, MD, FNKF
Brian Lee, MD, FNKF
David Leehey, MD, FNKF
Edgar Lerma, MD, FNKF
Andrew Levey, MD, FNKF
Philip Li, MD, FNKF
Charmaine E. Lok, MD, FNKF
Adit Mahale, MD, FNKF
Samir Mallat, MD, FNKF
Peter McCullough, MD, MPH, FNKF
Rita McGill, MD, FNKF
Rajnish Mehrotra, MD, FNKF
Tina Melanson, MD, FNKF
Sergio Mezzano, MD, FNKF
Neal Mittman, MD, FNKF
Tariq Mubin, MD, FNKF
Bruce Mueller, PharmD, FNKF
Allen Nissenson, MD, FNKF
Uday Nori, MD, FNKF
Paul Olson, MD, FNKF
Paul Palevsky, MD, FNKF
Saurabh Pande, MD, FNKF
Dipen Parikh, MD, FNKF
Mark Perazella, MD, FNKF
Jeffrey Perlmutter, MD, FNKF
Ronald Perrone, MD, FNKF
Beth Piraino, MD, FNKF
Fernando Raudales, MD, FNKF
Giuseppe Remuzzi, MD,FNKF
Michael Rocco, MD, FNKF
Mario Rubin, MD, FNKF
Sachin Sachdev, MD, FNKF
Heidi Schaefer, MD, FNKF
Charles Schleifer, MD, FNKF
Adam Segal, MD, FNKF
Jonathan Segal, MD, FNKF
Craig Shadur, MD, FNKF
Tariq Shafi, MBBS, MHS, FNKF
Michael Shlipak, MD, FNKF
Mawya Shocair, MD, FNKF
Sandeep Soman, MD, FNKF
Stephen Sozio, MD, FNKF
Matthew Sparks, MD, FNKF
John Sperati, MD, FNKF
Stuart Sprague, DO, FNKF
Wendy St. Peter, PharmD, FNKF
Gerald Stephanz, MD, FNKF
Leonard Stern, MD, FNKF
Giovanni Strippoli, MD, FNKF
Rachel Sturdivant, MD, FNKF
Lynda Szczech, MD, MSCE, FNKF
Harold Szerlip, MD, FNKF
Ahmad Tarakji, MD, FNKF
Charuhas Thakar, MD, FNKF
John Wang, MD, FNKF
Bradley Warady, MD, FNKF
Marc Weber, MD, FNKF
Eric Wechsler, MD, FNKF
Daniel Weiner, MD, FNKF
Lawrence Weisberg, MD, FNKF
Steven Weisbord, MD, MSC, FNKF
Miriam Weiss, MD, FNKF
Robert Weiss, MD, FNKF
Adam Whaley-Connell, DO, FNKF
David Wheeler, MD, FNKF
Jerry Yee, MD, FNKF
Melvin Yudis, MD, FNKF
Alfredo Zannier, MD, MSC, FNKF
Carmine Zoccali, MD, FNKF

104
GAYLORD NATIONAL RESORT & CONVENTION CENTER
PRINCE GEORGE’S EXHIBITION HALLS
801
601
701
901
1001
1101
1201
1300
Questcor
40'
Medical
Ltd
20'
20'
Sanofi Otsuka
20'
20'
20'
20'
20'
Amgen Mitsubishi
DaVita
20' Tanabe
20'
20'
Alexion
Pharmaceuticals
Cybernius
1203
1302
Nephrology
News &
Issues
Pharma,
Inc
Watson
1205
20'
RPG
1304
JA
Health,
Inc
Pentec
82
711
811
1211
1310
20'
Binding
Site
611
20'
Ascend
Clinical
813
20'
Bristol-
Myers
Squibb
Cranberry
Marketing
Committee
20'
25'
815
20'
Fresenius
Medical
Nutrition
USA
717
20'
20'
Reata
Gambro
819
Covidien
817
American
20'
HomeChoice Innovative US Renal Acumen
Regent
Partners Dialysis
Systems
Care, Inc nEHR
Baxter
918
1019 1118 1119 1218
20'
Nephro-
Rockwell Otsuka America
Renal Dialysis
Tech,
Pharmaceutical,
Business
Medical
at Sea
Inc
Inc
Today Cruises
916 917
1017 1116 1117 1216
National
National Kidney
Kidney Disease
Health and Urologic
Falcon E
Diseases Information
CROWNWeb
Education
informatics Clearinghouse
Program
H R
(NKUDIC)
914
1015 1114 1115 1214
Abbott
Athena Nephroceuticals Litholink Nephropath
DCRX Keryx
913
20'
20'
20' 20'
20' 20'
Abbott
Nutrition
910 911 1010 1011 1110 1111 1210
GA
Renal &
Urology
News
NK
1217
20'
20'
Takeda
722
723
923
1022
1023
1122 1123
1222
Medical,
Inc
NKF SCM12
30'
Roo
Healthcare
Solutions
NutrePletion
Resources
ICU
Global
Health
Products
1024
20'
1124 1125
1224
1225
Fresenius
Medical
Care
NKF
40'
Explore
Transplant
Medical
Education
Institute
NKF
Councils
40'
1026 1027
1126 1127
American
Society of
Nephrology
Renal
Physicians
Association
1226
Nationwide
Laboratory
Services
Dialysis
Patient
Citizens
Nephrology
Times
Arbor
Research-
DOPPS
The
Gideons
International
Cadillac
30'
POSTERS
J:\
20
20
4/2
Spectra
Laboratories
1030 1031
Kidney
Mayo
Community
Emergency
Clinic
Response
Coalition
1028 1029
Liberty
Dialysis
931
DaVita
Labs
Pfizer
1130 1131
Nursing
NxStage
Medical
1128 1129
1228
40'
Certification
Commission
Nephrology
International
Society of
Nephrology
20'
631
1230
Genentech, a
Member of the
Roche Group
Biotech,
Inc
Kibow
Propath
Lounge
835
Mom's Libre & The
SHOWER SHIRT
Meals Co., LLC
933 934 935 1033
1034 1035
1134
1135
HealthWell
Foundation
Exhibitor
Showcase
30'
50'
IN
S
S
C
F
Dim
10'x
10'x
10'x
10'x
20'x
20'x
20'x
20'x
40'x
Inv
MAY 10 - 12, 2012

2012 EXHIBITORS
Exhibiting Company* Booth#
Abbott . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .913
Abbott Nutrition . . . . . . . . . . . . . . . . . . . . . .911
Acumen nEHR . . . . . . . . . . . . . . . . . . . . . . .1218
Affymax/Takeda Pharmaceuticals
U.S.A., Inc . . . . . . . . . . . . . . . . . . . . . . .1217
Alexion Pharmaceuticals . . . . . . . . . . . . . .1201
American Regent . . . . . . . . . . . . . . . . . . . . .918
American Society of Nephrology . . . . . . .1125
Amgen . . . . . . . . . . . . . . . . . . . . . . . . . . . . .901
Arbor Research – DOPPS . . . . . . . . . . . . . .1127
Ascend Clinical . . . . . . . . . . . . . . . . . . . . . . .711
Athena Diagnostics . . . . . . . . . . . . . . . . . . .910
B. Braun Medical Inc. . . . . . . . . . . . . . . . . .1035
Baxter Healthcare Corporation . . . . . . . . .917
Binding Site . . . . . . . . . . . . . . . . . . . . . . . . . .811
Bristol-Myers Squibb . . . . . . . . . . . . . . . . . 1211
Cadillac ...........................1225
Covidien . . . . . . . . . . . . . . . . . . . . . . . . . . . .817
Cranberry Marketing Committee . . . . . . .1310
CROWNWeb . . . . . . . . . . . . . . . . . . . . . . . .1115
Cybernius Medical Ltd . . . . . . . . . . . . . . . .1300
DaVita . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1101
DaVita Labs . . . . . . . . . . . . . . . . . . . . . . . . .1130
DCRX Infusion . . . . . . . . . . . . . . . . . . . . . . .1111
Dialysis at Sea Cruises . . . . . . . . . . . . . . . .1216
Dialysis Patient Citizens . . . . . . . . . . . . . . .1027
Elsevier – Represented by
Atlantic Medical Books . . . . . . . . . . . . .1034
Explore Transplant . . . . . . . . . . . . . . . . . . .1024
Falcon EHR . . . . . . . . . . . . . . . . . . . . . . . . .1214
Fresenius Medical Care –
Renal Therapies Group . . . . . . . . . . . . . .722
Fresenius Medical Services . . . . . . . . . . . . .611
Gambro . . . . . . . . . . . . . . . . . . . . . . . . . . . . .819
Genentech, a Member of
the Roche Group . . . . . . . . . . . . . . . . . .1030
Global Health Products . . . . . . . . . . . . . . .1222
Health Informatics International, Inc . . . .1015
HealthSTAR Clinical Education Solutions . .1134
Healthwell Foundation . . . . . . . . . . . . . . .1033
HomeChoice Partners . . . . . . . . . . . . . . . .1019
ICU Medical, Inc. . . . . . . . . . . . . . . . . . . . .1123
Innovative Dialysis Systems . . . . . . . . . . . .1118
International Society
of Nephrology . . . . . . . . . . . . . . . . . . . .1228
Keryx Biopharmaceuticals, Inc . . . . . . . . .1210
Kibow Biotech, Inc. . . . . . . . . . . . . . . . . . .1031
Kidney Community Emergency
Response Coalition . . . . . . . . . . . . . . . .1029
Liberty Dialysis . . . . . . . . . . . . . . . . . . . . . . .931
Libre & The SHOWER SHIRT Co., LLC . . . . .935
Litholink Corporation . . . . . . . . . . . . . . . . .1011
Mayo Clinic . . . . . . . . . . . . . . . . . . . . . . . . .1028
Medical Education Institute . . . . . . . . . . .1124
Medical Nutrition USA . . . . . . . . . . . . . . . . . .815
Mitsubishi Tanabe Pharma . . . . . . . . . . . .1001
Mom’s Meals . . . . . . . . . . . . . . . . . . . . . . . .934
National Kidney and Urologic Diseases
Information Clearinghouse (NKUDIC) . .1114
National Kidney Disease
Education Program . . . . . . . . . . . . . . . . . . 914
National Kidney Foundation . . . . . . . . . . . .723
National Kidney Foundation Professional
Councils . . . . . . . . . . . . . . . . . . . . . . . . . .923
Nationwide Laboratory Services . . . . . . . .1026
Nephroceuticals, LLC . . . . . . . . . . . . . . . . .1010
Nephrology News & Issues . . . . . . . . . . . .1203
Nephrology Nursing
Certification Commission . . . . . . . . . . .1128
Nephrology Times . . . . . . . . . . . . . . . . . . .1126
NKF SCM12
Nephropath . . . . . . . . . . . . . . . . . . . . . . . .1110
Nephro-Tech, Inc. . . . . . . . . . . . . . . . . . . . . .916
NutrePletion Resources . . . . . . . . . . . . . . .1122
NxStage Medical . . . . . . . . . . . . . . . . . . . .1129
Otsuka America
Pharmaceutical, Inc . . . . . . . . . . . . . . . . .701
Otsuka America
Pharmaceutical, Inc . . . . . . . . . . . . . . . .1116
Pentec Health, Inc. . . . . . . . . . . . . . . . . . .1205
Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1131
ProPath . . . . . . . . . . . . . . . . . . . . . . . . . . . .1230
Questcor Pharmaceuticals, Inc. . . . . . . . .801
Reata Pharmaceuticals . . . . . . . . . . . . . . . .717
Renal Dietitians (RPG) . . . . . . . . . . . . . . . .1304
Renal Physicians Association . . . . . . . . . . .1224
Renal & Urology News . . . . . . . . . . . . . . . . .813
Renal Business Today . . . . . . . . . . . . . . . . .1117
Rockwell Medical . . . . . . . . . . . . . . . . . . . .1017
Roo Healthcare Solutions . . . . . . . . . . . . .1022
Sanofi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .601
Spectra Laboratories . . . . . . . . . . . . . . . . .1023
The Gideons International . . . . . . . . . . . . .1226
U.S. Renal Care, Inc. . . . . . . . . . . . . . . . . .1119
Watson Pharma, Inc. . . . . . . . . . . . . . . . . .1302
*Bolded companies are sponsors.
105 105

106
EXHIBITOR PRODUCT/SERVICE DESCRIPTIONS
ABBOTT – 913
Abbott is a global, broad-based
healthcare company devoted to
discovering new medicines, new
technologies and new ways to
manage health. Our products span the
continuum of care, from nutritional
products to medical devices and
pharmaceutical therapies. Our
comprehensive product line encircles
life itself – addressing important health
needs for all ages.
ABBOTT NUTRITION – 911
Abbott Nutrition is one of the world’s
leading authorities in science-based
nutrition for all stages of life. As your
nutrition partner, we invite you to
visit us and explore our portfolio
of products, including Nepro and
Suplena, to help your patients grow
and achieve greater well-being.
ACUMEN NEHR – 1218
Acumen nEHR is the only CCHIT and
ONC-ATCB certified electronic medical
record designed by nephrologists for
the practice of nephrology. It provides
convenient access to complete patient
data anytime, anywhere nephrologists
see their patients.
AFFYMAX/TAKEDA
PHARMACEUTICALS USA, INC. – 1217
Takeda Pharmaceuticals U.S.A., Inc. –
Deerfield, IL, Takeda Pharmaceuticals
U.S.A., Inc. currently markets oral
diabetes, insomnia, rheumatology and
gastroenterology treatments. Takeda
is committed to strive towards better
health for patients worldwide through
leading innovation in medicine. To
learn more about Takeda, visit
www.tpna.com.
Affymax, Inc. – Palo Alto, California,
Affymax, Inc. is a biopharmaceutical
company committed to developing
novel drugs to improve the treatment
of serious and often life-threatening
conditions. Please visit
www.affymax.com.
ALEXION PHARMACEUTICALS –
1201
Alexion Pharmaceuticals is a global
biotechnology company committed to
meeting the needs of patients living
with severe, life-threatening and
ultra-rare diseases. Alexion is engaged
in the discovery, development and
commercialization of therapeutic
products aimed at treating patients
with a wide array of severe disease
states, including hematologic and
kidney diseases, transplant, other
inflammatory disorders, and cancer.
AMERICAN REGENT – 918
American Regent is the manufacturer
and distributor of Venofer ® , (iron
sucrose injection, USP), the #1 selling
IV Iron in the U.S. 1 Venofer ® is available
in 50 mg/2.5 mL, 100 mg/5 mL and
200 mg/10 mL single dose vials.
Venofer ® is preservative free and latex
free . 1Based on IMS Health, National
Sales Perspectives – (January
2012) Fourth Quarter 2011 Results –
dollar volume ($) and units (100 mg
equivalents).
AMERICAN SOCIETY OF
NEPHROLOGY – 1125
The American Society of Nephrology
(ASN) leads the fight against
kidney disease by educating health
professionals, sharing new knowledge,
advancing research, and advocating
the highest quality care for patients.
Please visit www.asn-online.org.
AMGEN – 901
Amgen (NASDAQ:AMGN), a
biotechnology pioneer, discovers,
develops, and delivers innovative
human therapeutics. Our medicines
help millions of patients in the fight
against cancer, kidney disease,
rheumatoid arthritis, bone disease,
and other serious illnesses. With a
deep and broad pipeline of potential
new medicines, we continue to
advance science to serve patients.
NKF SCM12
ARBOR RESEARCH – DOPPS – 1127
Arbor Research is a not-for-profit
research organization based in Ann
Arbor, Michigan, USA, conducting large
studies in epidemiology and public
health. With particular expertise in
biostatistical analysis, clinical practice,
the management and integration of
large data sets, economics, and public
policy, Arbor Research engages in
health outcomes research on chronic
disease and end-stage organ failure,
currently including the international
Dialysis Outcomes and Practice
Patterns Study (www.dopps.org).
ASCEND CLINICAL – 711
Ascend Clinical is the ESRD laboratory
testing leader for independent and
hospital dialysis clinics in the U.S.
LabCheck, LabCheck GO and
Ascend Chart deliver the most
complete suite of clinical services
built for independents, with realtime
laboratory results, on-demand
reporting, workflow, and treatment
features that save time and provide
infinite flexibility.
ATHENA DIAGNOSTICS – 910
Athena Diagnostics is the leader in
genetic testing for renal disorders.
We assist the physician in diagnosing
and confirming renal disorders
at the genetic level - allowing for
accurate treatment and patient
management. We offer genetic testing
for renal disorders such as PKD, Alport
syndrome, FSHS, nephrotic syndrome,
and others.
B. BRAUN MEDICAL INC. – 1035
The Renal Therapies Division of B.
Braun Medical welcomes you to Las
Vegas! Stop by the B. Braun booth
# 1035 to learn about Adimea, a
new technology for monitoring
dialysis dose, and see other exciting
products being offered by B. Braun
for hemodialysis and continuous renal
replacement therapy (CRRT). B. Braun
is your complete, quality supplier

for hemodialysis and CRRT products.
For more information, please call
800 .848 .2066 .
BAXTER HEALTHCARE
CORPORATION – 917
Baxter International Inc.’s Renal
franchise is a leader in renal home
therapies through its products for
Peritoneal Dialysis (PD), providing
PD solutions including Low Glucose,
devices, related supplies and services
to help end-stage kidney disease
patients perform dialysis treatment in
the home .
BINDING SITE – 811
Freelite ® serum free light chain
assays are more sensitive than
electrophoretic methods for detecting
multiple myeloma and AL amyloidosis
patients who often first present with
renal failure. NCCN Guidelines and
International Myeloma Working Group
recommend the use of Freelite in the
initial diagnostic workup of multiple
myeloma and related disorders.
BRISTOL-MYERS SQUIBB – 1211
Bristol-Myers Squibb welcomes you
to Washington, D.C. We invite you
to visit our exhibit and meet our
representatives to discuss the products
and services we have to offer.
CADILLAC — 1225
Cadillac has been a leading luxury
auto brand since 1902. In recent years,
Cadillac has engineered a historic
renaissance led by artful engineering
and advanced technology. More
information on Cadillac can be found
at Cadillac .com .
COVIDIEN – 817
Covidien is a leading healthcare
company that is committed to
advancing the treatment of vascular
disease worldwide. With the
acquisition of ev3, and areas of focus in
peripheral, venous and neurovascular,
we offer the world’s broadest portfolio
of innovative vascular therapies
backed by compelling clinical evidence
and educational excellence. For more
information, visit: www.covidien.com .
CRANBERRY MARKETING
COMMITTEE – 1310
The Cranberry Marketing Committee
represents the U.S. cranberry industry
and was established as a Federal
Marketing Order in 1962. The CMC
promotes the use of cranberries
through a generic promotions program
which educates consumers about the
cranberry’s unique health benefits,
culinary versatility and great taste.
For more information, please visit our
website: www.uscranberries.com.
CROWNWEB – 1115
CROWNWeb, the Centers for Medicare
and Medicaid Services (CMS) data
collection system for end-stage
renal disease, is changing the way
Medicare-certified dialysis facilities
submit ESRD patient data and evaluate
their facility’s performance. Visit the
CROWNWeb exhibit to discover the
latest system developments, obtain
information on training opportunities,
and learn how you can become ready
for CROWNWeb.
CYBERNIUS MEDICAL LTD. – 1300
CYBERNIUS MEDICAL LTD. (CML)
focuses on the development,
sale, deployment and support of
the cyberREN Renal Patient Care
Management Systems. cyberREN
is a comprehensive Nephrology
based Electronic Medical Record,
Clinical Data Analysis, and Reporting
System. Also available: cyberREN
OFFICE, (Nephrologist Private Practice
System) and cyberFUNDS (Billing for
Nephrology) 1.800.276.8128
Web: www.cyberren.com
Email: info@cyberren.com
DAVITA – 1101
DaVita Inc., a Fortune 500 ® company,
is a leading provider of kidney care in
the United States, delivering dialysis
services to patients with chronic
kidney failure and end-stage renal
disease. As of December 31, 2011,
NKF SCM12
DaVita operated or provided
administrative services at 1,809
dialysis facilities, serving approximately
142,000 patients.
DAVITA LABS – 1130
DaVita Labs provides quality, on-time,
accurate results to help effectively
identify and manage kidney patients
across the nation. As a cutting-edge
chronic kidney disease (CKD) specialty
laboratory, DaVita Labs features the
latest in end-stage renal diseasespecific
methodology and technology
for delivering quality dialysis test
results. DaVita Labs is fully accredited
by the federal and state governmental
agencies and the College of American
Pathologists. For more information,
please visit www.davitalabs.com or call
877 .200 .3181 .
DCRX INFUSION – 1111
As the nation’s premier provider of renal
nutrition support therapies, Intradialytic
Parenteral Nutrition (IDPN) and
Intraperitoneal Nutrition (IPN), dialysis
professionals have come to trust DCRX
Infusion. We provide the service and
support necessary to fulfill the nutritional
therapy needs of your patients.
DIALYSIS AT SEA CRUISES – 1216
We are the world’s largest provider
of dialysis services aboard cruise
ships. For over 30 years we have
helped thousands of individuals on
dialysis and their families experience
the pleasures of cruising and the
excitement of taking their dream
vacation.
DIALYSIS PATIENT CITIZENS – 1027
Dialysis Patient Citizens (DPC) is the
nation’s largest patient-led dialysis
organization. With a membership
of more than 23,000 dialysis and
pre-dialysis patients and their
family members, DPC is working
to improve the quality of life for all
dialysis patients through education
and advocacy. Contact DPC at
1.866.877.4242,
www.dialysispatients.org,
www.facebook.com/patientcitizens or
@PatientCitizen.
107 107

108
EXHIBITOR PRODUCT/SERVICE DESCRIPTIONS continued
ELSEVIER – REPRESENTED BY
ATLANTIC MEDICAL BOOKS – 1034
Official Elsevier affiliated book
seller helping to advance medicine
by delivering superior education,
reference information and decision
support tools to doctors, nurses and
health practitioners.
EXPLORE TRANSPLANT – 1024
Explore Transplant is a nonprofit
organization whose mission is to
increase informed transplant decision
making to promote the highest
possible quality-of-life for patients.
We educate medical professionals,
patients, potential living donors and
the public about transplant and living
donation and improve access to
transplant education in underserved
communities. Visit us at
www.ExploreTransplant.org.
FALCON EHR – 1214
Falcon EHRTM is the certified,
innovative nephrology-focused EHR.
Our web-based system gives you
access wherever you have Internet
connectivity. Falcon Dialysis is part of
the Falcon software suite. Our dialysis
center system will empower physicians
and teammates to maintain focus on
providing superior clinical care while
better managing time and resources.
FRESENIUS MEDICAL CARE –
RENAL THERAPIES GROUP – 722
In-center offerings include Optiflux ®
dialyzers, and the 2008 series
hemodialysis machines. Home
therapies include the 2008K@home,
Liberty ® cycler, with stay safe ® . Kidney
Options ® , Advanced Renal Education
Program, and success@homeTM provide extraordinary educational
resources. Pharmaceutical offerings
include Venofer ® , and the Venofer ®
pump, and Phoslyra ® . To learn more,
visit us at www.fmcna.com or contact
us at 800.662.1237.
FRESENIUS MEDICAL SERVICES – 611
The mission of Fresenius Medical
Services (FMS), a division of Fresenius
Medical Care North America, is
“Through UltraCare ® , improving
the Quality of Life of Every Patient,
Every Treatment.” FMS considers
its relationships with nephrology
professionals to be critical in
fulfilling that mission in providing
exceptional patient care. Learn latest
developments about UltraCare ® at
Home, Clinical Services, Fresenius
Rx, Patient Travel Service, Inpatient
Services, UltraCare-Dialysis.com,
employment opportunities nationwide
and more!
GAMBRO – 819
Gambro is a global medical technology
company and a leader in developing,
manufacturing, and supplying
products and therapies for the dialysis
marketplace .
GENENTECH, A MEMBER OF THE
ROCHE GROUP – 1030
Considered the founder of the
biotechnology industry, Genentech
has been delivering on the promise of
biotechnology for more than 35 years,
using human genetic information
to discover, develop, manufacture
and commercialize medicines to
treat patients with serious or lifethreatening
medical conditions. Today,
Genentech is among the world’s
leading biotech companies, with
multiple products on the market and a
promising development pipeline.
GLOBAL HEALTH PRODUCTS – 1222
Global Health designs, manufactures
and, distributes innovative products
that help promote health and wellness
for everyone. Our goal is to provide
the best products for all stages of
life. Product line includes: LiquaCel,
LiquaCel Freeze Pops, ProCel and
ProCel 100 along with a renal vitamin
and calcium and fiber supplements.
NKF SCM12
HEALTH INFORMATICS
INTERNATIONAL, INC. – 1015
Health Informatics International (HII) is
the renal industry leader in electronic
medical records (EMR/EHR) and billing
software in the U.S., U.K., and Ireland.
Our TIME System, offered through our
AMI and Medical divisions, provides
usability and efficient information
management to increase patient
care. HII also offers outsourced billing
services from our HMG division. Learn
more about our products and services
at www.hiiweb.com .
HEALTHSTAR CLINICAL EDUCATION
SOLUTIONS - 1134
HealthSTAR Clinical Education
Solutions provides contracted clinical
educator services on a full-time, parttime,
or per diem basis, as well as
consulting services for organizations
wishing to implement or optimize
their own educator programs. Clinical
educators provide disease state and/
or product training to healthcare
professionals, staff, and patients.
HEALTHWELL FOUNDATION – 1033
The HealthWell Foundation ® is an
independent non-profit organization
that provides financial assistance to
insured individuals who cannot afford
their prescription drug copayments,
premiums, deductibles, or other
out-of-pocket healthcare costs. To
date, HealthWell has helped over
150,000 patients living with chronic
and life-altering illnesses afford
the medications they desperately
need. Learn more at www.
healthwellfoundation.org.
HOMECHOICE PARTNERS – 1019
HomeChoice Partners provides service
excellence in Intradialytic Parenteral
Nutrition (IDPN) and Intraperitoneal
Nutrition (IPN) therapies. Our
mulitdisciplinary team provides 24/7
support which includes Registered
Dietitians with extensive renal
experience. Every IDPN/IPN formula
is customized. HCP will guide your

team through the referral process,
initiation, and clinical monitoring of
both therapies.
ICU MEDICAL, INC. – 1123
The Tego Needlefree Hemodialysis
connector by ICU Medical is the
world’s first and only needle-free
connector FDA-cleared for use in
hemodialysis applications. The
Tego creates a mechanically and
microbiologically closed system when
attached to the hub of a catheter,
eliminating open catheter hubs and
lowering the chance of contamination
and infection.
INNOVATIVE DIALYSIS SYSTEMS – 1118
Since 1984, Innovative Dialysis has
been partnering with nephrologists
in joint ventures to build, operate,
and manage dialysis facilities across
the country. Our experience is broad
and ranges from home-only dialysis
programs, to acute programs, to
combined multi-station hemodialysis/
PD centers. Find out more at
www.idsdialysis.com.
INTERNATIONAL SOCIETY OF
NEPHROLOGY – 1228
The ISN is dedicated to pursuing
the worldwide advancement of
kidney care by supporting education,
science and patient health. It strikes
a balance between the developing
and developed worlds in researching,
diagnosing, treating, and preventing
kidney disease. www.theisn.org
KERYX BIOPHARMACEUTICALS, INC.
– 1210
Keryx Biopharmaceuticals is developing
Zerenex (ferric citrate), an oral, ferric
iron-based phosphate binder for the
treatment of hyperphosphatemia in
end-stage renal disease patients. The
Phase 3 clinical program, consisting
of a successfully completed shortterm
study and an ongoing long-term
study, is being conducted under an SPA
agreement with the FDA.
KIBOW BIOTECH, INC. – 1031
An internationally recognized
biotech company based in suburban
Philadelphia, Kibow Biotech specializes
in the development of probiotic dietary
supplements. Our flagship product,
RenadylTM is scientifically formulated
to metabolize nitrogenous waste and
support healthy kidney function. It has
the potential to delay the progression
of chronic kidney disease (CKD) and/or
reduce the need for dialysis.
KIDNEY COMMUNITY EMERGENCY
RESPONSE COALITION – 1029
Comprised of partners from the
entire kidney community, the Kidney
Community Emergency Response
(KCER) Coalition provides technical
assistance to ESRD Networks, CMS
organizations, emergency managers,
and other groups to ensure timely and
efficient emergency preparedness,
response, and recovery for dialysis and
transplant patients, in the event of any
emergency/disaster.
LIBERTY DIALYSIS – 931
Liberty Dialysis is dedicated to
providing an exceptional dialysis
experience for the patient. Our
physician partners enjoy ownership
and decision-making in their
own dialysis clinics; local medical
directors, not business managers,
make clinical policies. We strive
to achieve outstanding quality
outcomes for our patients and
rewarding career experiences for
our caregivers. We are committed to
providing this exceptional experience
in an atmosphere of compassion,
professionalism and respect.
LIBRE & THE SHOWER SHIRT CO.,
LLC – 935
Libre’s clothing is a warm and
comfortable solution for dialysis.
Openings in the arms, chest, or legs
safely allow access to treatment sites.
Sizes: small – 5XL. NKF Price $32.
The SHOWER SHIRT is the only waterresistant
garment designed to protect
dialysis catheters from water while
showering. NKF Conference Price: $37.11
NKF SCM12
LITHOLINK CORPORATION – 1011
Founded in 1995 by Dr. Fredric Coe,
an international thought leader in
kidney stone disease, Litholink is the
only integrated diagnostic testing and
kidney stone disease management
service for physicians of all levels of
experience. It combines state-of-theart
scientific methods, complete
practice management support and
personal consultation with the world’s
leading stone specialists.
MAYO CLINIC– 1028
Mayo Clinic is a not-for-profit medical
practice and medical research group
specializing in treating difficult
patients (tertiary care). Patients are
referred to Mayo Clinic from across
the United States and the world, and
it is known for innovative and effective
treatments.
MEDICAL EDUCATION INSTITUTE – 1124
Medical Education Institute (MEI) is
a nonprofit organization dedicated to
helping people with chronic disease
learn to manage and improve their
health. We conduct health behavior
research and develop evidencebased
patient education materials.
MEI administers Life Options (www.
lifeoptions.org), created Kidney School
(www.kidneyschool.org), Home
Dialysis Central (www.homedialysis.
org), and KDQOL COMPLETE
(www.kdqol-complete.org).
MEDICAL NUTRITION USA – 815
Medical Nutrition USA, known for
their various formulations of Pro-Stat
(liquid protein supplement), develops
nutrition-medicine products for the
nutritionally at risk.
Pro-Stat is clinically proven to improve
protein anabolism in hemodialysis
patients (published in Journal of Renal
Nutrition). Medical Nutrition is a
proud supporter of the AKF’s Patient
Assistance Safety Net Grant Program.
Medical Nutrition USA is now part of
Nutricia (a wholly owned subsidiary
of Danone North America – the global
leader in medical nutrition).
109 109

110
EXHIBITOR PRODUCT/SERVICE DESCRIPTIONS continued
MITSUBISHI TANABE PHARMA – 1001
Mitsubishi Tanabe Pharma is a
research-driven pharmaceutical
company based in Japan dedicated
to creating and delivering innovative
pharmaceuticals for the healthier lives
of people around the world.
Our current mission in the U.S. is
to advance care of kidney disease
through partnership with the
nephrology community. Visit
www.mt-pharma-america.com.
MOM’S MEALS – 934
Mom’s Meals is the #1 fresh-made,
home-delivered meal service,
providing nutritionally balanced meals
to seniors and patients nationwide.
Only Mom’s Meals offers dietitiandeveloped,
chef-prepared meals
with over 70 fresh choices, including
renal, heart-healthy, diabetic-friendly,
gluten-free, and vegetarian menus.
Family-owned Mom’s Meals has been
nourishing independence for over 10
years. www.MomsMeals.com
NATIONAL KIDNEY AND UROLOGIC
DISEASES INFORMATION
CLEARINGHOUSE (NKUDIC) – 1114
The National Kidney and Urologic
Diseases Information Clearinghouse
(NKUDIC) is an information and referral
service of the National Institute of
Diabetes & Digestive & Kidney Diseases
(NIDDK), one of the National Institutes
of Health. The clearinghouse responds
to inquiries, develops and distributes
publications, and provides referrals to
kidney and urologic organizations.
NATIONAL KIDNEY DISEASE
EDUCATION PROGRAM – 914
NKDEP helps to educate health
professionals and the public about
kidney disease detection and
treatment, focusing especially on the
primary care setting. The program
offers tools and materials that help
various types of health professionals
better educate themselves and their
patients about kidney disease.
NATIONAL KIDNEY FOUNDATION – 723
The National Kidney Foundation (NKF)
is the leading organization in the U.S.
dedicated to the awareness, prevention
and treatment of kidney disease for
hundreds of thousands of healthcare
professionals, millions of patients, and
tens of millions of Americans at risk.
Since 1950, the NKF has advanced
kidney health through science, services
and education, providing hope,
connection and support in the fight
against kidney disease.
With local offices throughout the
United States, NKF conducts extensive
public and professional education,
provides free early detection
screenings, advocates for patients
through legislative action, works to
increase organ donation, and supports
research .
To celebrate the 2012 election year, we
are asking you to explore each section
of the NKF booth and CAST YOUR
VOTE for your favorite NKF initiative to
receive a FREE GIFT!
At the NKF booth, you’ll learn more
about:
Patient Support and Education
Check out the NKF website to see
the easy to use online “A – Z Health
Guide,” Kidney Kitchen and vast array
of patient information available,
including the NKF Store where you can
purchase brochures to distribute to
your patients Learn more about “NKF
Cares,” the NKF Patient Information
Help Line, and our Peers program
that connects kidney patients with a
trained mentor and to targeted on-line
CKD stage and kidney failure-specific
information.
Public Health and Awareness
Pick up the schedules for NKF’s Kidney
Early Evaluation Program (KEEP®)
screening in your area and learn
how you can volunteer. Put a team
together and participate in a Kidney
Walk. If you are a golfer, you can
participate in an NKF Cadillac Golf
NKF SCM12
Classic tournament in your area. The
top three winners are invited to Pebble
Beach to compete in the National Finals.
Find out who to contact to become a
presenter at a local health education
program sponsored by the NKF.
Professional Education
Discover how the unique,
interdisciplinary nature of NKF’s
programs creates unmatched
opportunities for Professional
Members to advance careers, and
enhance capabilities. Explore the full
array of NKF educational resources
and practical tools, including free
Smartphone medical apps, for
physicians and other healthcare
professionals. Find the latest NKF
peer-reviewed journals, including the
American Journal of Kidney Diseases
and Advances in Chronic Kidney
Disease as well as printed and online
KDOQI and KDIGO guideline resources,
and free CME/CE activities. Review
dozens of up-to-date educational
brochures and teaching tools for CKD
patients, their families and those
at increased risk for CKD. Ask how
NKF can customize solutions for your
unique and unmet educational needs.
Advocacy
Become part of the “Take Action
Network” and learn how you can get
involved with legislation and public
policy issues. Find out what you can
do to increase funding for patient care
and research, and to “End the Wait!”
by maximizing efforts to shorten the
wait time for your patients who are on
the transplant waiting list.
What Can You Do? – You’ll find
information about how you can
volunteer to help kidney patients and
their families at a local NKF office,
join a local NKF Medical Advisory
Board, and how you can participate in
building awareness of kidney disease
and increasing financial support for
YOUR NKF.

NATIONAL KIDNEY FOUNDATION
PROFESSIONAL COUNCILS – 923
Learn about NKF’s four Professional
Councils and how you can benefit
from membership. Council Executive
Committee members will be available
to discuss upcoming council projects
and resources, current initiatives
in progress, and to answer any
membership questions you may have.
The National Kidney Foundation
Council of Advanced Practitioners
(CAP) provides a diversified, advanced
educational curriculum for nephrology
nurse practitioners, physician
assistants and clinical nurse specialists
and supports the growth of advanced
practitioners coming to nephrology,
as well as those already in practice.
Members educate the public about
this growing sector of the nephrology
team and advocate for health policies
and legislation that support sound
practice and good outcomes for kidney
health professionals and patients. CAP
aims to elevate the voices of PAs, NPs
and CNSs in nephrology to better serve
their patients, enhance their practices
and educate them on innovations in
research and patient care.
The National Kidney Foundation
Council of Nephrology Nurses and
Technicians (CNNT) is a strong
volunteer professional membership
organization that promotes and
participates in the establishment
of public services directed toward
prevention, detection and care of
persons with kidney and/or related
diseases. Members collaborate in the
development of health policies that
impact professional practices and
the delivery of patient care. CNNT
advocates for and contributes to the
professional development of members
through education, networking and the
dissemination of information related
to professional practice and quality of
patient care.
The National Kidney Foundation
Council of Nephrology Social Workers
(CNSW) upholds and supports the
profession of nephrology social
work through advocacy and the
creation of patient and professional
education materials. Members provide
assistance, education and support to
patients and their families in dealing
with the psychosocial stresses and
lifestyle readjustments encountered
by patients in all stages of CKD, and
facilitate treatment programs that
will maximize rehabilitation potential.
CNSW supports the federal regulations
governing ESRD reimbursement in
regard to standards for social work
practice and in the definition of a
qualified social worker.
The National Kidney Foundation
Council on Renal Nutrition (CRN)
is dedicated to promoting quality
nutritional care and education for
kidney patients. Members impact
regulatory and legislative issues, and
actively promote the professional
education of the renal dietitian. CRN
offers frequent opportunities for
collaboration and networking with
colleagues to improve clinical practice
and promote career advancement.
The Council supports and disseminates
nutrition-related research, and
develops patient and professional
public education materials encouraging
quality nutrition care for CKD patients.
NATIONWIDE LABORATORY
SERVICES – 1026
Come join the hundreds of
independent dialysis providers
who already know that Nationwide
Laboratory Services provides superior
value focused on their needs. At
Nationwide Laboratory Services,
we provide clinical AND financial
solutions tailored to independent
dialysis providers. Nationwide
Laboratory Services, the independents’
overwhelming choice for ESRD and
CKD laboratory services!
NEPHROCEUTICALS, LLC – 1010
Discovering and developing sciencebased
nutritional supplements that
promote health in people with chronic
kidney disease, dialysis and heart
disease .
NKF SCM12
NEPHROLOGY NEWS & ISSUES –
1203
Nephrology News & Issues is a peerreviewed
news journal that takes
a global approach to covering the
political, social, and economic issues
surrounding the delivery of dialysis
and transplantation. Stop by the booth
for a complimentary copy of the latest
issue of NN&I and find the latest news
developments in renal care at our
website, www.NephrologyNews.com.
NEPHROLOGY NURSING
CERTIFICATION COMMISSION –
1128
The Nephrology Nursing Certification
Commission (NNCC) exists to establish
credentialing mechanisms to promote
patient safety and to improve the
quality of care provided to nephrology
patients. The Nephrology Nursing
Certification Commission (NNCC)
supports the philosophy that there
should be a diversity of examinations
that will effectively provide the
opportunity for certification at various
levels of education, experience, and
areas of practice within nephrology
nursing.
NEPHROLOGY TIMES – 1126
Nephrology Times (www.
nephrologytimes.com) provides timely,
authoritative, and engaging coverage
of the news that affects nephrology
professionals. We put the latest
clinical advances, emerging trends,
and public policy developments into
context with expert commentary and
analysis. Please visit our booth for
a complimentary copy of our latest
issue!
NEPHROPATH – 1110
Nephropath is a private renal
pathology laboratory offering
more than 30 years of experience
interpreting renal biopsies. Because
we understand the critical effect timeto-diagnosis
can have on the outcome
of many renal diseases, we provide
light, immunofluorescence, and
electron microscopy results the same
day we receive a biopsy. Website:
www.nephropath.com.
111 111

112
EXHIBITOR PRODUCT/SERVICE DESCRIPTIONS continued
NEPHRO-TECH, INC. – 916
Nephro-Tech, Inc. provides high-quality
pharmaceuticals at affordable prices.
Our newest addition, RenaPlex-D ® ,
along with Vital-D Rx ® , treats
vitamin D (25-OH D) deficiency daily.
RenaPlex-D ® is available at $12.00/100
through Nephro-Tech, Inc. We also
sell Calphron ® which is 667mg calcium
acetate and costs $15.00/200 through
Nephro-Tech, Inc. Order online
today at www.nephrotech.com. Call
800.879.4755 for more information.
NUTREPLETION RESOURCES – 1122
NutrePletion Resources has been the
provider of nutritional support to the
renal population for over 25 years. Our
specialized nutrition support therapies
include intradialytic parenteral
nutrition (IDPN) and intraperitoneal
nutrition (IPN). NutrePletion
Resources is the only company to
individualize nutritional prescriptions
for all our patients and to offer two
concentrations of amino acids.
NXSTAGE MEDICAL – 1129
NxStage is leading a movement to
transform renal care. To make it
simpler. To make it portable. To expand
treatment options for clinicians by
overcoming traditional barriers.
NxStage is finding itself at the forefront
of dramatically improved renal care,
thanks to innovative yet simple
therapeutic solutions that benefit
patients, caregivers, and society. For
more information visit
www.nxstage.com.
OTSUKA AMERICA
PHARMACEUTICAL, INC. – 701 & 1116
Otsuka America Pharmaceutical, Inc.
(OAPI) is a successful, innovative,
fast-growing healthcare company that
commercializes Otsuka-discovered
products and other product
opportunities in North America, with
a strong focus on and commitment
to neuroscience, cardiovascular,
oncologic, and gastrointestinal
therapeutic treatments. For additional
information, please visit
www.otsuka–us.com.
PENTEC HEALTH, INC. – 1205
Pentec Health, which started
operations over 25 years ago, is a
national, privately held specialty
infusion services company focused
on providing complex pharmaceutical
products and clinical services to
non-hospitalized patients via cost
effective methods. Pentec Health,
headquartered in Boothwyn,
Pennsylvania, has focused on the
parenteral nutrition therapies of
Intradialytic Parenteral Nutrition
(IDPN) and Intraperitoneal Nutrition
(IPN) for patients with CKD-5 dialysis;
and in addition provides therapies
for patients with chronic pain
management and spasticity.
PFIZER – 1131
At Pfizer, we apply science and our
global resources to improve health and
well-being at every stage of life. Every
day, Pfizer colleagues work across
developed and emerging markets
to advance wellness, prevention,
treatments, and cures that challenge
the most feared diseases of our time.
PROPATH – 1230
ProPath is one of the largest physician
owned pathology group practices
serving nephrologists, transplant
surgeons and others by providing
renal biopsy interpretations. We
provide comprehensive diagnostic
tissue interpretation and consultation
of renal biopsies including light
microscopy, immunohistochemistry,
and electron microscopy. Call
800.258.1253, or visit
www.propath.com for more
information.
NKF SCM12
QUESTCOR PHARMACEUTICALS,
INC. – 801
Questcor Pharmaceuticals is a
biopharmaceutical company whose
lead product, HP Acthar ® Gel
(repository corticotropin injection), is
used in a variety of serious conditions.
The indications include inducing a
diuresis or remission of proteinuria
in nephrotic syndrome without
uremia of the idiopathic type or that
is due to lupus erythematosus. Visit
www.Acthar.com for full prescribing
information.
REATA PHARMACEUTICALS – 717
Reata Pharmaceuticals is evaluating
the effects of bardoxolone methyl
on delaying time to ESRD or
cardiovascular death in Stage 4 CKD
patients with type 2 diabetes in the
Phase 3 BEACON study. Bardoxolone
methyl activates Nrf2, a transcription
factor that drives the production of
anti-inflammatory and antioxidant
mediators, and inhibits the proinflammatory
NF-κB pathway.
RENAL DIETITIANS (RPG) – 1304
With the largest membership of
renal dietitians in the country, Renal
Dietitians (RPG) dietetic practice
group of the Academy of Nutrition
and Dietetics is uniquely situated to
lead the future of renal nutrition. RPG
promotes and supports its members as
the experts within renal nutrition. Visit
us at www.renalnutrition.org.
RENAL PHYSICIANS ASSOCIATION
– 1224
The Renal Physicians Association
is a national organization with the
expertise and successful track record of
pro-actively defending the discipline of
the nephrology practice. Membership
is comprised of healthcare providers in
the subspecialty of internal medicine
known as nephrology. Stop by to
check out RPA’s latest programs and
publications or visit us at
www.renalmd.org .

RENAL & UROLOGY NEWS – 813
Renal & Urology News is a monthly
tabloid with a circulation of 16,000
nephrologists, transplantation
surgeons and urologists. The
publication’s primary editorial
mission is to report on new scientific
developments of interest to these
three specialist groups. News coverage
focuses on medical conferences but
also includes reporting on recently
published papers in peer-reviewed
journals. Various features and
departments complement the news
coverage.
RENAL BUSINESS TODAY – 1117
Renal Business Today ® has an extensive
reach to professionals in the business
of renal care management. The topnotch
editorial includes the latest
business and technology trends, expert
advice, strategic business solutions and
more. Setting the industry benchmark
for editorial, renal professionals turn
to Renal Business Today ® , giving your
product the exposure it needs.
ROCKWELL MEDICAL – 1017
Rockwell manufactures/delivers
Calcitriol (Active Vitamin-D) Injection
in 1mcg and 2mcg vials along with
hemodialysis solutions/powders,
offering CitraPure ® (the only acetatefree
citric-based concentrate for all
hemo-patients), Dri-Sate ® Dry Acid,
RenalPure ® Acid and Bicarbonate,
and SteriLyte ® Liquid Bicarbonate.
Rockwell’s Phase III trial for its novel
SFP-iron-delivery, via dialysate, is
accepting clinical sites.
ROO HEALTHCARE SOLUTIONS – 1022
Roo Healthcare Solutions develops
vascular access covering systems
that improve patient comfort, clinical
efficiency and standard of care.
Our first product, the patented Roo
Defender ® , is an efficient, disposable,
antimicrobial dialysis catheter cover
which protects between treatment
sessions and enhances patient
comfort. Learn more at
www.roohealthcaresolutions.com.
SANOFI – 601
Sanofi, a global and diversified
healthcare leader, discovers, develops
and distributes therapeutic solutions
focused on patients’ needs. Sanofi has
core strengths in the field of healthcare
with seven growth platforms: diabetes
solutions, human vaccines, innovative
drugs, consumer healthcare, emerging
markets, animal health and the new
Genzyme.
SPECTRA LABORATORIES – 1023
Spectra delivers renal-specific testing,
analysis, and reporting with the
reliability you require to ensure the
best outcomes possible for your
patients. Our team of clinical experts,
paired with our patient-centric tools
and resources help you comply with
new industry guidelines.
NKF SCM12
THE GIDEONS INTERNATIONAL – 1226
The Gideons International distributes
white New Testaments with Psalms
and Proverbs to all medical personnel
free of charge .
US RENAL CARE, INC. – 1119
U.S. Renal Care, Inc. works in
partnership with nephrologists to
develop, acquire, and operate quality
dialysis treatment centers. USRC
operates in 12 states, serving 6,200
dialysis patients in 127 centers. We
combine the clinical strengths of our
physician partners with the proven skill
and expertise of U.S. Renal Care.
WATSON PHARMA, INC. – 1302
Watson is a global leader in the
development and distribution of
generic products with a specialized
portfolio of branded pharmaceuticals
focused in urology and women’s
health. Through the passion and
commitment to its customers, Watson
seeks to leverage its technologies in
drug development and delivery to help
people live better.
113 113

114
NOW SHOWING IN THE EXHIBIT HALL
Exhibitor Showcase!
FRIDAY, MAY 11
BOOTH #1135
TAKE A BREAK FROM THE CROWDED EXHIBIT HALL FLOOR!
Enjoy a comfortable, small group setting
and interactive learning format at an
Exhibitor Showcase – Booth #1135.
12:15pm – 12:50pm Understanding and Managing Hyponatermia: A Specific Approach to Treatment
Supported by Otsuka America Pharmaceutical, Inc.
1:15pm – 1:50pm Insights in the Management of Secondary Hyperparathyroidism in Patients on Dialysis
Supported by Amgen
SATURDAY, MAY 12
8:15am – 8:50am Update on Anemia Management in Dialysis
Supported by Affymax/Takeda Pharmaceuticals USA, Inc.
NKF SCM12

FACULTY
Kenneth Abreo, MD
Louisiana State University Health
Sciences Center
Shreveport, LA
Keli Adis, CCS-P
Henry Ford Health Systems
Westaland, MI
Anil Agarwal, MD, FNKF
The Ohio State University
Dublin, OH
Rajiv Agarwal, MBBS, MD, FAHA,
FASN, FASH
Indiana University School of Medicine
Veterans Affairs Medical Center
Indianapolis, IN
Enver Akalin, MD
Montefiore Medical Center
Albert Einstein College of Medicine
New York, NY
Michael Allon, MD
University of Alabama at Birmingham
Birmingham, AL
Tracy Anderson-Haag, PharmD, BCPS
Hennepin County Medical Center
Minneapolis, MN
Kenneth Andreoni, MD
The Ohio State University
Columbus, OH
Gerald B. Appel, MD
Columbia Presbyterian Hospital
New York, NY
Akhtar Ashfaq, MD
Amgen
Thousand Oaks, CA
Arif Asif, MD, FNKF
University of Miami School of Medicine
Miami, FL
Juan Carlos Ayus, MD, FACP, FASN
Renal Consultants of Houston
Houston, TX
George Bakris, MD
University of Chicago
Pritzker School of Medicine
Chicago, IL
Lynda Ball, RN, MSN, CNN
Fresenius Medical Care –
North America
Everett, WA
Kyle Ballew, DPM
Mexia, TX
James Balow, MD
National Institute of Diabetes and
Digestive and Kidney Diseases
Bethesda, MD
Joanne Bargman, MD, FRCPC
Toronto General Hospital
University of Toronto
Toronto, ON, Canada
Gerald Beathard, MD, PhD, FASN
Lifeline Vascular Access
Houston, TX
Bryan N. Becker, MD, MMM, FACP,
FNKF
University of Illinois
Chicago, IL
Lorraine Bell, MD, FRCPC
McGill University Health Centre
Montreal Children’s Hospital
Montreal, Quebec, Canada
Deborah Benner, MA, RD, CSR
DaVita, Inc.
Yorba Linda, CA
Laurie E. Benton, PhD, MPAS, PA-C, RN
Scott & White Hospital
Temple, TX
Judith Beto, PhD, RD, FADA
Loyola University Medical Center
Maywood, IL
Roy Bloom, MD
University of Pennsylvania
Philadelphia, PA
Carl Boethel, MD
Scott & White Clinic
Temple, TX
Steve Bogatz, MBA, MSW, LCSW
Fresenius Medical Services
Central Connecticut Dialysis Center
Meridan, CT
W. Kline Bolton, MD, FASN
University of Virginia Hospital
Charlottesville, VA
Andrew Bomback, MD, MPH
Columbia University Medical Center
New York, NY
Marc Brazie, MD
Metropolitan Nephrology Associates
Alexandria, VA
Patrick Brophy, MD
University of Iowa
Iowa City, IA
NKF SCM12
Rebecca Brosch, RD, LD, BS
DaVita, Inc.
Cypress, TX
Teri Browne, PhD, MSW, LSW
University of South Carolina
College of Social Work
Columbia, SC
John Burnett, MD
Mayo Foundation
Rochester, MN
Jerrilynn Burrowes, PhD, RD, CDN
C.W. Post Campus of
Long Island University
Brookville, NY
Mary Beth Callahan, ACSW, LCSW,
MSSW
Dallas Transplant Institute
Dallas, TX
Mona Calvo, PhD
U.S. Food and Drug Administration
Laurel, MD
Vito Campese, MD
University of Southern California
Medical Center
Los Angeles, CA
Katie E. Cardone, PharmD, BCACP
Albany College of Pharmacy and Health
Sciences
Albany, NY
Hugh Carey, MD
Metabolism Associates
New Haven, CT
Juan Carrero, PharmD, PhD, MBA
Karolinska Institute
Huddinge, Stockholm, Sweden
Ellen Case, MSW, LICSW
Mayo Clinic
Rochester, MN
Lee Cauble, RN, BSN, BSB
Dialysis Clinics, Inc.
Tucson, AZ
Kerri Cavanaugh, MD, MHS, FNKF
Vanderbilt University Medical Center
Nashville, TN
Michael Cervantes, MA, MSW, LCSW,
NSW-C
Fresenius Medical Care –
North America
Rancho Cucamonga, CA
115 115

116
FACULTY continued
Micah R. Chan, MD, MPH, FNKF
University of Wisconsin
School of Medicine and Public Health
Madison, WI
Lakhmir Chawla, MD
George Washington University
Washington, DC
Jianghua Chen, MD, FCSN
Zhejiang University
Hangzhou, Zhejiang, China
Alfred Cheung, MD
University of Utah
Salt Lake City, UT
Michael J. Choi, MD, FNKF
Johns Hopkins University School
of Medicine
Baltimore, MD
Louise Clement, MS, RD, CSR, LD
Fresenius Medical Care –
North America
Lubbock, TX
Carolyn Cochran, RD, LD, MS, CDE
Dallas Nephrology Associates
Dallas, TX
Lewis Cohen, MD
Tufts University School of Medicine
Springfield, MA
Lisa Colaianni
Washington Regional Transplant
Community
Annandale, VA
Jill Cole, MSW, LMSW
Greenfield Health Systems –
Henry Ford Health System
Bingham Farms, MI
Allan J. Collins, MD, FACP
Hennepin Faculty Associates
Minneapolis, MN
Danilo Concepcion, CHT, CCHT, CBNT
St. Joseph Hospital
Orange, CA
Luis Concepcion, MD
Scott & White Hospital
Temple, TX
Sandra Coorough, ACSW, LCSW,
NSW-C
Phoenix Children’s Hospital
Phoenix, AZ
Daniel Coyne, MD
Washington University
School of Medicine
Saint Louis, MO
William Cushman, MD, FACP, FAHA,
FASH
Veterans Affairs Medical Center
Memphis, TN
William Dager, PharmD, BCPS
University of California Davis
Medical Center
Sacramento, CA
Ingemar Davidson, MD, PhD
University of Texas
Southwestern Medical Center
Dallas, TX
Connie Davis, MD
University of Washington
Seattle, WA
Jane Davis, MSN, DNP, NP
University of Alabama at Birmingham
Birmingham, AL
Angela Degnan, MSW, LCSW, LSCSW
The Children’s Mercy Hospital
Kansas City, KS
Sevag Demirjian, MD
Cleveland Clinic
Cleveland, OH
Peter B. DeOreo, MD, FACP
Centers for Dialysis Care
Cleveland, OH
Maya Doyle, MSW, LCSW
Children’s Hospital at Montefiore
New York, NY
Amy Dwyer, MD, FACP
University of Louisville
Louisville, KY
Kim English, MSN, RN, FNP
Scott & White Memorial Hospital
Killeen, TX
Lisa Farris, DNP, CRNP
Kirklin Clinic
University of Alabama at Birmingham
Birmingham, AL
Harvey Feldman, MD
Nova Southeastern University
Ft. Lauderdale, FL
Maria Ferris, MD, MPH, PhD
University of North Carolina
Chapel Hill, NC
NKF SCM12
Fernando C. Fervenza, MD, PhD, FNKF
Mayo Clinic
Rochester, MN
Frederic Finkelstein, MD, FNKF
Hospital of St. Raphael
Yale University Renal Research Institute
New Haven, CT
Catherine Firanek, MBA, BSN, RN
Baxter Healthcare Corporation
Deerfield, IL
Agnes Fogo, MD
Vanderbilt University Medical Center
Nashville, TN
Nancy Foley, RN, CNN
Renal Ventures Management
Lakewood, CO
Charles Foulks, MD
University of Oklahoma – Tulsa
Tulsa, OK
Kelly Frank, RN, BSN
Iowa Department of Inspections
and Appeals
Des Moines, IA
Marion Franz, MS, RD, CDE
Nutrition Concepts by Franz, Inc.
Minneapolis, MN
Barry Freedman, MD
Wake Forest School of Medicine
Winston-Salem, NC
Linda Fried, MD, MPH, FNKF
VA Pittsburgh Healthcare System
Pittsburgh, PA
Trisha Fuhrman, MS, RD, LD, FADA
Coram
Ballwin, MO
Michael Germain, MD
Baystate Medical Center
Springfield, MA
Jeffrey Giullian, MD
South Denver Nephrology Associates
Denver, CO
Richard J. Glassock, MD
University of California – Los Angeles
Los Angeles, CA
Joel Glickman, MD
University of Pennsylvania
Philadelphia, PA
Elaine Go, RN, NP, MSN, CNN
St. Joseph Hospital
Orange, CA

Christina Goalby, MSW
Washington University
School of Medicine
Saint Louis, MO
Thomas A. Golper, MD, FACP, FASN
Vanderbilt Medical Center
Nashville, TN
Janelle Gonyea, BS, RD, LD
Mayo Clinic Dialysis System
Rochester, MN
Simin Goral, MD
University of Pennsylvania
Philadelphia, PA
Bonnie Greenspan, RN, BSN, MBA
BBG Consulting, LLC
Alexandria, VA
Philip Gregory, PharmD, FACN
Natural Medicines
Comprehensive Database
Creighton University
Omaha, NE
Stephen Grimm, DDS
Howard University College of Dentistry
Washington, DC
Kimberly Gusse, MSW, LMSW, ACSW
Helen DeVos Children’s Hospital
Grand Rapids, MI
Lisa Gutekunst, MSEd, RD, CSR, CDN
Cleve-Hill Dialysis
Buffalo, NY
Lisa Hall, MSSW, LICSW
Northwest Renal Network #16
Seattle, WA
Kevin Harned, MD
University of Louisville
Louisville, KY
Amber Harper, MSW, LCSW, NSW-C
ESRD Network #13
Oklahoma City, OK
Sarah Harper, CCHT
University of Virginia
Lynchburg Dialysis
Appomattox, VA
Alexis Harris, MD
Nephropathology Associates
Little Rock, AR
Lori Hartwell
Renal Support Network
Glendale, CA
Jeanette Hasse, PhD, RD, FADA, CNSC
Baylor University Medical Center
Dallas, TX
Rebecca Hays, MSW, APSW, NSW-C
University of Wisconsin
Hospital and Clinics
Madison, WI
Aaron Herold, MSW, LICSW
Northwest Kidney Centers
Seattle, WA
Jonathan Himmelfarb, MD
University of Washington
Seattle, WA
Sangeeta Hingorani, MD, MPH
University of Washington
Seattle, WA
Diana Hlebovy, RN, BSN, CNH, CNN
Fresenius Medical Care –
North America
Elyria, OH
Sue Hoekwater, LMSW, MSW
Regional Dialysis Services
Midland, MI
R. Michael Hofmann, MD
University of Wisconsin
Madison, WI
Susan Hou, MD, FACP
Loyola University Stritch
School of Medicine
River Forest, IL
Andrew Howard, MD, FACP
Metropolitan Nephrology Associates
Alexandria, VA
John Hubbard, PhD, PT
Texas A&M Health Science Center
College of Medicine
Temple, TX
Adriana Hung, MD, MPH
Vanderbilt University Medical Center
Nashville, TN
Craig Hurwitz, MD
Northern Nephrology and
Hypertension
Plattsburgh, NY
Cathy Husser, BS, MEd, RN, CNN
University of Virginia
Lynchburg, VA
Lesley Inker, MD, MS
Tufts Medical Center
Boston, MA
Joachim Ix, MD, MAS, FASN
UC San Diego
VA San Diego Healthcare System
San Diego, CA
NKF SCM12
Sophie Jamal, MD, PhD, FRCPC
Women’s College Research Institute
Toronto, ON, Canada
Charles Jennette, MD
University of North Carolina
Chapel Hill, NC
R. Allan Jhagroo, MD
The University of Wisconsin
Madison, WI
Kirsten Johansen, MD
San Francisco Veterans Affairs
Medical Center
San Francisco, CA
Rebecca Johnson, PhD
Children’s Mercy Hospitals and Clinics
Kansas City, MO
Sharon Johnson, MS, RD, LD, JD
State of Florida and
DaVita Healthcare
Orlando, FL
Stephanie Johnstone, LCSW, MSW
Fresenius Medical Care –
North America
La Jolla, CA
Luis Juncos, MD, FASN, FAHA
University of Mississippi Medical Center
Jackson, MS
Claudine Jurkovitz, MD, MPH
Christiana Care Center Health System
Newark, DE
Kamyar Kalantar-Zadeh, MD, MPH,
PhD, FNKF
University of California – Los Angeles
Schools of Medicine & Public Health
Torrance, CA
Kamel Kamel, MD, FRCP(C)
St. Michael’s Hospital
Toronto, ON, Canada
Judith Kari, MSSW, ACSW, LICSW
Centers for Medicare &
Medicaid Services
Baltimore, MD
Bertram Kasiske, MD
Hennepin County Medical Center
Minneapolis, MN
Mary Pat Kelly, MS, RD, RN, RNP
Veterans Administration
Palo Alto Health Care System
Palo Alto, CA
Kay Kendall, MSW, LISW, ACSW,
CCTSW
Cleveland Clinic
Cleveland, OH
117 117

118
FACULTY continued
Jackie Kite, MSW, LICSW
Seattle Children’s Hospital
Seattle, WA
Stephen Knohl, MD
Upstate Medical University
Syracuse, NY
Nina Kolbe, RD, CSR, LD
Washington, DC
Dawn Koonkongsatian, MSN Ed,
RN, CNN
Fresenius Medical Care –
North America
Las Vegas, NV
Jeffrey Kopp, MD
National Institute of Diabetes and
Digestive and Kidney Diseases
National Institutes of Health
Bethesda, MD
Nelson Kopyt, DO, FACP, FNKF, ABIM
Lehigh Valley Hospital
Allentown, PA
Csaba P. Kovesdy, MD, FASN
Salem Veterans Affairs Medical Center
Salem, VA
Holly Kramer, MD, MPH
Loyola University Medical Center
Maywood, IL
Raymond Krediet, MD, PhD
Academic Medical Center
University of Amsterdam
Amsterdam, The Netherlands
Alison Kregness, RN, CNN
Western Pacific Renal Network #17
Novato, CA
Karen Kritsch, PhD, RD
University of Wisconsin
Hospital and Clinics
Madison, WI
Dana Kumjian, MD
Medical Associates of Savannah, P.C.
Savannah, GA
Kathy Lahr, BS, RD
DaVita, Inc.
Roseville, CA
David Lammert, BMEd, MM
Scott & White Memorial Hospital
Temple, TX
Carol Langford, MD, MHS
Cleveland Clinic
Cleveland, OH
Timothy Latimer, MSSW, LCSW
William S. Middleton
Veterans Memorial Hospital
Madison, WI
Timmy Lee, MD, MSPH, FACP, FASN
University of Cincinnati
Cincinnati, OH
David Leehey, MD, FACP
Hines-Loyola Medical Center
Hines, IL
Janeen Leon, MS, RD, LD
MetroHealth Medical Center
Cleveland, OH
Mary Leonard, MD, MSCE
Children’s Hospital of Philadelphia
Philadelphia, PA
Thomas Lepetich, MSW, LCSW
DSI – Philadelphia
Philadelphia, PA
Marianna Leung, PharmD, BSc
Providence Health Care
Vancouver, BC, Canada
Nelson Leung, MD
Mayo Clinic
Rochester, MN
Philip K.T. Li, MD, FRCP, FACP, FNKF
Chinese University of Hong Kong
Hong Kong, China
Mike Lilly, MD
University of Maryland
Baltimore, MD
Anita Lipman, MS, BSN, CNN
Satellite Healthcare WellBound
Farmingdale, NJ
Kathleen Liu, MD, PhD, MAS
University of California
San Francisco, CA
Charmaine E. Lok, MD, MSc, FNKF
Toronto General Hospital
University of Toronto
Toronto, ON, Canada
Gloria Ramos Lozano, MPA, MSW, ACSW
Fresenius Dialysis
Los Angeles, CA
Eileen MacFarlane, BSN, RN, CNN
Satellite Healthcare –
WellBound of Mercer
Hamilton, NJ
Hartmut Malluche, MD, FACP
University of Kentucky
Lexington, KY
NKF SCM12
Barbara Weis Malone, FNP, RN, CFNP
University of Colorado
Health Sciences Center
Golden, CO
Bradley Manton, MSW
Carolina Dialysis
Carrboro, NC
Kevin J. Martin, MB, BCh, FACP
St. Louis University
Health Sciences Center
Saint Louis, MO
Linda McCann, BS, RD, CSR
Satellite Healthcare, Inc.
San Jose, CA
Maureen McCarthy, MPH, RD, CSR, LD
Oregon Health & Science University
Portland, OR
Melissa McCool, MSW, LCSW
STI Innovations
Encinitas, CA
Peter McCullough, MD, MPH, FACC,
FACP, FNKF
St. John Providence Health System
Novi, MI
Matthew McDonough, MS
Florida Medical Quality Assurance, Inc.
(FMQAI) –
The Florida ESRD Network
Tampa, FL
Mary McKinney, MSW, MPA,
LCSW, ACSW
Montefiore Medical Center
Bronx, NY
Anthony Meade, BSc, MND, APD
Central Northern Adelaide Renal and
Transplantation Service
Adelaide, SA, Australia
Rajnish Mehrotra, MBBS, MD, FNKF
Harbor-UCLA Medical Center
Torrance, CA
Erika Meredith, PharmD
Emory University Hospital
Atlanta, GA
Klemens Meyer, MD
Tufts Medical Center
Boston, MA
Miriam Michael, MD
Howard University
Washington, DC

Rosemarie Miller, RN
New York State Department of Health
Cary, NC
Tracy Greene Mintz, MA, MSW, LCSW
Senior Care Training
Redondo Beach, CA
Sharon Moe, MD, FASN, FACP, FAHA
Indiana University
Indianapolis, IN
Louise Moist, MD, MSc, FRCPC
University of Western Ontario
London, ON, Canada
Jean Moody-Williams, RN, MPP
Centers for Medicare &
Medicaid Services
Baltimore, MD
Eileen Moore, BS, CNSD, RD, LD
Pentec Health
Parma, OH
Ranjani Moorthi, MD, MPH, MS
Indiana University
Indianapolis, IN
Stuart Mott, BA, BS
DCI
Fulaton, MO
Bruce Mueller, PharmD, FCCP,
FASN, FNKF
University of Michigan
College of Pharmacy
Ann Arbor, MI
Mohanaram Narayanan, MD, FASN
Scott & White Clinic
Temple, TX
Annette Needham, NP-C, CNN-NP,
CCTC, MSN
Florida Hospital
Orlando, FL
Christina Nelms, MS, RD, CSP,
CNSC, LD
Clarkson College
Kearney, NE
Sharon Nessim, MD, MSc
McGill University
Jewish General Hospital
Montreal, Quebec, Canada
Shari Neul, PhD
Baylor College of Medicine
Houston, TX
Marianne Neumann, RN, CNN
IPRO – ESRD Network of New York
Albany, NY
Mark Neumann, MS
Nephrology News & Issues
Scottsdale, AZ
Vandana Niyyar, MD, FASN
Emory University
School of Medicine
Atlanta, GA
Thomas Nolin, PharmD, PhD, FCCP
University of Pittsburgh
School of Pharmacy
Pittsburgh, PA
Linda Noto, RD, BS
Pentec Health
Boothwyn, PA
Joyce O’Dea, RD, CSR
DaVita, Inc.
West Hartford, CT
Ann O’Hare, MD
University of Washington
Seattle, WA
Jennifer O’Neill, BSc
The Adelaide & Meath Hospital
incorporating the
National Children’s Hospital
Dublin, Ireland
Ali Olyaei, PharmD
Oregon State Univeristy
Portland, OR
Paul Palevsky, MD, FNKF
Veterans Affairs
Pittsburgh Healthcare System
Pittsburgh, PA
Alan Pao, MD
Stanford University
Palo Alto, CA
Heather Paradis, CHT
Liberty Dialysis
Council, ID
Rulan Parekh, MD, MS
The Hospital for Sick Children
Toronto, ON, Canada
Chirag Parikh, MD, PhD
Yale University
West Haven, CT
Chhaya Patel, MA, RD, CSR
DaVita, Inc.
Walnut Creek, CA
Priti Patel, MD, MPH
Centers for Disease Control and
Prevention
Atlanta, GA
Uptal Patel, MD
Duke Clinical Research Institute
Durham, NC
Jessie Pavlinac, RD, CSR, LD
Oregon Health & Science University
Portland, OR
NKF SCM12
Danielle Peabody, MSW, LICSW
Mayo Clinic
Rochester, MN
Leanne Peace, MSW, LCSW, MHA
University of Missouri
Columbia, MO
Eileen Peacock, RN, MSN, CNN,
CIC, CPHQ
DaVita, Inc.
Maple Glen, PA
Mark Perazella, MD, FNKF
Yale University School of Medicine
New Haven, CT
Pablo Pergola, MD, PhD
Renal Associates
San Antonio, TX
Gary Petingola, RSW, BA, BSW
Hôpital Régional de Sudbury Regional
Hospital
Sudbury, ON, Canada
Jessica Phipps, MSW, LSW
Fresenius Medical Care –
North America
South Plainfield, NJ
Lynn Poole, FNP-BC
McLean, VA
Michael Powe, BS
American Academy of
Physician Assistants
Alexandria, VA
Megan Prescott, MSW, LCSW
University of Colorado Hospital
Highlands Ranch, CO
Lynn Puma, LCSW
Levine Children’s Hospital
Huntersville, NC
Susan Quaggin, MD
Samuel Lunenfeld Research Institute
Toronto, ON, Canada
Alejandro Quiroga, MD
Helen DeVos Children’s Hospital
Grand Rapids, MI
Jai Radhakrishnan, MBBS, MD, MS
Columbia University
New York, NY
Vernadette Ramos, CCLS, BS
St. Joseph Hospital
Orange, CA
Forest Rawls, CCHT, CHT
Emory Healthcare
Atlanta, GA
119 119

120
FACULTY continued
Heather Reich, MD, PhD
Toronto General Hospital
University of Toronto
Toronto, ON, Canada
James Riley, JD
McGuireWoods, LLP
Chicago, IL
Kathy Riley, MSBS, PA-C
Dermatology Specialists of Virginia
Reston, VA
Eberhard Ritz, MD
International Society of Nephrology
Heidelberg, Germany
Bruce Robinson, MD, MS, FACP
Arbor Research Collaborative
for Health
Ann Arbor, MI
Alex Rosenblum, BS, RN, CNN
Fresenius Medical Care –
North America
Coppell, TX
Mitchell Rosner, MD, FACP
University of Virginia
Charlottesville, VA
Jamie Ross, MD, FACP
University of California Davis
School of Medicine
Sacramento, CA
Lainie Friedman Ross, MD, PhD
University of Chicago
Chicago, IL
Mario Rubin, MD, FNKF
Massachusetts General Hospital
Boston, MA
George Saab, MD
Washington University School of
Medicine
Saint Louis, MO
Bharat Sachdeva, MD
Louisiana State University
Shreveport, LA
Loay Salman, MD
University of Miami
Miami, FL
Anthony Samaha, MD
The Kidney and Hypertension Center
Cincinnati, OH
Heidi Schaefer, MD, FNKF
Vanderbilt University Medical Center
Nashville, TN
Dori Schatell, MS
Medical Education Institute
Madison, WI
Jesse Schold, PhD, M. Stat
Cleveland Clinic Foundation
Cleveland, OH
Wendy Schrag, MSW, LMSW, ACSW
Fresenius Medical Care –
North America
Newton, KS
Martin Schreiber, MD
Cleveland Clinic Foundation
Cleveland, OH
Sarah Schuh, MSW, LICSW
Hennepin County Medical Center
Minneapolis, MN
Nancy Scott, BS
Dialysis Patient Citizens
Newark, DE
Dorry Segev, MD, PHD
Johns Hopkins University
Baltimore, MD
Maritsa Serlemitsos-Day, PharmD
Howard University College of
Pharmacy
Howard University Hospital
Washington, DC
Sanjeev Sethi, MD, PhD
Mayo Clinic
Rochester, MN
Amma Sewaah-Bonsu, MSN, DNP, NP-C
Nephrology Associates of
Central Florida
Orlando, FL
Amit Sharma, MD, FACP, FASN
Pacific Renal Research Institute
Meridian, ID
Diana Shelkov, CHT
Fresenius Medical Care –
North America
Englewood, NJ
Paula Shelton, RN, BSN
University of Louisville
Louisville, KY
Michael Shlipak, MD, MPH, FNKF
San Francisco Veterans Affairs
Medical Center
University of California
San Francisco, CA
NKF SCM12
Edward Siew, MD, MSCI
Vanderbilt University Medical Center
Nashville, TN
Vernon Silva, MSW, LCSW, NSW-C
Kidney Dialysis Center of
West Los Angeles
Los Angeles, CA
Terri Silverman, ASN, RN, CNN
Fresenius Medical Care –
North America
Schenectady, NY
Christopher Simon, MSW, LCSW-C
Independent Dialysis Foundation, Inc.
Baltimore, MD
Shane Simon, MBA
DaVita, Inc.
El Segundo, CA
Renata Sledge, MSW, LCSW
RAI Care Center
Fairview Heights, IL
Vivek Soi, MD
Henry Ford Health System
Detroit, MI
Ulrich Specks, MD
Mayo Clinic
Rochester, MN
Teri Spencer, RN
TB Spencer Consulting, LLC
Fallbrook, CA
John Sperati, MD, MHS, FNKF
Johns Hopkins University
School of Medicine
Baltimore, MD
David Spiegel, MD
University of Colorado
Denver, CO
Wendy St. Peter, PharmD, FCCP, FASN,
BCPS, FNKF
University of Minnesota
Minneapolis, MN
Randall Starling, MD, MPH
Cleveland Clinic Foundation
Cleveland, OH
Alison Steiber, PhD, RD, LD
Case Western Reserve University
Cleveland, OH
Peter Stenvinkel, MD, PhD
Karolinska Institutet
Stockholm, Sweden

Brian Stephany, MD
Cleveland Clinic
Cleveland, OH
Stephanie Stewart, MBA, MSW,
LICSW, NSW-C
Mayo Clinic Health System
Rochester, MN
Kristin Stockard, MSW, LICSW, NSW-C
Seattle Children’s Hospital
Seattle, WA
Chef Duane Sunwold
Spokane Community College
Spokane, WA
Lynda A. Szczech, MD, MSCE,
FASN, FNKF
Duke University School of Medicine
Durham, NC
Harold Szerlip, MD, FACP, FCCP,
FASN, FNKF
The University of Arizona
College of Medicine
Tucson, AZ
Manjula Kurella Tamura, MD, MPH
Stanford University
Palo Alto, CA
W.H. Wilson Tang, MD, FACC, FAHA
Cleveland Clinic Foundation
Cleveland, OH
Eric Taylor, MD, MSc
Maine Medical Center
Portland, ME
Victor Test, MD, FACP
University of Oklahoma
School of Community Medicine
Tulsa, OK
Ravi Thadhani, MD, MPH
Massachusetts General Hospital
Boston, MA
Charuhas V. Thakar, MD, FNKF
University of Cincinnati
Cincinnati Veterans Affairs
Medical Center
Cincinnati, OH
Charlie Thomas, MSW, LCSW, ACSW
Banner Good Samaritan
Medical Center
Chandler, AZ
Aliza Thompson, MD
Food and Drug Administration
Silver Spring, MD
Raymond Townsend, MD
University of Pennsylvania
Philadelphia, PA
Laura Troidle, BS, PA-C
Metabolism Associates
New Haven Center for Assessment and
Policy Development (CAPD)
Branford, CT
Mandy Trolinger, MS, RD, PA-C
Denver Nephrology
Denver, CO
Katherine Tuttle, MD, FASN, FACP
Providence Sacred Heart Medical
Center and Children’s Hospital
Spokane, WA
Aris Urbanes, MD
Lifeline Vascular Access
Grosse Pointe Park, MI
Tushar Vachharajani, MD, FACP, FASN
W. G. (Bill) Hefner VA Medical Center
Salisbury, NC
Suzann VanBuskirk, BSN, BAN,
RN, CNN
DaVita, Inc.
Elkton, MD
Joseph Vassalotti, MD, FASN
National Kidney Foundation
New York, NY
Joseph G. Verbalis, MD
Georgetown University
Washington, DC
Bradley A. Warady, MD, FNKF
Children’s Mercy Hospital
Kansas City, MO
Richard Ward, PhD
University of Louisville
Louisville, KY
Amy D. Waterman, PhD
Washington University
School of Medicine
Saint Louis, MO
Emily Watson, MSW
Satellite Healthcare
Santa Cruz, CA
Lawrence Weisberg, MD
Cooper University Hospital
Camden, NJ
Catherine Wells, DNP, ACNP-BC,
CNN-NP
University of Mississippi Health Care
Jackson, MS
Adam Whaley-Connell, DO, MSPH,
FNKF, FASN
University of Missouri
Columbia School of Medicine
Columbia, MO
NKF SCM12
Karen Wiesen, MS, RD, LD
Washington University
School of Medicine
Saint Louis, MO
Dawn Wilson, BS, MSW, ACSW,
LCSW, NSW-C
DaVita, Inc.
Covington, VA
Cheryl Winterich, BS
Centers for Dialysis Care
Shaker Heights, OH
Alexander Wiseman, MD, FACP
University of Colorado
Health Sciences Center
Denver, CO
Jay Wish, MD
University Hospitals
Case Medical Center
Cleveland, OH
Beth Witten, MSW, ACSW, LSCSW
Witten and Associates, LLC
Overland Park, KS
Myles Wolf, MD, MMSC
University of Miami Miller
School of Medicine
Miami, FL
William Wolfe, MSW
Women’s Institute for Family Health
of Philadelphia
Philadelphia, PA
Karl Womer, MD
Johns Hopkins University
School of Medicine
Baltimore, MD
Jerry Yee, MD, FACP, FASN, FNKF
Henry Ford Health System
Detroit, MI
Alexander Yevzlin, MD
University of Wisconsin
Madison, WI
Troy Zimmerman, BA
National Kidney Foundation
Washington, DC
Kim Zuber, MS, PA-C
Metropolitan Nephrology
Alexandria, VA
121 121

122
GAYLORD NATIONAL RESORT, WASHNGTON, D.C.
HOTEL MAP
Overview Map
NKF SCM12

KEY
Elevators
Restrooms
Phones
Smoking
Hotel within a Hotel
Fort Washington
Boardroom
Baltimore
Hotel Ballroom Level
Hotel Registration
Ground Level Restaurants & Retail
Annapolis
1
2
3
B
4 C
5 D
Woodrow Wilson
Ballroom
4 3 2 1
A
3 2 1
Cherry Blossom
Ballroom
Prince George’s Exhibition Hall
9
Maryland Ballroom
Chesapeake
6
5 Conference Rooms
4 B
L K J
3
D
I
12
H
11
2 A
G
10
1
F
C
E
9 8
D
7
C 6
B 5
A
4
3 2
Stage
1
Magnolia
A
11
10
13
15 14
12
1
1 2 3
B
3
NKF SCM12
2
Camellia
Convention Center
8
5
7
4
Azalea
C
National Harbor Conference Rooms
Convention Center Conference Facilities
6
A
Prince George’s Exhibition Hall
National Harbor
Conference Rooms
B
Presidential
Boardroom
D
Potomac Ballroom
C
D
6
5
4
3
2
1
E
Level 3
Level 2
Level 1
123 123

124
02-77-4714_CBC
Help Your Patients
Connect to Each Other
Invite your patients to call today!
855.653.7337 (855.NKF.PEER)
or email nkfpeers@kidney.org
Visit www.kidney.org/patients/peers to learn
more and to access free educational materials.
NKF SCM12
PEERS
Lending Support
A new program that connects patients who want
support with someone who has been there.
• A national, telephone-based peer support
program from the National Kidney Foundation
•
Helps patients adjust to living with chronic kidney
disease, kidney failure, or a kidney transplant
• Matches people in need of support with peer
mentors who are positive role models
• Includes an online CKD stage and/or treatmentspecific
education component. (Accessible by all
patients, not just those paired with a mentor.)

Check Out What’s
New With KEEP –
KEEP®
KIDNEY EARLY EVALUATION PROGRAM
Topics / Presenters:
1. Access to Healthcare in the KEEP – Andrew Bomback, MD, MPH
The largest detection program in the U.S. ,
reaching over 170,000 participants!
Healthcare Access in the Kidney Early Evaluation Program:
Implications on Outcomes
Saturday, May 12, 2012 9:30am — 11:00am
Chairs: Peter McCullough, MD, MPH, FNKF and Adam Whaley-Connell, DO, MSPH, FNKF
2. KEEP: The Role of Healthcare Access in Risk Factor Control – Claudine Jurkovitz, MD
3. KEEP: The Role of Healthcare Access on Mortality – Georges Saab, MD
KEEP Poster in Exhibit Hall
Poster #170
Associations Between Access to Care and Awareness of Chronic Kidney Disease
Anuja Shah, MD, Linda F. Fried, MD, MPH, Shu-Cheng Chen, MS, MPH,
Yang Qiu, MS, Suying Li, PhD, Kerri L. Cavanaugh, MD, MHS, Keith C. Norris, MD,
Adam T. Whaley-Connell, DO, MSPH, Peter A. McCullough, MD, MPH, and
Rajnish Mehrotra, MD, FNKF, on behalf of the NKF’s KEEP Investigators.
Visit NKF Booth #723
Pick up the latest issue of the KEEP Annual Data Report.
CD-ROM Version of KEEP Report available only at this meeting!
SPECIAL THANKS TO OUR SPONSORS

NOTES

NOTES

NOTES

NOTES

MARK YOUR CALENDARS...
NATIONAL KIDNEY FOUNDATION
2013 SPRING CLINICAL MEETINGS
April 2–6, 2013
Walt Disney World Swan and Dolphin
Orlando, FL
www.nkfclinicalmeetings.org

All NKF members receive:
Highlights for each membership type:
• P hysicians
– Subscriptions to both the monthly
American Journal of Kidney Diseases and the bimonthly
Advances in Chronic Kidney Disease (a $450 savings!)
• Council of Nephrology Social Workers – Receive the Journal
of Nephrology Social Work and apply for Nephrology Social
Worker certification (NSW-C) through the NKF
• Council of Nephrology Nurses and Technicians –
Bimonthly issues of Advances in Chronic Kidney Disease
and the new online Conversion Calculators resource
• Council on Renal Nutrition – Bimonthly issues of the
Journal of Renal Nutrition and a copy of the Pocket Guide
to Nutrition Assessment of the Patient with Chronic
Kidney Disease, 4th Ed.
• Council of Advanced Practitioners – Receive a copy
of NKF’s respected Primer on Kidney Diseases, a valuable
resource examining all aspects of kidney and related
diseases (an $85 value!)
There’s an NKF
professional membership
just right for you!
JOIN NKF TODAY
Thousands of healthcare professionals in the U.S. and around the
world, and more than 1,500 at the Spring Clinical Meetings, are taking
advantage of the resources and savings NKF membership offers.
Save with a
2-Year Membership!
• Discounts on NKF publications, NKF Store materials, events and educational programs
•• Eligibility to apply for research grants, educational stipends and award recognition
Three easy ways to JOIN TODAY!
Stop by the membership desk in the Registration Area
Visit www.kidney.org and click on Get Involved
Call 888.JOIN.NKF
© 2011 National Kidney Foundation, Inc. All rights reserved.

Your new online destination for all Amgen product
reimbursement and patient support services
Amgen Assist ® and Amgen Inc. do not guarantee success in obtaining
reimbursement. Third-party payment for medical products and services
is affected by numerous factors, not all of which can be anticipated or
resolved by our Amgen Assist ® staff.
© 2012 Amgen Inc. All rights reserved. 62200-R1-V1 3-12
• Insurance Verifi cation
• Prior Authorization
• Patient Assistance
Program Information
• Billing and Claims
Processing Support
Making ccess easier.
www.amgenassist.com
1-800-272-9376